Aijaz Ahmed, MD

4.7/5

21 Patient Ratings

229 Patient Reviews

Aijaz Ahmed, MD

Hepatologist, Transplant hepatologist

Professor of Medicine (Gastroenterology and Hepatology)

View Professional Summary

Additional Languages Spoken:

Urdu

Insurance Coverage

Resources for Referring Physicians

Biography

Dr. Ahmed is an internationally recognized hepatologist with expertise in the treatment of acute and chronic liver diseases. He is a board-certified specialist in gastroenterology and hepatology, transplant hepatology, and obesity medicine. Currently, he serves as the Medical Director of the Adult Liver Transplant Program at Stanford University.

Dr. Ahmed graduated from Dow Medical College, Karachi, Pakistan. He completed his residency training in Internal Medicine at Brown University, Providence, RI and fellowship training in Gastroenterology and Hepatology at Stanford University. During his fellowship, he focused on clinical and research training in General and Transplant Hepatology.

For patients under his care, Dr. Ahmed remains dedicated to creating a personalized, comprehensive, and above-all a compassionate treatment plan. He outlines the diagnostic and follow-up management pathway in an individualized fashion; he updates his patients and their family/support at each step of the decision-making process; and he focuses on prioritizing the wishes of his patients and their family/support for an optimal outcome and quality of life.

Dr. Ahmed remains clinically active and has been instrumental in establishing a wide network of hepatology outreach clinics in remote and underserved regions of California and Nevada.

In addition to his patient care responsibilities, Dr. Ahmed remains committed to the educational mission of Stanford ford University. He remains deeply interested in mentoring trainees and students al levels from undergraduates to trainee physicians and junior colleagues. Dr. Ahmed has received several teaching awards during his career.

Dr. Ahmed’s research interests include 1) multidisciplinary approach to nonalcoholic fatty liver disease (NAFLD), 2) disparities in the management of chronic liver disease, 3) improving screening and management of hepatocellular carcinoma (HCC), and 4) outcomes research in NAFLD, HCC, viral hepatitis, alcoholic liver disease, and liver transplantation. He heads a busy and productive outcomes research team. In addition, he collaborates with basic scientists and is participating in several translational research projects at Stanford University.

He has published his findings in textbooks, abstracts, case reports, and high- profile medical journals including Gastroenterology, Journal of Hepatology, Hepatology American Journal of Gastroenterology, and other well-renowned peer-reviewed publications.

Dr. Ahmed and his team has made presentations to his peers at many national and international conferences: the American Association for the Study of Liver Disease, International Liver Congress, European Association for the Study of the Liver, Asian Pacific Association for the Study of the Liver, and more. His presentations have addressed leading-edge approaches to the treatment of chronic liver disease, liver cancer, and liver failure. He also has presented his insights into the gastrointestinal impact of COVID-19.

For his clinical, research, and teaching achievements, Dr. Ahmed has earned extensive recognition. His honors include being named as one of America’s Top Physicians by the Consumers’ Research Council of America.

He is an active member of the American Gastroenterological Association and the American Association for the Study of Liver Diseases.

View Full Biography

Professional Summary

Education & Certifications

Fellowship: Stanford University Division of Gastroenterology and Hepatology (1999) CA
Board Certification: American Board of Internal Medicine, Gastroenterology (2023)
Board Certification: American Board of Internal Medicine, Transplant Hepatology (2022)

Board Certification: American Board of Obesity Medicine, Obesity Medicine (2020)

Residency: Brown University Internal Medicine Residency (1996) RI

Internship: University of Minnesota Medical Center Family Medicine Residency (1993) MN

Internship: Dow Medical College (1991) Pakistan

Medical Education: Dow Medical College (1990) Pakistan

Administrative Appointments

Member, Stanford Diabetes Research Center (2018 - Present)

Publications

Treatment strategies for chronic hepatitis C: Update since the 1997 National Institutes of Health Consensus Development Conference
Ahmed, A., & Keeffe, E. B. (1999). Treatment strategies for chronic hepatitis C: Update since the 1997 National Institutes of Health Consensus Development Conference. Presented at the 1st University-of-California-San-Francisco/Stanford Asia Liver Symposium, HONG KONG,HONG KONG,HONG KONG,HONG KONG,HONG KONG,HONG KONG,HONG KONG,HONG KONG: WILEY-BLACKWELL PUBLISHING, INC.
A novel technique for endoscopic removal of expandable biliary Wallstent
Ahmed, A., Keeffe, E. B., & Imperial, J. C. (1999). A novel technique for endoscopic removal of expandable biliary Wallstent. GASTROINTESTINAL ENDOSCOPY, 50(2), 279–81.
An uncommon aetiology of perforated gastric ulcer
Ahmad, M., Vaidyan, P., & Ahmed, A. (1999). An uncommon aetiology of perforated gastric ulcer. POSTGRADUATE MEDICAL JOURNAL, 75(880), 113–14.

The successful use of telemedicine in acute variceal hemorrhage
Ahmed, A., Slosberg, E., Prasad, P., Keeffe, E. B., & Imperial, J. C. (1999). The successful use of telemedicine in acute variceal hemorrhage. JOURNAL OF CLINICAL GASTROENTEROLOGY, 29(2), 212–213.

Cost-effective evaluation of acute viral hepatitis
Ahmed, A., & Keeffe, E. B. (2000). Cost-effective evaluation of acute viral hepatitis. WESTERN JOURNAL OF MEDICINE, 172(1), 29–32.

Differential diagnosis of gallstone-induced complications
Ahmad, M., Cheung, R. C., Keeffe, E. B., & Ahmed, A. (2000). Differential diagnosis of gallstone-induced complications. SOUTHERN MEDICAL JOURNAL, 93(3), 261–264.

Management of gallstones and their complications
Ahmed, A., Cheung, R. C., & Keeffe, E. B. (2000). Management of gallstones and their complications. AMERICAN FAMILY PHYSICIAN, 61(6), 1673–80.

The differential diagnosis of eosinophilic esophagitis
Ahmad, M., Soetikno, R. M., & Ahmed, A. (2000). The differential diagnosis of eosinophilic esophagitis. JOURNAL OF CLINICAL GASTROENTEROLOGY, 30(3), 242–244.

A novel endoscopic appearance of idiopathic eosinophilic esophagitis
Ahmed, A., Matsui, S., & Soetikno, R. (2000). A novel endoscopic appearance of idiopathic eosinophilic esophagitis. ENDOSCOPY, 32(6), S33–S33.

Delayed fatal hemorrhage from pseudoaneurysm of the hepatic artery after percutaneous liver biopsy
Ahmed, A., Samuels, S. L., Keeffe, E. B., & Cheung, R. C. (2001). Delayed fatal hemorrhage from pseudoaneurysm of the hepatic artery after percutaneous liver biopsy. AMERICAN JOURNAL OF GASTROENTEROLOGY, 96(1), 233–237.

Overview of interferon therapy for chronic hepatitis C.
Ahmed, A., & Keeffe, E. B. (1999). Overview of interferon therapy for chronic hepatitis C. Clinics in Liver Disease, 3(4), 757–73.

Hepatitis C virus and liver transplantation.
Ahmed, A., & Keeffe, E. B. (2001). Hepatitis C virus and liver transplantation. Clinics in Liver Disease, 5(4), 1073–90.

Liver transplantation: Evolving patient selection criteria
Yu, A. S., Ahmed, A., & Keeffe, E. B. (2001). Liver transplantation: Evolving patient selection criteria. CANADIAN JOURNAL OF GASTROENTEROLOGY, 15(11), 729–38.

The epidemiology of hepatitis C virus infection
Yen, T., Keeffe, E. B., & Ahmed, A. (2003). The epidemiology of hepatitis C virus infection. JOURNAL OF CLINICAL GASTROENTEROLOGY, 36(1), 47–53.

Prophylaxis against chemotherapy-induced reactivation of hepatitis B virus infection with lamivudine
Simpson, N. D., Simpson, P. W., Ahmed, A. M., Nguyen, M. H., Garcia, G., Keeffe, E. B., & Ahmed, A. (2003). Prophylaxis against chemotherapy-induced reactivation of hepatitis B virus infection with lamivudine. JOURNAL OF CLINICAL GASTROENTEROLOGY, 37(1), 68–71.

Living donor liver transplantation in a patient with hepatic epithelioid hemangioendothelioma
Simpson, N. D., Ahmed, A. M., Simpson, P. W., Parkar, J. A., Keeffe, E. B., & Ahmed, A. (2003). Living donor liver transplantation in a patient with hepatic epithelioid hemangioendothelioma. JOURNAL OF CLINICAL GASTROENTEROLOGY, 37(4), 349–350.

Hypoglycemic coma in a pregnant woman in association with hepatitis B virus carrier state and hepatocellular carcinoma
Ahmed, A., & Keeffe, E. B. (2004). Hypoglycemic coma in a pregnant woman in association with hepatitis B virus carrier state and hepatocellular carcinoma. JOURNAL OF CLINICAL GASTROENTEROLOGY, 38(2), 135–136.

Update on chronic hepatitis C.
Ahmed, A., & Keeffe, E. B. (2003). Update on chronic hepatitis C. Comprehensive Therapy, 29(4), 224–32.

Chronic hepatitis C with normal aminotransferase levels
Ahmed, A., & Keeffe, E. B. (2004). Chronic hepatitis C with normal aminotransferase levels. GASTROENTEROLOGY, 126(5), 1409–15.

Older age and liver transplantation: A review
Keswani, R. N., Ahmed, A., & Keeffe, E. B. (2004). Older age and liver transplantation: A review. LIVER TRANSPLANTATION, 10(8), 957–67.

Endoscopic approach to the treatment of gastrointestinal bleeding.
Lim, J. K., & Ahmed, A. (2004). Endoscopic approach to the treatment of gastrointestinal bleeding. Techniques in Vascular and Interventional Radiology, 7(3), 123–29.

Progressive asymptomatic occlusion of a TIPS in a patient with Budd-Chiari syndrome
Sze, D. Y., Frisoli, J. K., Macksood, D. J., Dovichi, E. A., Ahmed, A., & Keeffe, E. B. (2006). Progressive asymptomatic occlusion of a TIPS in a patient with Budd-Chiari syndrome. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 17(4), 737–39.

Portal, spienic, and superior mesenteric vein thrombosis in a patient with latent essential thrombocythemia and hyperhomocysteinemia
Berk, D. R., & Ahmed, A. (2006). Portal, spienic, and superior mesenteric vein thrombosis in a patient with latent essential thrombocythemia and hyperhomocysteinemia. JOURNAL OF CLINICAL GASTROENTEROLOGY, 40(3), 227–228.

Global transcriptional response to interferon is a determinant of HCV treatment outcome and is modified by race
He, X.-S., Ji, X., Hale, M. B., Cheung, R., Ahmed, A., Guo, Y., … Greenberg, H. B. (2006). Global transcriptional response to interferon is a determinant of HCV treatment outcome and is modified by race. HEPATOLOGY, 44(2), 352–59.

Dermatologic disorders associated with chronic hepatitis C: Effect of interferon therapy
Berk, D. R., Bayliss Mallory, S., Keeffe, E. B., & Ahmed, A. (2007). Dermatologic disorders associated with chronic hepatitis C: Effect of interferon therapy. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 5(2), 142–151.

Current indications and contraindications for liver transplantation.
Ahmed, A., & Keeffe, E. B. (2007). Current indications and contraindications for liver transplantation. Clinics in Liver Disease, 11(2), 227–47.

Long-term survival of patients with unresectable hepatocellular carcinoma treated with transcatheter arterial chemoinfusion
Ha, B. Y., Ahmed, A., Sze, D. Y., Razavi, M. K., Simpson, N., Keeffe, E. B., & Nguyen, M. H. (2007). Long-term survival of patients with unresectable hepatocellular carcinoma treated with transcatheter arterial chemoinfusion. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 26(6), 839–46.

Bidirectionally Adjustable TIPS Reduction by Parallel Stent and Stent-Graft Deployment
Sze, D. Y., Hwang, G. L., Kao, J. S., Frisoli, J. K., Kee, S. T. W., Razavi, M. K., & Ahmed, A. (2008). Bidirectionally Adjustable TIPS Reduction by Parallel Stent and Stent-Graft Deployment. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 19(11), 1653–58.

Prevalence of Colorectal Neoplasms in Asian Americans
Lam, K. D., Garcia, R. T., Nguyen, L. H., Trinh, H., Triadafilopoulos, G., Phan, J. T., … Nguyen, M. H. (2009). Prevalence of Colorectal Neoplasms in Asian Americans. DIGESTIVE DISEASES AND SCIENCES, 54(1), 160–67.

Adenovirus-Induced Acute Liver Failure
Rothenberg, M., Cheung, R., & Ahmed, A. (2009). Adenovirus-Induced Acute Liver Failure. DIGESTIVE DISEASES AND SCIENCES, 54(2), 218–21.

Management of Biliary Strictures Following Liver Transplantation
Alexopoulos, S. P., Henningsen, J. A., Jeffrey, R. B., Bonham, C. A., Ahmed, A., & Gonzalez, S. A. (2009). Management of Biliary Strictures Following Liver Transplantation. DIGESTIVE DISEASES AND SCIENCES, 54(1), 25–27.

Ultra-Deep Pyrosequencing of Hepatitis B Virus Quasispecies from Nucleoside and Nucleotide Reverse-Transcriptase Inhibitor (NRTI)-Treated Patients and NRTI-Naive Patients
Margeridon-Thermet, S., Shulman, N. S., Ahmed, A., Shahriar, R., Liu, T., Wang, C., … Shafer, R. W. (2009). Ultra-Deep Pyrosequencing of Hepatitis B Virus Quasispecies from Nucleoside and Nucleotide Reverse-Transcriptase Inhibitor (NRTI)-Treated Patients and NRTI-Naive Patients. JOURNAL OF INFECTIOUS DISEASES, 199(9), 1275–85.

Transarterial Chemoinfusion for Hepatocellular Carcinoma as Downstaging Therapy and a Bridge toward Liver Transplantation
De Luna, W., Sze, D. Y., Ahmed, A., Ha, B. Y., Ayoub, W., Keeffe, E. B., … Nguyen, M. H. (2009). Transarterial Chemoinfusion for Hepatocellular Carcinoma as Downstaging Therapy and a Bridge toward Liver Transplantation. AMERICAN JOURNAL OF TRANSPLANTATION, 9(5), 1158–68.

The Asymptomatic Outpatient with Abnormal Liver Function Tests
Krier, M., & Ahmed, A. (2009). The Asymptomatic Outpatient with Abnormal Liver Function Tests. CLINICS IN LIVER DISEASE, 13(2), 167-?

Pseudomyxoma Peritonei Masquerading As Ascites Secondary to Alcoholic Cirrhosis
Nguyen, T., & Ahmed, A. (2009). Pseudomyxoma Peritonei Masquerading As Ascites Secondary to Alcoholic Cirrhosis. DIGESTIVE DISEASES AND SCIENCES, 54(10), 2053–55.

Diabetes Mellitus Increases the Risk of Mortality Following Liver Transplantation Independent of MELD Score
Samuelson, A. L., Lee, M., Kamal, A., Keeffe, E. B., & Ahmed, A. (2010). Diabetes Mellitus Increases the Risk of Mortality Following Liver Transplantation Independent of MELD Score. DIGESTIVE DISEASES AND SCIENCES, 55(7), 2089–94.

Ethnic Differences in Viral Dominance Patterns in Patients with Hepatitis B Virus and Hepatitis C Virus Dual Infection
Nguyen, L. H., Ko, S., Wong, S. S., Tran, P. S., Trinh, H. N., Garcia, R. T., … Nguyen, M. H. (2011). Ethnic Differences in Viral Dominance Patterns in Patients with Hepatitis B Virus and Hepatitis C Virus Dual Infection. HEPATOLOGY, 53(6), 1839–45.

High Rate of Complete Viral Suppression With Combination Therapy in Patients With Chronic Hepatitis B and Prior Treatment Failure
Wong, C. R., Trinh, H. N., Yip, B., Nguyen, H. A., Garcia, R. T., Ahmed, A., … Nguyen, M. H. (2011). High Rate of Complete Viral Suppression With Combination Therapy in Patients With Chronic Hepatitis B and Prior Treatment Failure. JOURNAL OF CLINICAL GASTROENTEROLOGY, 45(10), 900–905.

Comparison of the Frequency of Coronary Artery Disease in Alcohol-Related Versus Non-Alcohol-Related Endstage Liver Disease
Patel, S., Kiefer, T. L., Ahmed, A., Ali, Z. A., Tremmel, J. A., Lee, D. P., … Fearon, W. F. (2011). Comparison of the Frequency of Coronary Artery Disease in Alcohol-Related Versus Non-Alcohol-Related Endstage Liver Disease. AMERICAN JOURNAL OF CARDIOLOGY, 108(11), 1552–55.

Prospective study of risk factors for hepatitis C virus acquisition by Caucasian, Hispanic, and Asian American patients
Ho, E. Y., Ha, N. B., Ahmed, A., Ayoub, W., Daugherty, T., Garcia, G., … Nguyen, M. H. (2012). Prospective study of risk factors for hepatitis C virus acquisition by Caucasian, Hispanic, and Asian American patients. JOURNAL OF VIRAL HEPATITIS, 19(2), E105–E111.

Risk factors for hepatocellular carcinoma in patients with chronic liver disease: a case-control study
Ha, N. B., Ha, N. B., Ahmed, A., Ayoub, W., Daugherty, T. J., Chang, E. T., … Nguyen, M. H. (2012). Risk factors for hepatocellular carcinoma in patients with chronic liver disease: a case-control study. CANCER CAUSES & CONTROL, 23(3), 455–462.

Incidence of Hepatocellular Carcinoma Among US Patients With Cirrhosis of Viral or Nonviral Etiologies
Mair, R. D., Valenzuela, A., Ha, N. B., Ayoub, W. S., Daugherty, T., Lutchman, G. A., … Nguyen, M. H. (2012). Incidence of Hepatocellular Carcinoma Among US Patients With Cirrhosis of Viral or Nonviral Etiologies. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 10(12), 1412–17.

High Frequency of Recurrent Viremia After Hepatitis B e Antigen Seroconversion and Consolidation Therapy
Chaung, K. T., Ha, N. B., Trinh, H. N., Garcia, R. T., Nguyen, H. A., Nguyen, K. K., … Nguyen, M. H. (2012). High Frequency of Recurrent Viremia After Hepatitis B e Antigen Seroconversion and Consolidation Therapy. JOURNAL OF CLINICAL GASTROENTEROLOGY, 46(10), 865–70.

Tenofovir Monotherapy and Tenofovir Plus Entecavir Combination as Rescue Therapy for Entecavir Partial Responders
Yip, B., Chaung, K., Wong, C. R., Trinh, H. N., Nguyen, H. A., Ahmed, A., … Nguyen, M. H. (2012). Tenofovir Monotherapy and Tenofovir Plus Entecavir Combination as Rescue Therapy for Entecavir Partial Responders. DIGESTIVE DISEASES AND SCIENCES, 57(11), 3011–16.

Low hepatitis B envelope antigen seroconversion rate in chronic hepatitis B patients on long-term entecavir 0.5 mg daily in routine clinical practice
Liu, A., Ha, N. B., Lin, B., Yip, B., Trinh, H. N., Nguyen, H. A., … Nguyen, M. H. (2013). Low hepatitis B envelope antigen seroconversion rate in chronic hepatitis B patients on long-term entecavir 0.5 mg daily in routine clinical practice. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 25(3), 338–43.

Precore and basal core promoter mutations in Asian American patients with hepatitis B e antigen-positive chronic hepatitis B
VuTien, P., Trinh, H. N., Nguyen, K., Garcia, R. T., Nguyen, H. A., Levitt, B. S., … Nguyen, M. H. (2013). Precore and basal core promoter mutations in Asian American patients with hepatitis B e antigen-positive chronic hepatitis B. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 37(4), 464–72.

Low incidence of hepatitis B e antigen seroconversion in patients treated with oral nucleos(t)ides in routine practice.
Lin, B., Ha, N. B., Liu, A., Trinh, H. N., Nguyen, H. A., Nguyen, K. K., … Nguyen, M. H. (2013). Low incidence of hepatitis B e antigen seroconversion in patients treated with oral nucleos(t)ides in routine practice. Journal of Gastroenterology and Hepatology, 28(5), 855–60.

Splenic rupture: An unusual complication of colonoscopy
Ahmed, A., Eller, P. M., & Schiffman, F. J. (1997). Splenic rupture: An unusual complication of colonoscopy. AMERICAN JOURNAL OF GASTROENTEROLOGY, 92(7), 1201–4.

A fatal case of Rhodotorula meningitis in AIDS.
Ahmed, A., Aggarwal, M., Chiu, R., Ramratnam, B., Rinaldi, M., & Flanigan, T. P. (1998). A fatal case of Rhodotorula meningitis in AIDS. Medicine and Health, Rhode Island, 81(1), 22–23.

Bloody diarrhea caused by Plesiomonas shigelloides proctitis in a human immunodeficiency virus-infected patient
Ahmad, M., Aggarwal, M., & Ahmed, A. (1998). Bloody diarrhea caused by Plesiomonas shigelloides proctitis in a human immunodeficiency virus-infected patient. CLINICAL INFECTIOUS DISEASES, 27(3), 657–57.

Asymptomatic elevation of aminotransferase levels and fatty liver secondary to heterozygous hypobetalipoproteinemia
Ahmed, A., & Keeffe, E. B. (1998). Asymptomatic elevation of aminotransferase levels and fatty liver secondary to heterozygous hypobetalipoproteinemia. AMERICAN JOURNAL OF GASTROENTEROLOGY, 93(12), 2598–99.

Lamivudine therapy for chemotherapy-induced reactivation of hepatitis B virus infection
Ahmed, A., & Keeffe, E. B. (1999). Lamivudine therapy for chemotherapy-induced reactivation of hepatitis B virus infection. AMERICAN JOURNAL OF GASTROENTEROLOGY, 94(1), 249–51.

RISK FACTORS FOR HEPATOCELLULAR CARCINOMA AMONG PATIENTS WITH UNDERLYING CHRONIC LIVER DISEASE: A PROSPECTIVE STUDY
Ha, N. B., Ha, N. B., Ahmed, A., Ayoub, W. S., Daugherty, T., Lutchman, G. A., … Nguyen, M. H. (2010). RISK FACTORS FOR HEPATOCELLULAR CARCINOMA AMONG PATIENTS WITH UNDERLYING CHRONIC LIVER DISEASE: A PROSPECTIVE STUDY. HEPATOLOGY, 52(4), 682A–682A.

LOW PREVALENCE OF HEPATITIS B VIRUS REVERSE TRANSCRIPTASE MUTATIONS IN TREATMENT-NAiVE PATIENTS WITH CHRONIC HEPATITIS B USING INNO-LIPA HBV DR3 IN A MULTICENTER STUDY
Nguyen, M. H., Trinh, H. N., Garcia, R. T., Nguyen, H. A., Nguyen, K., Cooper, A. D., … Ahmed, A. (2010). LOW PREVALENCE OF HEPATITIS B VIRUS REVERSE TRANSCRIPTASE MUTATIONS IN TREATMENT-NAiVE PATIENTS WITH CHRONIC HEPATITIS B USING INNO-LIPA HBV DR3 IN A MULTICENTER STUDY. HEPATOLOGY. BOSTON,MA,MA,MA,MA,MA,MA,MA,MA,MA,MA,MA,MA,MA: WILEY-BLACKWELL.

HEPATITIS B VIRUS (HBV) REVERSE TRANSCRIPTASE MUTATION IS RARE IN TREATMENT-NAIVE PATIENTS WITH CHRONIC HEPATITIS B (CHB): A PROSPECTIVE MULTICENTER STUDY USING INNO-LIPA HBV DR3 ASSAY
Nguyen, M. H., Trinh, H. N., Garcia, R. T., Nguyen, H. A., Levitt, B. S., Cooper, A. D., … Da Silveira, E. B. (2011). HEPATITIS B VIRUS (HBV) REVERSE TRANSCRIPTASE MUTATION IS RARE IN TREATMENT-NAIVE PATIENTS WITH CHRONIC HEPATITIS B (CHB): A PROSPECTIVE MULTICENTER STUDY USING INNO-LIPA HBV DR3 ASSAY. Presented at the 62nd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), SAN FRANCISCO,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA: WILEY-BLACKWELL.

HEPATOCELLULAR CARCINOMA (HCC) INCIDENCE IN US PATIENTS WITH VIRAL OR NON-VIRAL ETIOLOGY OF CIRRHOSIS
Mair, R. D., Valenzuela, A., Ha, N. B., Ahmed, A., Ayoub, W. S., Daugherty, T., … Nguyen, M. H. (2011). HEPATOCELLULAR CARCINOMA (HCC) INCIDENCE IN US PATIENTS WITH VIRAL OR NON-VIRAL ETIOLOGY OF CIRRHOSIS. Presented at the 62nd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), SAN FRANCISCO,CA,CA,CA,CA,CA,CA: WILEY-BLACKWELL.

Higher rates of hepatitis B surface antigen (HBsAg) seroclearance in males and in hepatitis B e-antigen negative chronic hepatitis B (CHB) among treatment naive patients in a large multicenter US cohort study
Nguyen, L. H., Sonu, I. S., Kin, K. C., Trinh, H. N., Li, J., Zhang, J. Q., … Nguyen, M. H. (2012). Higher rates of hepatitis B surface antigen (HBsAg) seroclearance in males and in hepatitis B e-antigen negative chronic hepatitis B (CHB) among treatment naive patients in a large multicenter US cohort study. Presented at the 63rd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), BOSTON,MA,MA,MA,MA,MA,MA,MA,MA: WILEY-BLACKWELL.

Incidence and Risk Factors in the Development of Hepatocellular Carcinoma (HCC) in Non-Cirrhotic and Cirrhotic Patients with Chronic Hepatitis B (CHB): Results of a Multicenter US Cohort Study
Sonu, I. S., Nguyen, L. H., Chen, C., Kin, K. C., Ha, N. B., Trinh, H. N., … Nguyen, M. H. (2012). Incidence and Risk Factors in the Development of Hepatocellular Carcinoma (HCC) in Non-Cirrhotic and Cirrhotic Patients with Chronic Hepatitis B (CHB): Results of a Multicenter US Cohort Study. Presented at the 63rd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), BOSTON,MA,MA,MA,MA,MA,MA,MA,MA,MA,MA,MA,MA: WILEY-BLACKWELL.

Should we throw fat on the fire? Comment
Ahmed, A., & Triadafilopoulos, G. (1999). Should we throw fat on the fire? Comment. INFLAMMATORY BOWEL DISEASES, 5(3), 236–237.

Sustained virological response to interferon-based antiviral therapy by viral genotype in recurrent hepatitis C patients following liver transplantation
Waechter, A., Williams, J., Lee, J., Shapiro, L., Lee, M., Kamal, A., … Ahmed, A. (2007). Sustained virological response to interferon-based antiviral therapy by viral genotype in recurrent hepatitis C patients following liver transplantation. Presented at the 72nd Annual Meeting of the American-College-of-Gastroenterology, PHILADELPHIA,PA,PA,PA,PA,PA,PA,PA,PA,PA,PA: NATURE PUBLISHING GROUP.

Incidence and Predictors of Recurrent Hepatocellular Carcinoma (HCC) Following Partial Hepatectomy
Vergara, A. M. V., Gallo, A., Nghiem Ha, N., Bonham, C., Esquivel, C., Concepcion, W., … Mindie Nguyen, M. (2011). Incidence and Predictors of Recurrent Hepatocellular Carcinoma (HCC) Following Partial Hepatectomy. Presented at the 76th Annual Scientific Meeting of the American-College-of-Gastroenterology, WASHINGTON,DC,DC,DC,DC,DC,DC,DC,DC,DC,DC,DC,DC,DC,DC,DC,DC,DC,DC: NATURE PUBLISHING GROUP.

Long term outcomes of liver transplantation in a high-MELD cohort
Lee, J., Lee, M., Shapiro, L., Yang, A. L., Lapasaran, A. S., Parvez, S., … Ahmed, A. (2007). Long term outcomes of liver transplantation in a high-MELD cohort. HEPATOLOGY. BOSTON,MA,MA,MA,MA,MA,MA,MA,MA,MA,MA,MA,MA,MA: WILEY-BLACKWELL.

The pre-operative utility of dobutamine stress echocardiography in patients undergoing liver transplantation
Shapiro, L., Lee, M., Lee, J., Lapasaran, A. S., Fearon, W., Kamal, A., & Ahmed, A. (2007). The pre-operative utility of dobutamine stress echocardiography in patients undergoing liver transplantation. Presented at the 72nd Annual Meeting of the American-College-of-Gastroenterology, PHILADELPHIA,PA,PA,PA,PA,PA,PA,PA,PA,PA,PA,PA,PA,PA: NATURE PUBLISHING GROUP.

Diminutive colon polyps in Asians are more likely to be adenomatous compared to non-Asians
Lam, K. D., Nguyen, M. H., Trinh, H. N., Nguyen, L. H., Nguyen, K. K., Nguyen, H. A., … Garcia, R. T. (2005). Diminutive colon polyps in Asians are more likely to be adenomatous compared to non-Asians. AMERICAN JOURNAL OF GASTROENTEROLOGY. HONOLULU,HI,HI,HI,HI,HI,HI,HI,HI,HI,HI,HI,HI: NATURE PUBLISHING GROUP.

LOW INCIDENCE OF HEPATITIS B E ANTIGEN (HBEAG) SEROCONVERSION WITH ORAL MONOTHERAPY IN CHRONIC HEPATITIS B (CHB) TREATMENT-NAiVE PATIENTS AT YEAR 1 IN CLINICAL PRACTICE
Lin, B., Ha, N. B., Liu, A., Trinh, H. N., Nguyen, H. A., Nguyen, K., … Nguyen, M. H. (2011). LOW INCIDENCE OF HEPATITIS B E ANTIGEN (HBEAG) SEROCONVERSION WITH ORAL MONOTHERAPY IN CHRONIC HEPATITIS B (CHB) TREATMENT-NAiVE PATIENTS AT YEAR 1 IN CLINICAL PRACTICE. Presented at the 62nd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), SAN FRANCISCO,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA: WILEY-BLACKWELL.

RAPID COMPLETE VIRAL SUPPRESSION WITH COMBINATION THERAPY IN 109 TREATMENT-EXPERIENCED PATIENTS WITH CHRONIC HEPATITIS B
Wong, C. R., Trinh, H. N., Yip, B., Nguyen, H. A., Garcia, R. T., Ahmed, A., … Nguyen, M. H. (2010). RAPID COMPLETE VIRAL SUPPRESSION WITH COMBINATION THERAPY IN 109 TREATMENT-EXPERIENCED PATIENTS WITH CHRONIC HEPATITIS B. HEPATOLOGY, 52(4), 544A–544A.

A pharmacoeconomic analysis of the registration trials: Peginterferon alfa-2a plus ribvarin versus peginterferon alfa-2b plus ribavarin for treatment of genotype 1 chronic hepatitis C
Kamal, A., Lim, J. K., Crockett, S., & Ahmed, A. (2005). A pharmacoeconomic analysis of the registration trials: Peginterferon alfa-2a plus ribvarin versus peginterferon alfa-2b plus ribavarin for treatment of genotype 1 chronic hepatitis C. HEPATOLOGY, 42(4), 352A–352A.

Significant histologic disease in HBV-infected patients with normal to minimally elevated ALT levels at initial evaluation
Nguyen, M. H., Trinh, H., Garcia, R. T., Ahmed, A., & Keeffe, E. B. (2005). Significant histologic disease in HBV-infected patients with normal to minimally elevated ALT levels at initial evaluation. HEPATOLOGY, 42(4), 593A–593A.

Treatment outcomes of transcatheter arterial chemoinfusion (TACI) in patients with unresectable hepatocellular carcinoma (HCC)
Choi, B. Y., Ahmed, A., Razavi, M., Sze, D., Simpson, N., Garcia, R. T., … Nguyen, M. H. (2004). Treatment outcomes of transcatheter arterial chemoinfusion (TACI) in patients with unresectable hepatocellular carcinoma (HCC). AMERICAN JOURNAL OF GASTROENTEROLOGY, 99(10), S83–S83.

Adefovir (ADV) Partial Response in Patients with Chronic Hepatitis B (CHB): Switch Versus Add-On Therapy
Yip, B., Huy Trinh, H., Khanh Nguyen, K., Huy Nguyen, H., Garcia, R., Keeffe, E., … Mindie Nguyen, M. (2011). Adefovir (ADV) Partial Response in Patients with Chronic Hepatitis B (CHB): Switch Versus Add-On Therapy. Presented at the 76th Annual Scientific Meeting of the American-College-of-Gastroenterology, WASHINGTON,DC,DC,DC,DC: NATURE PUBLISHING GROUP.

Disease Presentation and Treatment in Patients with Hepatocellular Carcinoma (HCC) Associated with Hepatitis B Virus (HBV/HCC) and Patients with Hepatitis C Virus Associated HCC (HCV/HCC)
Wantuck, J. M., Ha, N. B., Yip, B., Lin, H., Lee, P., Ahmed, A., & Nguyen, M. H. (2012). Disease Presentation and Treatment in Patients with Hepatocellular Carcinoma (HCC) Associated with Hepatitis B Virus (HBV/HCC) and Patients with Hepatitis C Virus Associated HCC (HCV/HCC). Presented at the 63rd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), BOSTON,MA,MA,MA,MA,MA,MA,MA: WILEY-BLACKWELL.

The role of recombinant human erythropoietin (epoetin alfa) in the management of ribavirin (RBV)-induced anemia
Ahmed, A., Nguyen, M., Keswani, R. N., Grossi, J., & Keeffe, E. B. (2002). The role of recombinant human erythropoietin (epoetin alfa) in the management of ribavirin (RBV)-induced anemia. AMERICAN JOURNAL OF GASTROENTEROLOGY, 97(9), S104–S104.

Treatment, outcomes of transcatheter arterial chemoinfusion (TACI) in patients with unresectable hepatocellular carcinoma (HCC) prior to orthotropic liver transplantation.
de Luna, W., Ha, B. Y., Ahmed, A., Sze, D., Keeffe, E. B., & Nguyen, M. H. (2007). Treatment, outcomes of transcatheter arterial chemoinfusion (TACI) in patients with unresectable hepatocellular carcinoma (HCC) prior to orthotropic liver transplantation. HEPATOLOGY. BOSTON,MA,MA: WILEY-BLACKWELL.

Treatment outcomes of transcatheter arterial chemoinfusion (TACI) in patients with unresectable hepatocellular carcinoma (HCC) prior to orthotropic liver transplantation
de Lunq, W., Choi, B. Y., Ahmed, A., Sze, D., Keefe, E. B., & Nguyen, M. H. (2007). Treatment outcomes of transcatheter arterial chemoinfusion (TACI) in patients with unresectable hepatocellular carcinoma (HCC) prior to orthotropic liver transplantation. Presented at the 72nd Annual Meeting of the American-College-of-Gastroenterology, PHILADELPHIA,PA: NATURE PUBLISHING GROUP.

Tuberculous peritonitis: Fatality associated with delayed diagnosis
Ahmad, M., & Ahmed, A. (1999). Tuberculous peritonitis: Fatality associated with delayed diagnosis. SOUTHERN MEDICAL JOURNAL, 92(4), 406–408.

Both HCV and HBV are Major Causes of Liver Cancer in Southeast Asians.
Lin, H., Ha, N. B., Ahmed, A., Ayoub, W., Daugherty, T. J., Lutchman, G. A., … Nguyen, M. H. (2013). Both HCV and HBV are Major Causes of Liver Cancer in Southeast Asians. Journal of Immigrant and Minority Health , 15(6), 1023–29.

Prophylactic TIPS for large gastric varices: A pilot study with four-year prospective experience
Kamal, A., Crockett, S., Yeh, R. W., Roost, J., Keeffe, E. B., & Ahmed, A. (2005). Prophylactic TIPS for large gastric varices: A pilot study with four-year prospective experience. AMERICAN JOURNAL OF GASTROENTEROLOGY, 100(9), S110–S110.

Novel endoscopic approach for removal of a rectal foreign body
Ahmed, A., & Cummings, S. A. (1999). Novel endoscopic approach for removal of a rectal foreign body. GASTROINTESTINAL ENDOSCOPY, 50(6), 872–874.

Donor Diabetes Mellitus Is an Independent Risk Factor for Graft Loss in HCV Positive but Not HCV Negative Liver Transplant Recipients
Wu, Y., Ahmed, A., & Kamal, A. (2013). Donor Diabetes Mellitus Is an Independent Risk Factor for Graft Loss in HCV Positive but Not HCV Negative Liver Transplant Recipients. DIGESTIVE DISEASES AND SCIENCES, 58(2), 574–578.

Clinical Presentation and Survival of Asian and Non-Asian Patients with HCV-Related Hepatocellular Carcinoma
Yip, B., Wantuck, J. M., Kim, L. H., Wong, R. J., Ahmed, A., Garcia, G., & Nguyen, M. H. (2014). Clinical Presentation and Survival of Asian and Non-Asian Patients with HCV-Related Hepatocellular Carcinoma. DIGESTIVE DISEASES AND SCIENCES, 59(1), 192–200.

Review article: the epidemiology and therapy of chronic hepatitis C genotypes 4, 5 and 6
Wantuck, J. M., Ahmed, A., & Nguyen, M. H. (2014). Review article: the epidemiology and therapy of chronic hepatitis C genotypes 4, 5 and 6. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 39(2), 137–47.

Primary surgical resection versus liver transplantation for transplant-eligible hepatocellular carcinoma patients.
Wong, R. J., Wantuck, J., Valenzuela, A., Ahmed, A., Bonham, C., Gallo, A., … Nguyen, M. H. (2014). Primary surgical resection versus liver transplantation for transplant-eligible hepatocellular carcinoma patients. Digestive Diseases and Sciences, 59(1), 183–91.

Mutations in HBV DNA polymerase associated with nucleos(t)ide resistance are rare in treatment-naive patients.
Vutien, P., Trinh, H. N., Garcia, R. T., Nguyen, H. A., Levitt, B. S., Nguyen, K., … Nguyen, M. H. (2014). Mutations in HBV DNA polymerase associated with nucleos(t)ide resistance are rare in treatment-naive patients. Clinical Gastroenterology and Hepatology , 12(8), 1363–70.

Ethnic Disparities in the Association of Body Mass Index with the Risk of Hypertension and Diabetes
Wong, R. J., Chou, C., Sinha, S. R., Kamal, A., & Ahmed, A. (2014). Ethnic Disparities in the Association of Body Mass Index with the Risk of Hypertension and Diabetes. JOURNAL OF COMMUNITY HEALTH, 39(3), 437–45.

Nonalcoholic Steatohepatitis Is the Most Rapidly Growing Indication for Liver Transplantation in Patients With Hepatocellular Carcinoma in the U. S.
Wong, R. J., Cheung, R., & Ahmed, A. (2014). Nonalcoholic Steatohepatitis Is the Most Rapidly Growing Indication for Liver Transplantation in Patients With Hepatocellular Carcinoma in the U. S. HEPATOLOGY, 59(6), 2188–95.

Improved survival outcomes in patients with non-alcoholic steatohepatitis and alcoholic liver disease following liver transplantation: an analysis of 2002-2012 United Network for Organ Sharing data.
Wong, R. J., Chou, C., Bonham, C. A., Concepcion, W., Esquivel, C. O., & Ahmed, A. (2014). Improved survival outcomes in patients with non-alcoholic steatohepatitis and alcoholic liver disease following liver transplantation: an analysis of 2002-2012 United Network for Organ Sharing data. Clinical Transplantation, 28(6), 713–21.

Esophageal perforation from Maloney dilator following esophageal biopsy.
Aggarwal, M., Vaidyan, P. B., & Ahmed, A. (1998). Esophageal perforation from Maloney dilator following esophageal biopsy. Medicine and Health, Rhode Island, 81(4), 144–145.

Recurrent Hepatocellular Carcinoma and Poorer Overall Survival in Patients Undergoing Left-sided Compared With Right-sided Partial Hepatectomy.
Valenzuela, A., Ha, N. B., Gallo, A., Bonham, C., Ahmed, A., Melcher, M., … Nguyen, M. H. (2015). Recurrent Hepatocellular Carcinoma and Poorer Overall Survival in Patients Undergoing Left-sided Compared With Right-sided Partial Hepatectomy. Journal of Clinical Gastroenterology, 49(2), 158–64.

Obesity and non-alcoholic fatty liver disease: Disparate associations among Asian populations.
Wong, R. J., & Ahmed, A. (2014). Obesity and non-alcoholic fatty liver disease: Disparate associations among Asian populations. World Journal of Hepatology, 6(5), 263–73.

Hepatic Encephalopathy Is Associated With Significantly Increased Mortality Among Patients Awaiting Liver Transplantation
Wong, R. J., Gish, R. G., & Ahmed, A. (2014). Hepatic Encephalopathy Is Associated With Significantly Increased Mortality Among Patients Awaiting Liver Transplantation. LIVER TRANSPLANTATION, 20(12), 1454–61.

Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States.
Wong, R. J., Aguilar, M., Cheung, R., Perumpail, R. B., Harrison, S. A., Younossi, Z. M., & Ahmed, A. (2015). Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States. Gastroenterology, 148(3), 547–55.

Cost-effectiveness of all-oral ledipasvir/sofosbuvir regimens in patients with chronic hepatitis C virus genotype 1 infection.
Younossi, Z. M., Park, H., Saab, S., Ahmed, A., Dieterich, D., & Gordon, S. C. (2015). Cost-effectiveness of all-oral ledipasvir/sofosbuvir regimens in patients with chronic hepatitis C virus genotype 1 infection. Alimentary Pharmacology & Therapeutics, 41(6), 544–563.

Cost-effectiveness analysis of sofosbuvir plus peginterferon/ribavirin in the treatment of chronic hepatitis C virus genotype 1 infection
Saab, S., Gordon, S. C., Park, H., Sulkowski, M., Ahmed, A., & Younossi, Z. (2014). Cost-effectiveness analysis of sofosbuvir plus peginterferon/ribavirin in the treatment of chronic hepatitis C virus genotype 1 infection. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 40(6), 657–675.

The impact of hepatitis C burden: an evidence-based approach
Younossi, Z. M., Kanwal, F., Saab, S., Brown, K. A., El-Serag, H. B., Kim, W. R., … Gordon, S. C. (2014). The impact of hepatitis C burden: an evidence-based approach. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 39(5), 518–31.

Commentary: physical activity and NAFLD - cause or effect?
Ahmed, A., & Forrest, E. H. (2012). Commentary: physical activity and NAFLD - cause or effect? ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 36(11-12), 1097–1098.

Outcomes after escalation of infliximab therapy in ambulatory patients with moderately active ulcerative colitis
Rostholder, E., Ahmed, A., Cheifetz, A. S., & Moss, A. C. (2012). Outcomes after escalation of infliximab therapy in ambulatory patients with moderately active ulcerative colitis. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 35(5), 562–567.

Diabetes Mellitus, and Not Obesity, Is Associated with Lower Survival Following Liver Transplantation
Wong, R. J., Cheung, R., Perumpail, R. B., Holt, E. W., & Ahmed, A. (2015). Diabetes Mellitus, and Not Obesity, Is Associated with Lower Survival Following Liver Transplantation. DIGESTIVE DISEASES AND SCIENCES, 60(4), 1036–1044.

Acute Liver Failure: A Potential Complication of Antithyroid Medication Use.
Chou, C., Wong, R. J., Higgins, J. P., Perumpail, R. B., & Ahmed, A. (2015). Acute Liver Failure: A Potential Complication of Antithyroid Medication Use. Digestive Diseases and Sciences, 60(7), 1924–27.

Hepatitis C Virus Infection and Coronary Artery Disease Risk: A Systematic Review of the Literature
Wong, R. J., Kanwal, F., Younossi, Z. M., & Ahmed, A. (2014). Hepatitis C Virus Infection and Coronary Artery Disease Risk: A Systematic Review of the Literature. DIGESTIVE DISEASES AND SCIENCES, 59(7), 1586–93.

Combination of racial/ethnic and etiology/disease-specific factors is associated with lower survival following liver transplantation in African Americans: an analysis from UNOS/OPTN database
Wong, R. J., & Ahmed, A. (2014). Combination of racial/ethnic and etiology/disease-specific factors is associated with lower survival following liver transplantation in African Americans: an analysis from UNOS/OPTN database. CLINICAL TRANSPLANTATION, 28(7), 755–61.

Long Term Trends and Racial/Ethnic Disparities in the Prevalence of Obesity
Wong, R. J., Chou, C., & Ahmed, A. (2014). Long Term Trends and Racial/Ethnic Disparities in the Prevalence of Obesity. JOURNAL OF COMMUNITY HEALTH, 39(6), 1150–60.

Sofosbuvir and simeprevir combination therapy in the setting of liver transplantation and hemodialysis
Perumpail, R. B., Wong, R. J., Ha, L. D., Pham, E. A., Wang, U., Luong, H., … Ahmed, A. (2015). Sofosbuvir and simeprevir combination therapy in the setting of liver transplantation and hemodialysis. TRANSPLANT INFECTIOUS DISEASE, 17(2), 275–78.

Esophageal perforation: A complication of nasogastric tube placement
Ahmed, A., Aggarwal, M., & Watson, E. (1998). Esophageal perforation: A complication of nasogastric tube placement. AMERICAN JOURNAL OF EMERGENCY MEDICINE, 16(1), 64–66.

Factors involved in the development of chronic arsenic poisoning in Bangladesh
Sinha, S. K., Misbahuddin, M., & Ahmed, A. N. N. (2003). Factors involved in the development of chronic arsenic poisoning in Bangladesh. ARCHIVES OF ENVIRONMENTAL HEALTH, 58(11), 699–700.

The impact of pretransplant hepatic encephalopathy on survival following liver transplantation
Wong, R. J., Aguilar, M., Gish, R. G., Cheung, R., & Ahmed, A. (2015). The impact of pretransplant hepatic encephalopathy on survival following liver transplantation. LIVER TRANSPLANTATION, 21(7), 873–80.

Elevated alpha-fetoprotein: differential diagnosis - hepatocellular carcinoma and other disorders.
Wong, R. J., Ahmed, A., & Gish, R. G. (2015). Elevated alpha-fetoprotein: differential diagnosis - hepatocellular carcinoma and other disorders. Clinics in Liver Disease, 19(2), 309–23.

Hepatocellular Carcinoma in the Setting of Non-cirrhotic Nonalcoholic Fatty Liver Disease and the Metabolic Syndrome: US Experience.
Perumpail, R. B., Wong, R. J., Ahmed, A., & Harrison, S. A. (2015). Hepatocellular Carcinoma in the Setting of Non-cirrhotic Nonalcoholic Fatty Liver Disease and the Metabolic Syndrome: US Experience. Digestive Diseases and Sciences, 60(10), 3142–48.

Advances in hepatocellular carcinoma: Nonalcoholic steatohepatitis-related hepatocellular carcinoma.
Khan, F. Z., Perumpail, R. B., Wong, R. J., & Ahmed, A. (2015). Advances in hepatocellular carcinoma: Nonalcoholic steatohepatitis-related hepatocellular carcinoma. World Journal of Hepatology, 7(18), 2155–61.

Hepatic encephalopathy is associated with significantly increased mortality among patients awaiting liver transplantation.
Wong, R. J., Gish, R. G., & Ahmed, A. (2014). Hepatic encephalopathy is associated with significantly increased mortality among patients awaiting liver transplantation. Liver Transplantation , 20(12), 1454–61.

Task-Shifting: An Approach to Decentralized Hepatitis C Treatment in Medically Underserved Areas
Jayasekera, C. R., Perumpail, R. B., Chao, D. T., Pham, E. A., Aggarwal, A., Wong, R. J., & Ahmed, A. (2015). Task-Shifting: An Approach to Decentralized Hepatitis C Treatment in Medically Underserved Areas. DIGESTIVE DISEASES AND SCIENCES, 60(12), 3552–57.

HCV infection is associated with lower survival in simultaneous liver kidney transplant recipients in the United States
Perumpail, R. B., Wong, R. J., Scandling, J. D., Ha, L. D., Todo, T., Bonham, C. A., … Ahmed, A. (2015). HCV infection is associated with lower survival in simultaneous liver kidney transplant recipients in the United States. CLINICAL TRANSPLANTATION, 29(10), 920–26.

The impact of viral hepatitis-related hepatocellular carcinoma to post-transplant outcomes
Younossi, Z. M., Stepanova, M., Saab, S., Ahmed, A., Lam, B., Srishord, M., … Henry, L. (2016). The impact of viral hepatitis-related hepatocellular carcinoma to post-transplant outcomes. JOURNAL OF VIRAL HEPATITIS, 23(1), 53–61.

Advances in alcoholic liver disease: An update on alcoholic hepatitis.
Liang, R., Liu, A., Perumpail, R. B., Wong, R. J., & Ahmed, A. (2015). Advances in alcoholic liver disease: An update on alcoholic hepatitis. World Journal of Gastroenterology, 21(42), 11893–903.

Nonalcoholic Fatty Liver Disease Review: Diagnosis, Treatment, and Outcomes
Ahmed, A., Wong, R. J., & Harrison, S. A. (2015). Nonalcoholic Fatty Liver Disease Review: Diagnosis, Treatment, and Outcomes. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 13(12), 2062–70.

A New Standard of Care? Standard Dose Sofosbuvir in an HCV-Infected Liver Transplant Recipient Undergoing Hemodialysis
Perumpail, R. B., Wong, R. J., Pham, E. A., Higgins, J. P., Daugherty, T. J., & Ahmed, A. (2016). A New Standard of Care? Standard Dose Sofosbuvir in an HCV-Infected Liver Transplant Recipient Undergoing Hemodialysis. DIGESTIVE DISEASES AND SCIENCES, 61(1), 39–41.

Elevated Alpha-Fetoprotein Differential Diagnosis - Hepatocellular Carcinoma and Other Disorders
Wong, R. J., Ahmed, A., & Gish, R. G. (2015). Elevated Alpha-Fetoprotein Differential Diagnosis - Hepatocellular Carcinoma and Other Disorders. CLINICS IN LIVER DISEASE, 19(2), 309-?

Update on hepatitis C: Direct-acting antivirals.
Seifert, L. L., Perumpail, R. B., & Ahmed, A. (2015). Update on hepatitis C: Direct-acting antivirals. World Journal of Hepatology, 7(28), 2829–2833.

Advances in cirrhosis: Optimizing the management of hepatic encephalopathy.
Liu, A., Perumpail, R. B., Kumari, R., Younossi, Z. M., Wong, R. J., & Ahmed, A. (2015). Advances in cirrhosis: Optimizing the management of hepatic encephalopathy. World Journal of Hepatology, 7(29), 2871–79.

Treatment strategies for chronic hepatitis C prior to and following liver transplantation.
Perumpail, R. B., Hahambis, T. A., Aggarwal, A., Younossi, Z. M., & Ahmed, A. (2016). Treatment strategies for chronic hepatitis C prior to and following liver transplantation. World Journal of Hepatology, 8(1), 69–73.

Pathogenesis of hepatocarcinogenesis in non-cirrhotic nonalcoholic fatty liver disease: Potential mechanistic pathways.
Perumpail, R. B., Liu, A., Wong, R. J., Ahmed, A., & Harrison, S. A. (2015). Pathogenesis of hepatocarcinogenesis in non-cirrhotic nonalcoholic fatty liver disease: Potential mechanistic pathways. World Journal of Hepatology, 7(22), 2384–88.

Hepatitis E virus infection in the liver transplant recipients: Clinical presentation and management.
Aggarwal, A., Perumpail, R. B., Tummala, S., & Ahmed, A. (2016). Hepatitis E virus infection in the liver transplant recipients: Clinical presentation and management. World Journal of Hepatology, 8(2), 117–22.

Effectiveness and tolerability of simeprevir and sofosbuvir in nontransplant and post-liver transplant patients with hepatitis C genotype 1.
Lutchman, G., Nguyen, N. H., Chang, C. Y., Ahmed, A., Daugherty, T., Garcia, G., … Nguyen, M. H. (2016). Effectiveness and tolerability of simeprevir and sofosbuvir in nontransplant and post-liver transplant patients with hepatitis C genotype 1. Alimentary Pharmacology & Therapeutics, 44(7), 738–46.

Chronic Hepatitis B Is Associated with Higher Inpatient Resource Utilization and Mortality Versus Chronic Hepatitis C.
Cholankeril, G., Perumpail, R. B., Hu, M., Skowron, G., Younossi, Z. M., & Ahmed, A. (2016). Chronic Hepatitis B Is Associated with Higher Inpatient Resource Utilization and Mortality Versus Chronic Hepatitis C. Digestive Diseases and Sciences, 61(9), 2505–15.

Long-term outcomes of lung transplant recipients with hepatitis C infection: a retrospective study of the US transplant registry
Koenig, A., Stepanova, M., Saab, S., Ahmed, A., Wong, R., & Younossi, Z. M. (2016). Long-term outcomes of lung transplant recipients with hepatitis C infection: a retrospective study of the US transplant registry. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 44(3), 271–78.

Real-World Outcomes of Ledipasvir/Sofosbuvir in Treatment-Naive Patients With Hepatitis C
Younossi, Z. M., Park, H., Gordon, S. C., Ferguson, J. R., Ahmed, A., Dieterich, D., & Saab, S. (2016). Real-World Outcomes of Ledipasvir/Sofosbuvir in Treatment-Naive Patients With Hepatitis C. AMERICAN JOURNAL OF MANAGED CARE, 22(6), SP205–SP211.

Task-shifting - A practical strategy to improve the global access to treatment for chronic hepatitis C.
Yoo, E. R., Perumpail, R. B., Cholankeril, G., Jayasekera, C. R., & Ahmed, A. (2016). Task-shifting - A practical strategy to improve the global access to treatment for chronic hepatitis C. International Journal of Nursing Studies, 62, 168–9.

Trends in Liver Transplantation Multiple Listing Practices Associated With Disparities in Donor Availability: An Endless Pursuit to Implement the Final Rule.
Cholankeril, G., Perumpail, R. B., Tulu, Z., Jayasekera, C. R., Harrison, S. A., Hu, M., … Ahmed, A. (2016). Trends in Liver Transplantation Multiple Listing Practices Associated With Disparities in Donor Availability: An Endless Pursuit to Implement the Final Rule. Gastroenterology, 151(3), 382–86.e2.

Hepatitis C Treatment Delivery Mandates Optimizing Available Health Care Human Resources A Case for Task Shifting
Jayasekera, C. R., Arora, S., & Ahmed, A. (2016). Hepatitis C Treatment Delivery Mandates Optimizing Available Health Care Human Resources A Case for Task Shifting. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 315(18), 1947–48.

Trends in Liver Transplantation in Hepatitis C Virus-Infected Persons, United States
Perumpail, R. B., Wong, R. J., Liu, A., Jayasekera, C. R., Dieterich, D. T., Younossi, Z. M., & Ahmed, A. (2016). Trends in Liver Transplantation in Hepatitis C Virus-Infected Persons, United States. EMERGING INFECTIOUS DISEASES, 22(3), 565–67.

Nonalcoholic Fatty Liver Disease: Epidemiology, Natural History, and Diagnostic Challenges.
Cholankeril, G., Perumpail, R. B., Pham, E. A., Ahmed, A., & Harrison, S. A. (2016). Nonalcoholic Fatty Liver Disease: Epidemiology, Natural History, and Diagnostic Challenges. Hepatology , 64(3), 954-?

Lower rates of receiving model for end-stage liver disease exception and longer time to transplant among nonalcoholic steatohepatitis hepatocellular carcinoma.
Young, K., Aguilar, M., Gish, R., Younossi, Z., Saab, S., Bhuket, T., … Wong, R. J. (2016). Lower rates of receiving model for end-stage liver disease exception and longer time to transplant among nonalcoholic steatohepatitis hepatocellular carcinoma. Liver Transplantation , 22(10), 1356–66.

Mutations in HBV DNA Polymerase Associated With Nucleos(t)ide Resistance Are Rare in Treatment-naive Patients.
Vutien, P., Trinh, H. N., Garcia, R. T., Nguyen, H. A., Levitt, B. S., Nguyen, K., … Nguyen, M. H. (2014). Mutations in HBV DNA Polymerase Associated With Nucleos(t)ide Resistance Are Rare in Treatment-naive Patients. Clinical Gastroenterology and Hepatology , 12(8), 1363–70.

Underutilization of Living Donor Liver Transplantation in the United States: Bias against MELD 20 and Higher.
Perumpail, R. B., Yoo, E. R., Cholankeril, G., Hogan, L., Deis, M., Concepcion, W. C., … Ahmed, A. (2016). Underutilization of Living Donor Liver Transplantation in the United States: Bias against MELD 20 and Higher. Journal of Clinical and Translational Hepatology, 4(3), 169–74.

The Value of Cure Associated with Treating Treatment-naive Chronic Hepatitis C Genotype 1: Are the New All Oral Regimens Good Value to Society?
Younossi, Z. M., Park, H., Dieterich, D., Saab, S., Ahmed, A., & Gordon, S. C. (2016). The Value of Cure Associated with Treating Treatment-naive Chronic Hepatitis C Genotype 1: Are the New All Oral Regimens Good Value to Society? Liver International .

Disparities in Liver Transplantation Resulting From Variations in Regional Donor Supply and Multiple Listing Practices.
Cholankeril, G., Yoo, E. R., Perumpail, R. B., Younossi, Z. M., & Ahmed, A. (2016). Disparities in Liver Transplantation Resulting From Variations in Regional Donor Supply and Multiple Listing Practices. Clinical Gastroenterology and Hepatology .

Assessment of cost of innovation versus the value of health gains associated with treatment of chronic hepatitis C in the United States: The quality-adjusted cost of care.
Younossi, Z. M., Park, H., Dieterich, D., Saab, S., Ahmed, A., & Gordon, S. C. (2016). Assessment of cost of innovation versus the value of health gains associated with treatment of chronic hepatitis C in the United States: The quality-adjusted cost of care. Medicine, 95(41).

Real-world experience with interferon-free, direct acting antiviral therapies in Asian Americans with chronic hepatitis C and advanced liver disease.
Chang, C. Y., Nguyen, P., Le, A., Zhao, C., Ahmed, A., Daugherty, T., … Nguyen, M. H. (2017). Real-world experience with interferon-free, direct acting antiviral therapies in Asian Americans with chronic hepatitis C and advanced liver disease. Medicine, 96(6).

Fatal Accelerated Cirrhosis after Imported HEV Genotype 4 Infection
Perumpail, R. B., Ahmed, A., Higgins, J. P., So, S. K., Cochran, J. L., Drobeniuc, J., … Teo, C.-G. (2015). Fatal Accelerated Cirrhosis after Imported HEV Genotype 4 Infection. EMERGING INFECTIOUS DISEASES, 21(9), 1679–81.

Future Therapy for Hepatitis B Virus: Role of Immunomodulators.
Pham, E. A., Perumpail, R. B., Fram, B. J., Glenn, J. S., Ahmed, A., & Gish, R. G. (2016). Future Therapy for Hepatitis B Virus: Role of Immunomodulators. Current Hepatology Reports, 15(4), 237–44.

Treatment of Patients Waitlisted for Liver Transplant with an All-Oral DAAs is a Cost-Effective Treatment Strategy in the United States.
Ahmed, A., Gonzalez, S. A., Cholankeril, G., Perumpail, R. B., McGinnis, J., Saab, S., … Younossi, Z. M. (2017). Treatment of Patients Waitlisted for Liver Transplant with an All-Oral DAAs is a Cost-Effective Treatment Strategy in the United States. Hepatology .

Treating Medicaid patients with hepatitis C: clinical and economic impact.
Younossi, Z., Gordon, S. C., Ahmed, A., Dieterich, D., Saab, S., & Beckerman, R. (2017). Treating Medicaid patients with hepatitis C: clinical and economic impact. American Journal of Managed Care, 23(2), 107–12.

Direct Acting Antivirals in Patients with Chronic Hepatitis C and Down Syndrome.
Yoo, E. R., Perumpail, R. B., Cholankeril, G., & Ahmed, A. (2016). Direct Acting Antivirals in Patients with Chronic Hepatitis C and Down Syndrome. Case Reports in Infectious Diseases, 2016, 2605302-?

Indications for antiviral therapy for chronic hepatitis B in pregnant mothers.
Yoo, E. R., Perumpail, R. B., Cholankeril, G., & Ahmed, A. (2016). Indications for antiviral therapy for chronic hepatitis B in pregnant mothers. BMJ Case Reports, 2016.

Disparities in Liver Transplantation Resulting From Variations in Regional Donor Supply and Multiple Listing Practices
Cholankeril, G., Yoo, E. R., Perumpail, R. B., Younossi, Z. M., & Ahmed, A. (2017). Disparities in Liver Transplantation Resulting From Variations in Regional Donor Supply and Multiple Listing Practices. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 15(2), 313–15.

Beneficial Effects of Statins on the Rates of Hepatic Fibrosis, Hepatic Decompensation, and Mortality in Chronic Liver Disease: A Systematic Review and Meta-Analysis.
Kamal, S., Khan, M. A., Seth, A., Cholankeril, G., Gupta, D., Singh, U., … Ahmed, A. (2017). Beneficial Effects of Statins on the Rates of Hepatic Fibrosis, Hepatic Decompensation, and Mortality in Chronic Liver Disease: A Systematic Review and Meta-Analysis. American Journal of Gastroenterology.

Sofosbuvir Use in the Setting of End-stage Renal Disease: A Single Center Experience.
Aggarwal, A., Yoo, E. R., Perumpail, R. B., Cholankeril, G., Kumari, R., Daugherty, T. J., … Ahmed, A. (2017). Sofosbuvir Use in the Setting of End-stage Renal Disease: A Single Center Experience. Journal of Clinical and Translational Hepatology, 5(1), 23–26.

The Role of e-Health in Optimizing Task-Shifting in the Delivery of Antiviral Therapy for Chronic Hepatitis C.
Yoo, E. R., Perumpail, R. B., Cholankeril, G., Jayasekera, C. R., & Ahmed, A. (2017). The Role of e-Health in Optimizing Task-Shifting in the Delivery of Antiviral Therapy for Chronic Hepatitis C. Telemedicine Journal and e-Health .

Hepatic encephalopathy: what the multidisciplinary team can do.
Liu, A., Yoo, E. R., Siddique, O., Perumpail, R. B., Cholankeril, G., & Ahmed, A. (2017). Hepatic encephalopathy: what the multidisciplinary team can do. Journal of Multidisciplinary Healthcare, 10, 113–19.

The importance of a multidisciplinary approach to hepatocellular carcinoma.
Siddique, O., Yoo, E. R., Perumpail, R. B., Perumpail, B. J., Liu, A., Cholankeril, G., & Ahmed, A. (2017). The importance of a multidisciplinary approach to hepatocellular carcinoma. Journal of Multidisciplinary Healthcare, 10, 95–100.

The Role of Direct-acting Antivirals in the Treatment of Children with Chronic Hepatitis C.
Yang, C. H. T., Yoo, E. R., & Ahmed, A. (2017). The Role of Direct-acting Antivirals in the Treatment of Children with Chronic Hepatitis C. Journal of Clinical and Translational Hepatology, 5(1), 59–66.

The value of cure associated with treating treatment-naive chronic hepatitis C genotype 1: Are the new all-oral regimens good value to society?
Younossi, Z. M., Park, H., Dieterich, D., Saab, S., Ahmed, A., & Gordon, S. C. (2017). The value of cure associated with treating treatment-naive chronic hepatitis C genotype 1: Are the new all-oral regimens good value to society? LIVER INTERNATIONAL, 37(5), 662–68.

Sofosbuvir-based Regimens with Task Shifting Is Cost-effective in Expanding Hepatitis C Treatment Access in the United States.
Jayasekera, C. R., Beckerman, R., Smith, N., Perumpail, R. B., Wong, R. J., Younossi, Z. M., & Ahmed, A. (2017). Sofosbuvir-based Regimens with Task Shifting Is Cost-effective in Expanding Hepatitis C Treatment Access in the United States. Journal of Clinical and Translational Hepatology, 5(1), 16–22.

Cirrhosis Patients with Nonalcoholic Steatohepatitis Are Significantly Less Likely to Receive Surveillance for Hepatocellular Carcinoma.
Tavakoli, H., Robinson, A., Liu, B., Bhuket, T., Younossi, Z., Saab, S., … Wong, R. J. (2017). Cirrhosis Patients with Nonalcoholic Steatohepatitis Are Significantly Less Likely to Receive Surveillance for Hepatocellular Carcinoma. Digestive Diseases and Sciences.

Long-term trends in chronic hepatitis B virus infection associated liver transplantation outcomes in the United States.
Young, K., Liu, B., Bhuket, T., Younossi, Z., Saab, S., Ahmed, A., & Wong, R. J. (2017). Long-term trends in chronic hepatitis B virus infection associated liver transplantation outcomes in the United States. Journal of Viral Hepatitis.

Patients With Diabetes and Chronic Liver Disease Are at Increased Risk for Overall Mortality: A Population Study From the United States.
Stepanova, M., Clement, S., Wong, R., Saab, S., Ahmed, A., & Younossi, Z. M. (2017). Patients With Diabetes and Chronic Liver Disease Are at Increased Risk for Overall Mortality: A Population Study From the United States. Clinical Diabetes : a Publication of the American Diabetes Association, 35(2), 79–83.

Optimal Timing for Hepatitis C Antiviral Therapy in the Peri-Transplant Period?
Cholankeril, G., Wong, R. J., Kim, D., & Ahmed, A. (2017). Optimal Timing for Hepatitis C Antiviral Therapy in the Peri-Transplant Period? Hepatology (Baltimore, Md.).

Task-shifting - A practical strategy to improve the global access to treatment for chronic hepatitis C
Yoo, E. R., Perumpail, R. B., Cholankeril, G., Jayasekera, C. R., & Ahmed, A. (2016). Task-shifting - A practical strategy to improve the global access to treatment for chronic hepatitis C. INTERNATIONAL JOURNAL OF NURSING STUDIES, 62, 168–69.

High prevalence of hepatic fibrosis in the setting of coexisting diabetes and hepatic steatosis: A case for selective screening in the general population?
Ahmed, A., Perumpail, R. B., & Harrison, S. A. (2016). High prevalence of hepatic fibrosis in the setting of coexisting diabetes and hepatic steatosis: A case for selective screening in the general population? HEPATOLOGY, 63(1), 20–22.

Enhanced efficacy of pegylated interferon alpha-2a over pegylated interferon and ribavirin in chronic hepatitis C genotype 4A randomized trial and quality of life analysis
Kamal, S. M., Ahmed, A., Mahmoud, S., Nabegh, L., El Gohary, I., Obadan, I., … Metaoei, M. (2011). Enhanced efficacy of pegylated interferon alpha-2a over pegylated interferon and ribavirin in chronic hepatitis C genotype 4A randomized trial and quality of life analysis. LIVER INTERNATIONAL, 31(3), 401–11.

Short Sleep Duration Is Associated With Abnormal Serum Aminotransferase Activities and Nonalcoholic Fatty Liver Disease.
Kim, D., Kim, H. J., Kushida, C. A., Heo, N.-Y. Y., Ahmed, A., & Kim, W. R. (2017). Short Sleep Duration Is Associated With Abnormal Serum Aminotransferase Activities and Nonalcoholic Fatty Liver Disease. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association.

Improved Outcomes in HCV Patients Following Liver Transplantation During the Era of Direct Acting Antiviral Agents.
Cholankeril, G., Li, A. A., March, K. L., Yoo, E. R., Kim, D., Snyder, H., … Ahmed, A. (2017). Improved Outcomes in HCV Patients Following Liver Transplantation During the Era of Direct Acting Antiviral Agents. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association.

Subclinical Hypothyroidism and Low-Normal Thyroid Function Are Associated With Nonalcoholic Steatohepatitis and Fibrosis.
Kim, D., Kim, W., Joo, S. K., Bae, J. M., Kim, J. H., & Ahmed, A. (2017). Subclinical Hypothyroidism and Low-Normal Thyroid Function Are Associated With Nonalcoholic Steatohepatitis and Fibrosis. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association.

Clinical epidemiology and disease burden of nonalcoholic fatty liver disease.
Perumpail, B. J., Khan, M. A., Yoo, E. R., Cholankeril, G., Kim, D., & Ahmed, A. (2017). Clinical epidemiology and disease burden of nonalcoholic fatty liver disease. World Journal of Gastroenterology, 23(47), 8263–76.

Increased Waitlist Mortality and Lower Rate for Liver Transplantation in Hispanic Patients With Primary Biliary Cholangitis.
Cholankeril, G., Gonzalez, H. C., Satapathy, S., Gonzalez, S. A., Hu, M., Khan, M. A., … Ahmed, A. (2018). Increased Waitlist Mortality and Lower Rate for Liver Transplantation in Hispanic Patients With Primary Biliary Cholangitis. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association.

Alcoholic Liver Disease Replaces Hepatitis C Virus Infection asthe Leading Indication for Liver Transplantation in the UnitedStates.
Cholankeril, G., & Ahmed, A. (2017). Alcoholic Liver Disease Replaces Hepatitis C Virus Infection asthe Leading Indication for Liver Transplantation in the UnitedStates. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association.

Expanding Donor Pool for Liver Transplantation by Utilizing Hepatitis C Virus-Infected Donors for Uninfected Recipients.
Cholankeril, G., Gadiparthi, C., Kim, D., & Ahmed, A. (2018). Expanding Donor Pool for Liver Transplantation by Utilizing Hepatitis C Virus-Infected Donors for Uninfected Recipients. Hepatology (Baltimore, Md.).

Severe Hepatic Encephalopathy is an Independent Predictor of Waitlist Mortality in Patients with High MELD
Gadiparthi, C., Yoo, E. R., Hu, M., Cholankeril, G., Howden, C. W., & Ahmed, A. (2017). Severe Hepatic Encephalopathy is an Independent Predictor of Waitlist Mortality in Patients with High MELD. HEPATOLOGY, 66, 908A.

Hepatocellular Carcinoma in Baby Boomers is associated with High Rates of Inpatient Morbidty and Mortality
Yoo, E. R., Gadiparthi, C., Hu, M., Cholankeril, G., & Ahmed, A. (2017). Hepatocellular Carcinoma in Baby Boomers is associated with High Rates of Inpatient Morbidty and Mortality. HEPATOLOGY, 66, 773A–774A.

Use of direct-acting antiviral agents in hepatitis C virus-infected liver transplant candidates
Gadiparthi, C., Cholankeril, G., Perumpail, B. J., Yoo, E. R., Satapathy, S. K., Nair, S., & Ahmed, A. (2018). Use of direct-acting antiviral agents in hepatitis C virus-infected liver transplant candidates. WORLD JOURNAL OF GASTROENTEROLOGY, 24(3), 315–22.

Hepatocellular Carcinoma results in Highest Number of Malignancy-related Hospitalizations in Baby Boomers
Gadiparthi, C., Yoo, E. R., Liu, A., Hu, M., Kim, D., Cholankeril, G., … Ahmed, A. (2017). Hepatocellular Carcinoma results in Highest Number of Malignancy-related Hospitalizations in Baby Boomers. HEPATOLOGY, 66, 774A.

The Declining Burden of HCV on the Liver Transplant Waitlist associated with the DAA era
Cholankeril, G., March, K. L., Yoo, E. R., Li, A. A., Cholankeril, R., Perumpail, R. B., … Ahmed, A. (2017). The Declining Burden of HCV on the Liver Transplant Waitlist associated with the DAA era. HEPATOLOGY. WILEY.

Alcohol Liver Disease is now the most rapidly rising Indication for Liver Transplant Waitlist Registration in the United States
Rahim, U., Cholankeril, G., Yoo, E. R., Liu, A., Li, A. A., Kim, D., … Goel, A. (2017). Alcohol Liver Disease is now the most rapidly rising Indication for Liver Transplant Waitlist Registration in the United States. HEPATOLOGY. WILEY.

Improved Short-Term Survival in HCV Patients following Liver Transplantation in the Era of Direct Acting Antiviral Agents
Cholankeril, G., Li, A. A., Yoo, E. R., Gonzalez, S. A., Younossi, Z. M., & Ahmed, A. (2017). Improved Short-Term Survival in HCV Patients following Liver Transplantation in the Era of Direct Acting Antiviral Agents. HEPATOLOGY. WILEY.

Rifaximin for the prevention of spontaneous bacterial peritonitis and hepatorenal syndrome in cirrhosis: a systematic review and meta-analysis
Kamal, F., Khan, M. A., Khan, Z., Cholankeril, G., Hammad, T. A., Lee, W. M., … Satapathy, S. K. (2017). Rifaximin for the prevention of spontaneous bacterial peritonitis and hepatorenal syndrome in cirrhosis: a systematic review and meta-analysis. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 29(10), 1109–17.

Implementation of Share 35 Policy has Improved Survival following Liver Transplantation
Cholankeril, G., Li, A. A., Nair, S., & Ahmed, A. (2017). Implementation of Share 35 Policy has Improved Survival following Liver Transplantation. HEPATOLOGY. WILEY.

Comparing Direct Acting Antivirals-Based Regimens Plus Ribavirin in Treatment-Experienced Hepatitis C Virus Genotype 3 Patients: A Systematic Review and Meta-Analysis
Khan, M. A., Cholankeril, G., Kamal, F., Shrestha, S., March, K. L., Rahim, U., … Ahmed, A. (2017). Comparing Direct Acting Antivirals-Based Regimens Plus Ribavirin in Treatment-Experienced Hepatitis C Virus Genotype 3 Patients: A Systematic Review and Meta-Analysis. HEPATOLOGY, 66, 846A–847A.

Nonalcoholic Steatohepatitis Remains the Fastest Growing Indication for Liver Transplantation in Patients with Hepatocellular Carcinoma in the United States
Li, A. A., Yoo, E. R., Cholankeril, G., Kim, D., Puri, P., Harrison, S. A., … Ahmed, A. (2017). Nonalcoholic Steatohepatitis Remains the Fastest Growing Indication for Liver Transplantation in Patients with Hepatocellular Carcinoma in the United States. HEPATOLOGY. WILEY.

Optimizing the Nutritional Support of Adult Patients in the Setting of Cirrhosis
Perumpail, B. J., Li, A. A., Cholankeril, G., Kumari, R., & Ahmed, A. (2017). Optimizing the Nutritional Support of Adult Patients in the Setting of Cirrhosis. NUTRIENTS, 9(10).

Need to Improve Organs Transplanted Per Donor Despite the Rising Utilization of Hepatitis C Virus-Positive Donors in the United States
Li, A. A., Rahim, U., Yoo, E. R., Cholankeril, G., Kim, D., & Ahmed, A. (2017). Need to Improve Organs Transplanted Per Donor Despite the Rising Utilization of Hepatitis C Virus-Positive Donors in the United States. HEPATOLOGY. WILEY.

National Drug Overdose Epidemic is a Significant Contributor to Deceased Donor Liver Organ Pool
Cholankeril, G., Li, A. A., Cholankeril, R., Sandhu, J., Kim, D., & Ahmed, A. (2017). National Drug Overdose Epidemic is a Significant Contributor to Deceased Donor Liver Organ Pool. HEPATOLOGY. WILEY.

Trends in Liver Transplantation among Patients with Primary Biliary Cholangitis
Cholankeril, R., Rahim, U., Yoo, E. R., Li, A. A., Sandhu, K., Perumpail, R. B., … Ahmed, A. (2017). Trends in Liver Transplantation among Patients with Primary Biliary Cholangitis. HEPATOLOGY. WILEY.

Poor Post-Transplant Survival in Donation after Cardiac Death (DCD)-related Liver Transplant Recipients with Severe Hepatic Decompensation
Cholankeril, G., Rahim, U., Gadiparthi, C., Gonzalez, S. A., & Ahmed, A. (2017). Poor Post-Transplant Survival in Donation after Cardiac Death (DCD)-related Liver Transplant Recipients with Severe Hepatic Decompensation. HEPATOLOGY, 66, 881A.

Increasing Acceptance of Severe Acute Alcoholic Hepatitis as an Indication for Liver Transplantation with Outcomes comparable to Fulminant Hepatic Failure
Cholankeril, G., Liu, A., Sandhu, J., Yoo, E. R., Li, A. A., Goel, A., … Ahmed, A. (2017). Increasing Acceptance of Severe Acute Alcoholic Hepatitis as an Indication for Liver Transplantation with Outcomes comparable to Fulminant Hepatic Failure. HEPATOLOGY. WILEY.

Hispanics with Primary Biliary Cholangitis present for Liver Transplant Listing at a Younger Age and with more Severe Hepatic Decompensation
Yoo, E. R., Li, A. A., Imam, M., Hu, M., Cholankeril, G., Lindor, K. D., & Ahmed, A. (2017). Hispanics with Primary Biliary Cholangitis present for Liver Transplant Listing at a Younger Age and with more Severe Hepatic Decompensation. HEPATOLOGY. WILEY.

Rising Trend and Poor Waitlist Outcomes in Young Adult Liver Transplant Registrants with Alcoholic Liver Disease
Cholankeril, G., Gadiparthi, C., Rahim, U., Goel, A., Puri, P., Sarin, S. K., & Ahmed, A. (2017). Rising Trend and Poor Waitlist Outcomes in Young Adult Liver Transplant Registrants with Alcoholic Liver Disease. HEPATOLOGY, 66, 943A–944A.

Direct-Acting Antiviral Therapy and Improvement in Graft Survival of Hepatitis C Liver Transplant Recipients
Cholankeril, G., Li, A. A., Yoo, E. R., & Ahmed, A. (2017). Direct-Acting Antiviral Therapy and Improvement in Graft Survival of Hepatitis C Liver Transplant Recipients. TRANSPLANTATION, 101(12), e349.

Liver Transplantation for Nonalcoholic Steatohepatitis in the US: Temporal Trends and Outcomes
Cholankeril, G., Wong, R. J., Hu, M., Perumpail, R. B., Yoo, E. R., Puri, P., … Ahmed, A. (2017). Liver Transplantation for Nonalcoholic Steatohepatitis in the US: Temporal Trends and Outcomes. DIGESTIVE DISEASES AND SCIENCES, 62(10), 2915–22.

Declining Rate of Acute Graft Failure in Liver Transplant Recipients with Hepatitis C
Cholankeril, G., Li, A. A., Yoo, E. R., Gonzalez, S. A., Nair, S., & Ahmed, A. (2017). Declining Rate of Acute Graft Failure in Liver Transplant Recipients with Hepatitis C. HEPATOLOGY. WILEY.

Demographics and Clinical Characteristics of Hepatitis C Virus-Positive Donors and Recipients
Li, A. A., Yoo, E. R., Sandhu, K., Perumpail, R. B., Cholankeril, G., Kim, D., & Ahmed, A. (2017). Demographics and Clinical Characteristics of Hepatitis C Virus-Positive Donors and Recipients. HEPATOLOGY. WILEY.

Impact of Drug Overdose Deaths on Solid Organ Transplantation in the United States.
Cholankeril, G., Li, A. A., Cholankeril, R., Toll, A. E., Glenn, J. S., & Ahmed, A. (2018). Impact of Drug Overdose Deaths on Solid Organ Transplantation in the United States. Journal of General Internal Medicine.

Rising Rates of Hepatocellular Carcinoma Leading to Liver Transplantation in Baby Boomer Generation with Chronic Hepatitis C, Alcohol Liver Disease, and Nonalcoholic Steatohepatitis-Related Liver Disease.
Cholankeril, G., Yoo, E. R., Perumpail, R. B., Liu, A., Sandhu, J. S., Nair, S., … Ahmed, A. (2017). Rising Rates of Hepatocellular Carcinoma Leading to Liver Transplantation in Baby Boomer Generation with Chronic Hepatitis C, Alcohol Liver Disease, and Nonalcoholic Steatohepatitis-Related Liver Disease. Diseases (Basel, Switzerland), 5(4).

Timing of Hepatitis C Virus Treatment in Liver Transplant Candidates in the Era of Direct-acting Antiviral Agents.
Cholankeril, G., Joseph-Talreja, M., Perumpail, B. J., Liu, A., Yoo, E. R., Ahmed, A., & Goel, A. (2017). Timing of Hepatitis C Virus Treatment in Liver Transplant Candidates in the Era of Direct-acting Antiviral Agents. Journal of Clinical and Translational Hepatology, 5(4), 363–67.

Nutritional Needs and Support for Children with Chronic Liver Disease.
Yang, C. H., Perumpail, B. J., Yoo, E. R., Ahmed, A., & Kerner, J. A. (2017). Nutritional Needs and Support for Children with Chronic Liver Disease. Nutrients, 9(10).

Case Report of Isoniazid-Related Acute Liver Failure Requiring Liver Transplantation.
Li, A. A., Dibba, P., Cholankeril, G., Kim, D., & Ahmed, A. (2018). Case Report of Isoniazid-Related Acute Liver Failure Requiring Liver Transplantation. Diseases (Basel, Switzerland), 6(2).

Leukocyte Telomere Shortening Is Associated With Nonalcoholic Fatty Liver Disease-Related Advanced Fibrosis.
Kim, D., Li, A. A., & Ahmed, A. (2018). Leukocyte Telomere Shortening Is Associated With Nonalcoholic Fatty Liver Disease-Related Advanced Fibrosis. Liver International : Official Journal of the International Association for the Study of the Liver.

Waitlist Outcomes in Liver Transplant Candidates with High MELD and Severe Hepatic Encephalopathy
Gadiparthi, C., Cholankeril, G., Yoo, E. R., Hu, M., Wong, R. J., & Ahmed, A. (2018). Waitlist Outcomes in Liver Transplant Candidates with High MELD and Severe Hepatic Encephalopathy. DIGESTIVE DISEASES AND SCIENCES, 63(6), 1647–53.

Liver Transplant (LT) Candidates with Primary Biliary Cholangitis (PBC) Experience Higher Wait List Mortality: Data from the Scientific Registry of Transplant Recipients (SRTR)
Younossi, Z. M., Stepanova, M., de Avila, L., Ahmed, A., Wong, R. J., Saab, S., … Racila, A. (2017). Liver Transplant (LT) Candidates with Primary Biliary Cholangitis (PBC) Experience Higher Wait List Mortality: Data from the Scientific Registry of Transplant Recipients (SRTR). HEPATOLOGY, 66, 176A–177A.

Inverse association of marijuana use with nonalcoholic fatty liver disease among adults in the United States
Kim, D., Kim, W., Kwak, M.-S., Chung, G. E., Yim, J. Y., & Ahmed, A. (2017). Inverse association of marijuana use with nonalcoholic fatty liver disease among adults in the United States. PLOS ONE, 12(10), e0186702.

Is Obesity associated with Increased Risk of Mortality and Re-transplantation in Liver Transplant Recipients? A Systematic Review and Meta-Analysis
Kamal, F., Khan, M. A., Ahmed, A., Nair, S., Ismail, M. K., & Satapathy, S. K. (2017). Is Obesity associated with Increased Risk of Mortality and Re-transplantation in Liver Transplant Recipients? A Systematic Review and Meta-Analysis. HEPATOLOGY, 66, 919A.

Societal Perspectives Analysis for Evaluating Direct-Acting Antiviral Affordability While Awaiting Liver Transplant REPLY
Ahmed, A., Beckerman, R., & Younossi, Z. M. (2018). Societal Perspectives Analysis for Evaluating Direct-Acting Antiviral Affordability While Awaiting Liver Transplant REPLY. HEPATOLOGY, 67(1), 450–51.

Health Outcomes Associated with Sofosbuvir- based Single-Tablet Regimens for Initial and Re-treatment of Chronic Hepatitis C in the US
Gordon, S. C., Ahmed, A., Saab, S., Dieterich, D. T., Wong, R. J., Kugelmas, M., … Younossi, Z. M. (2017). Health Outcomes Associated with Sofosbuvir- based Single-Tablet Regimens for Initial and Re-treatment of Chronic Hepatitis C in the US. HEPATOLOGY, 66, 635A–636A.

Post-Transplant Complications in Obese Liver Transplant Recipients: A Systematic Review and Meta-Analysis
Kamal, F., Khan, M. A., Ahmed, A., Nair, S., Ismail, M. K., & Satapathy, S. K. (2017). Post-Transplant Complications in Obese Liver Transplant Recipients: A Systematic Review and Meta-Analysis. HEPATOLOGY, 66, 916A.

Underutilization of Hepatitis C Virus Seropositive Donor Kidneys in the United States in the Current Opioid Epidemic and Direct-Acting Antiviral Era.
Li, A. A., Cholankeril, G., Cheng, X. S., Tan, J. C., Kim, D., Toll, A. E., … Ahmed, A. (2018). Underutilization of Hepatitis C Virus Seropositive Donor Kidneys in the United States in the Current Opioid Epidemic and Direct-Acting Antiviral Era. Diseases (Basel, Switzerland), 6(3).

Changing Trends in Etiology-based Annual Mortality From Chronic Liver Disease, From 2007 Through 2016.
Kim, D., Li, A. A., Gadiparthi, C., Khan, M. A., Cholankeril, G., Glenn, J. S., & Ahmed, A. (2018). Changing Trends in Etiology-based Annual Mortality From Chronic Liver Disease, From 2007 Through 2016. Gastroenterology.

Changing Trends in Etiology- and Ethnicity-Based Annual Mortality Rates of Cirrhosis and Hepatocellular Carcinoma in the United States.
Kim, D., Li, A. A., Perumpail, B. J., Gadiparthi, C., Kim, W., Cholankeril, G., … Ahmed, A. (2018). Changing Trends in Etiology- and Ethnicity-Based Annual Mortality Rates of Cirrhosis and Hepatocellular Carcinoma in the United States. Hepatology (Baltimore, Md.).

Non-alcoholic Fatty Liver Disease: A Review of Anti-diabetic Pharmacologic Therapies
Snyder, H. S., Sakaan, S. A., March, K. L., Siddique, O., Cholankeril, R., Cummings, C. D., … Cholankeril, G. (2018). Non-alcoholic Fatty Liver Disease: A Review of Anti-diabetic Pharmacologic Therapies. JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 6(2), 168–74.

Rupture of the spleen as the initial manifestation of Wilson's disease
Ahmed, A., & Feller, E. R. (1996). Rupture of the spleen as the initial manifestation of Wilson's disease. AMERICAN JOURNAL OF GASTROENTEROLOGY, 91(7), 1454–55.

Does antecedent splenectomy alter the course of HIV infection?
Ahmed, A., Watson, E. N., & Carpenter, C. C. (1996). Does antecedent splenectomy alter the course of HIV infection? Medicine and Health, Rhode Island, 79(9), 331–32.

Clinical utility of ledipasvir/sofosbuvir in the treatment of adolescents and children with hepatitis C
Yang, C. H. T., Goel, A., & Ahmed, A. (2018). Clinical utility of ledipasvir/sofosbuvir in the treatment of adolescents and children with hepatitis C. Adolescent Health, Medicine and Therapeutics, 9, 103–10.

The Role of Cannabinoids in the Setting of Cirrhosis.
Dibba, P., Li, A. A., Cholankeril, G., Iqbal, U., Gadiparthi, C., Khan, M. A., … Ahmed, A. (2018). The Role of Cannabinoids in the Setting of Cirrhosis. Medicines (Basel, Switzerland), 5(2).

Mechanistic Potential and Therapeutic Implications of Cannabinoids in Nonalcoholic Fatty Liver Disease.
Dibba, P., Li, A., Cholankeril, G., Iqbal, U., Gadiparthi, C., Khan, M. A., … Ahmed, A. (2018). Mechanistic Potential and Therapeutic Implications of Cannabinoids in Nonalcoholic Fatty Liver Disease. Medicines (Basel, Switzerland), 5(2).

Serum testosterone and non-alcoholic fatty liver disease in men and women in the US.
Yim, J. Y., Kim, J., Kim, D., & Ahmed, A. (2018). Serum testosterone and non-alcoholic fatty liver disease in men and women in the US. Liver International : Official Journal of the International Association for the Study of the Liver.

Can Ribavirin be Avoided in the Management of Hepatitis C Genotype 3 Patients When Treated With Direct Acting Antivirals? A Systematic Review and Meta-Analysis
Khan, M. A., Cholankeril, G., Gadiparthi, C., Siddiqui, M., Haq, K. F., Hahambis, T., & Ahmed, A. (2017). Can Ribavirin be Avoided in the Management of Hepatitis C Genotype 3 Patients When Treated With Direct Acting Antivirals? A Systematic Review and Meta-Analysis. AMERICAN JOURNAL OF GASTROENTEROLOGY, 112, S559–S560.

Disparities in Mortality for Chronic Liver Disease among Asian Sub-Populations in the United States from 2007 to 2016.
Li, A. A., Kim, D., Kim, W., Dibba, P., Wong, K., Cholankeril, G., … Ahmed, A. (2018). Disparities in Mortality for Chronic Liver Disease among Asian Sub-Populations in the United States from 2007 to 2016. Journal of Viral Hepatitis.

Continuous Positive Airway Pressure Therapy on Nonalcoholic Fatty Liver Disease in Patients With Obstructive Sleep Apnea.
Kim, D., Ahmed, A., & Kushida, C. (2018). Continuous Positive Airway Pressure Therapy on Nonalcoholic Fatty Liver Disease in Patients With Obstructive Sleep Apnea. Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine, 14(8), 1315–22.

Association between cagA negative Helicobacter pylori status and nonalcoholic fatty liver disease among adults in the United States
Kang, S. J., Kim, H. J., Kim, D., & Ahmed, A. (2018). Association between cagA negative Helicobacter pylori status and nonalcoholic fatty liver disease among adults in the United States. PLOS ONE, 13(8), e0202325.

Increasing Trends in Transplantation of HCV-positive Livers into Uninfected Recipients.
Cholankeril, G., Li, A. A., Dennis, B. B., Toll, A. E., Kim, D., Bonham, C. A., … Ahmed, A. (2018). Increasing Trends in Transplantation of HCV-positive Livers into Uninfected Recipients. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association.

Temporal Trends Associated with the Rise in Alcoholic Liver Disease Related Liver Transplantation in the United States.
Cholankeril, G., Gadiparthi, C., Yoo, E. R., Dennis, B. B., Li, A. A., Hu, M., … Ahmed, A. (2018). Temporal Trends Associated with the Rise in Alcoholic Liver Disease Related Liver Transplantation in the United States. Transplantation.

Predictors of Nonalcoholic Steatohepatitis and Significant Fibrosis in Non-Obese Nonalcoholic Fatty Liver Disease.
Kim, D., Kim, W., Joo, S. K., Kim, J. H., Harrison, S. A., Younossi, Z. M., & Ahmed, A. (2018). Predictors of Nonalcoholic Steatohepatitis and Significant Fibrosis in Non-Obese Nonalcoholic Fatty Liver Disease. Liver International : Official Journal of the International Association for the Study of the Liver.

Improved Short-Term Survival in HCV Seropositive Kidney Transplant Recipients during the Daa Era in the United States
Wong, K., Cholankeril, G., Gadiparthi, C., Somasundar, P., Busque, S., Esquivel, C. O., & Ahmed, A. (2018). Improved Short-Term Survival in HCV Seropositive Kidney Transplant Recipients during the Daa Era in the United States. HEPATOLOGY. WILEY.

Non-Alcoholic Fatty Liver Disease (NAFLD) and Alcoholic Fatty Liver Disease (AFLD): The Impact of Alcohol Consumption and Metabolic Syndrome on Mortality
Younossi, Z. M., Stepanova, M., Ong, J., Yilmaz, Y., Duseja, A. K., Eguchi, Y., … Afendy, A. (2018). Non-Alcoholic Fatty Liver Disease (NAFLD) and Alcoholic Fatty Liver Disease (AFLD): The Impact of Alcohol Consumption and Metabolic Syndrome on Mortality. HEPATOLOGY, 68, 801A–802A.

Pre-Operative Magnitude in the Rise of Meld Score Is a Predictor of Survival Following Liver Transplantation
Cholankeril, G., Yoo, E. R., Li, A. A., Kim, D., & Ahmed, A. (2018). Pre-Operative Magnitude in the Rise of Meld Score Is a Predictor of Survival Following Liver Transplantation. HEPATOLOGY. WILEY.

Trends in Causes of Mortality in Liver Transplantation Recipients: Comparison Among Nash, ALD, and HCV Cohorts
Yoo, E. R., Cholankeril, G., Li, A. A., Dibba, P., Iqbal, U., Khan, M. A., … Ahmed, A. (2018). Trends in Causes of Mortality in Liver Transplantation Recipients: Comparison Among Nash, ALD, and HCV Cohorts. HEPATOLOGY. WILEY.

Use of Antiplatelet Agents for the Prevention of Hepatic Fibrosis: A Systematic Review and Meta-Analysis
Iqbal, U., Li, A. A., Dibba, P., Yoo, E. R., Cholankeril, G., Khan, M. A., … Ahmed, A. (2018). Use of Antiplatelet Agents for the Prevention of Hepatic Fibrosis: A Systematic Review and Meta-Analysis. HEPATOLOGY. WILEY.

Anti-Diabetic Medications for the Pharmacologic Management of NAFLD.
Cholankeril, R., Patel, V., Perumpail, B. J., Yoo, E. R., Iqbal, U., Sallam, S., … Ahmed, A. (2018). Anti-Diabetic Medications for the Pharmacologic Management of NAFLD. Diseases (Basel, Switzerland), 6(4).

When to Initiate Weight Loss Medications in the NAFLD Population.
Yoo, E. R., Sallam, S., Perumpail, B. J., Iqbal, U., Shah, N. D., Kwong, W., … Ahmed, A. (2018). When to Initiate Weight Loss Medications in the NAFLD Population. Diseases (Basel, Switzerland), 6(4).

Judicious Use of Lipid Lowering Agents in the Management of NAFLD.
Iqbal, U., Perumpail, B. J., John, N., Sallam, S., Shah, N. D., Kwong, W., … Ahmed, A. (2018). Judicious Use of Lipid Lowering Agents in the Management of NAFLD. Diseases (Basel, Switzerland), 6(4).

Emerging Therapeutic Targets and Experimental Drugs for the Treatment of NAFLD.
Dibba, P., Li, A. A., Perumpail, B. J., John, N., Sallam, S., Shah, N. D., … Ahmed, A. (2018). Emerging Therapeutic Targets and Experimental Drugs for the Treatment of NAFLD. Diseases (Basel, Switzerland), 6(3).

Marijuana is not associated with progression of hepatic fibrosis in liver disease: a systematic review and meta-analysis.
Farooqui, M. T., Khan, M. A., Cholankeril, G., Khan, Z., Mohammed Abdul, M. K., Li, A. A., … Ahmed, A. (2018). Marijuana is not associated with progression of hepatic fibrosis in liver disease: a systematic review and meta-analysis. European Journal of Gastroenterology & Hepatology.

Potential Therapeutic Benefits of Herbs and Supplements in Patients with NAFLD.
Perumpail, B. J., Li, A. A., Iqbal, U., Sallam, S., Shah, N. D., Kwong, W., … Ahmed, A. (2018). Potential Therapeutic Benefits of Herbs and Supplements in Patients with NAFLD. Diseases (Basel, Switzerland), 6(3).

Liver Transplantation for HCV Non-Viremic Recipients with HCV Viremic Donors.
Kwong, A. J., Wall, A., Melcher, M., Wang, U., Ahmed, A., Subramanian, A., & Kwo, P. Y. (2018). Liver Transplantation for HCV Non-Viremic Recipients with HCV Viremic Donors. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Longitudinal trends in renal function in chronic hepatitis B patients receiving oral antiviral treatment.
Udompap, P., Kim, D., Ahmed, A., & Kim, W. R. (2018). Longitudinal trends in renal function in chronic hepatitis B patients receiving oral antiviral treatment. Alimentary Pharmacology & Therapeutics.

Association of Pre-Transplant Renal Function with Liver Graft and Patient Survival after Liver Transplantation in Patients with Nonalcoholic Steatohepatitis.
Molnar, M. Z., Joglekar, K., Jiang, Y., Cholankeril, G., Abdul, M. K., Kedia, S., … Satapathy, S. K. (2018). Association of Pre-Transplant Renal Function with Liver Graft and Patient Survival after Liver Transplantation in Patients with Nonalcoholic Steatohepatitis. Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Disparate Trends in Mortality of Etiology-specific Chronic Liver Disease Among Hispanic Sub-Populations.
Kim, D., Li, A. A., Perumpail, R. B., Cholankeril, G., Gonzalez, S. A., Kim, W., & Ahmed, A. (2018). Disparate Trends in Mortality of Etiology-specific Chronic Liver Disease Among Hispanic Sub-Populations. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association.

The Role of Vitamin E in the Treatment of NAFLD.
Perumpail, B. J., Li, A. A., John, N., Sallam, S., Shah, N. D., Kwong, W., … Ahmed, A. (2018). The Role of Vitamin E in the Treatment of NAFLD. Diseases (Basel, Switzerland), 6(4).

Hepatitis C in Pregnancy.
Dibba, P., Cholankeril, R., Li, A. A., Patel, M., Fayek, M., Dibble, C., … Ahmed, A. (2018). Hepatitis C in Pregnancy. Diseases (Basel, Switzerland), 6(2).

Low-Normal Thyroid Function is Associated with Advanced Fibrosis among Adults in the United States.
Kim, D., Yoo, E. R., Li, A. A., Fernandes, C. T., Tighe, S. P., Cholankeril, G., … Ahmed, A. (2018). Low-Normal Thyroid Function is Associated with Advanced Fibrosis among Adults in the United States. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association.

Effects of Alcohol Consumption and Metabolic Syndrome on Mortality in Patients with Non-alcoholic and Alcohol-Related Fatty Liver Disease.
Younossi, Z. M., Stepanova, M., Ong, J., Yilmaz, Y., Duseja, A., Eguchi, Y., … Afendy, A. (2018). Effects of Alcohol Consumption and Metabolic Syndrome on Mortality in Patients with Non-alcoholic and Alcohol-Related Fatty Liver Disease. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association.

Early Liver Transplantation is a Viable Treatment Option in Severe Acute Alcoholic Hepatitis
Puri, P., Cholankeril, G., Myint, T. Y., Goel, A., Sarin, S. K., Harper, A. M., & Ahmed, A. (2018). Early Liver Transplantation is a Viable Treatment Option in Severe Acute Alcoholic Hepatitis. ALCOHOL AND ALCOHOLISM, 53(6), 716–18.

Use of anti-platelet agents in the prevention of hepatic fibrosis in patients at risk for chronic liver disease: a systematic review and meta-analysis.
Iqbal, U., Dennis, B. B., Li, A. A., Cholankeril, G., Kim, D., Khan, M. A., & Ahmed, A. (2018). Use of anti-platelet agents in the prevention of hepatic fibrosis in patients at risk for chronic liver disease: a systematic review and meta-analysis. Hepatology International.

Nonalcoholic Fatty Liver Disease: Epidemiology, Liver Transplantation Trends and Outcomes, and Risk of Recurrent Disease in the Graft.
Liu, A., Galoosian, A., Kaswala, D., Li, A. A., Gadiparthi, C., Cholankeril, G., … Ahmed, A. (2018). Nonalcoholic Fatty Liver Disease: Epidemiology, Liver Transplantation Trends and Outcomes, and Risk of Recurrent Disease in the Graft. Journal of Clinical and Translational Hepatology, 6(4), 420–24.

Impact of Nonmalignant Portal Vein Thrombosis in Transplant Recipients With Nonalcoholic Steatohepatitis
Agbim, U., Jiang, Y., Kedia, S. K., Singal, A. K., Ahmed, A., Bhamidimarri, K. R., … Satapathy, S. K. (2019). Impact of Nonmalignant Portal Vein Thrombosis in Transplant Recipients With Nonalcoholic Steatohepatitis. LIVER TRANSPLANTATION, 25(1), 68–78.

Race/ethnicity-based temporal changes in prevalence of NAFLD-related advanced fibrosis in the United States, 2005-2016.
Kim, D., Kim, W., Adejumo, A. C., Cholankeril, G., Tighe, S. P., Wong, R. J., … Ahmed, A. (2019). Race/ethnicity-based temporal changes in prevalence of NAFLD-related advanced fibrosis in the United States, 2005-2016. Hepatology International.

A functional subset of CD8+ T cells during chronic exhaustion is defined by SIRPalpha expression.
Myers, L. M., Tal, M. C., Torrez Dulgeroff, L. B., Carmody, A. B., Messer, R. J., Gulati, G., … Hasenkrug, K. J. (2019). A functional subset of CD8+ T cells during chronic exhaustion is defined by SIRPalpha expression. Nature Communications, 10(1), 794.

Nonalcoholic Steatohepatitis Is the Fastest Growing Cause of Hepatocellular Carcinoma in Liver Transplant Candidates
Younossi, Z., Stepanova, M., Ong, J. P., Jacobson, I. M., Bugianesi, E., Duseja, A., … Afendy, A. (2019). Nonalcoholic Steatohepatitis Is the Fastest Growing Cause of Hepatocellular Carcinoma in Liver Transplant Candidates. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 17(4), 748-+.

The Therapeutic Implications of the Gut Microbiome and Probiotics in Patients with NAFLD.
Perumpail, B. J., Li, A. A., John, N., Sallam, S., Shah, N. D., Kwong, W., … Ahmed, A. (2019). The Therapeutic Implications of the Gut Microbiome and Probiotics in Patients with NAFLD. Diseases (Basel, Switzerland), 7(1).

The Epidemiology, Risk Profiling and Diagnostic Challenges of Nonalcoholic Fatty Liver Disease.
Iqbal, U., Perumpail, B. J., Akhtar, D., Kim, D., & Ahmed, A. (2019). The Epidemiology, Risk Profiling and Diagnostic Challenges of Nonalcoholic Fatty Liver Disease. Medicines (Basel, Switzerland), 6(1).

Associations between sarcopenia and nonalcoholic fatty liver disease and advanced fibrosis in the USA.
Wijarnpreecha, K., Kim, D., Raymond, P., Scribani, M., & Ahmed, A. (2019). Associations between sarcopenia and nonalcoholic fatty liver disease and advanced fibrosis in the USA. European Journal of Gastroenterology & Hepatology.

Kratom-Induced Cholestatic Liver Injury and Its Conservative Management.
Fernandes, C. T., Iqbal, U., Tighe, S. P., & Ahmed, A. (2019). Kratom-Induced Cholestatic Liver Injury and Its Conservative Management. Journal of Investigative Medicine High Impact Case Reports, 7, 2324709619836138.

Economic burden and healthcare utilization in nonalcoholic fatty liver disease
Yoo, E. R., Ahmed, A., & Kim, D. (2019). Economic burden and healthcare utilization in nonalcoholic fatty liver disease. HEPATOBILIARY SURGERY AND NUTRITION, 8(2), 181–83.

Elevated urinary bisphenol A levels are associated with non-alcoholic fatty liver disease among adults in the United States.
Kim, D., Yoo, E. R., Li, A. A., Cholankeril, G., Tighe, S. P., Kim, W., … Ahmed, A. (2019). Elevated urinary bisphenol A levels are associated with non-alcoholic fatty liver disease among adults in the United States. Liver International : Official Journal of the International Association for the Study of the Liver.

Drug-drug interactions in hepatitis C virus treatment: Do they really matter?
Ahmed, A., Lutchman, G. A., & Kwo, P. Y. (2017). Drug-drug interactions in hepatitis C virus treatment: Do they really matter? Clinical Liver Disease, 10(5), 111–15.

A New Standard of Care? Standard Dose Sofosbuvir in an HCV-Infected Liver Transplant Recipient Undergoing Hemodialysis.
Perumpail, R. B., Wong, R. J., Pham, E. A., Higgins, J. P., Daugherty, T. J., & Ahmed, A. (2016). A New Standard of Care? Standard Dose Sofosbuvir in an HCV-Infected Liver Transplant Recipient Undergoing Hemodialysis. Digestive Diseases and Sciences, 61(1), 39–41.

Genetic Factors and Continental Ancestry Account for Some Disparities in Nonalcoholic Fatty Liver Disease Among Hispanic Subgroups.
Yoo, E. R., Ahmed, A., & Kim, D. (2019). Genetic Factors and Continental Ancestry Account for Some Disparities in Nonalcoholic Fatty Liver Disease Among Hispanic Subgroups. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association.

Trends in overall, cardiovascular and cancer-related mortality among individuals with diabetes reported on death certificates in the United States between 2007 and 2017.
Kim, D., Li, A. A., Cholankeril, G., Kim, S. H., Ingelsson, E., Knowles, J. W., … Ahmed, A. (2019). Trends in overall, cardiovascular and cancer-related mortality among individuals with diabetes reported on death certificates in the United States between 2007 and 2017. Diabetologia.

Clinical utility of ledipasvir/sofosbuvir in the treatment of adolescents and children with hepatitis C.
Yang, C. H., Goel, A., & Ahmed, A. (2018). Clinical utility of ledipasvir/sofosbuvir in the treatment of adolescents and children with hepatitis C. Adolescent Health, Medicine and Therapeutics, 9, 103–110.

Significantly Higher Mortality Following Liver Transplantation Among Patients Aged 70 Years and Older.
Sharma, M., Ahmed, A., & Wong, R. J. (2017). Significantly Higher Mortality Following Liver Transplantation Among Patients Aged 70 Years and Older. Progress in Transplantation (Aliso Viejo, Calif.), 27(3), 225–231.

An Overview of Dietary Interventions and Strategies to Optimize the Management of Non-Alcoholic Fatty Liver Disease.
Perumpail, B. J., Cholankeril, R., Yoo, E. R., Kim, D., & Ahmed, A. (2017). An Overview of Dietary Interventions and Strategies to Optimize the Management of Non-Alcoholic Fatty Liver Disease. Diseases (Basel, Switzerland), 5(4).

Optimizing the Nutritional Support of Adult Patients in the Setting of Cirrhosis.
Perumpail, B. J., Li, A. A., Cholankeril, G., Kumari, R., & Ahmed, A. (2017). Optimizing the Nutritional Support of Adult Patients in the Setting of Cirrhosis. Nutrients, 9(10).

Rising Rate of Liver Transplantation in the Baby Boomer Generation with Non-alcoholic Steatohepatitis in the United States.
Siddique, O., Joseph-Talreja, M., Yoo, E. R., Perumpail, R. B., Cholankeril, G., Harrison, S. A., … Ahmed, A. (2017). Rising Rate of Liver Transplantation in the Baby Boomer Generation with Non-alcoholic Steatohepatitis in the United States. Journal of Clinical and Translational Hepatology, 5(3), 193–196.

Extrahepatic Manifestations of Hepatitis C Virus After Liver Transplantation.
Wong, R. J., Saab, S., & Ahmed, A. (2017). Extrahepatic Manifestations of Hepatitis C Virus After Liver Transplantation. Clinics in Liver Disease, 21(3), 595–606.

Expanding Treatment Access for Chronic Hepatitis C with Task-shifting in the Era of Direct-acting Antivirals.
Yoo, E. R., Perumpail, R. B., Cholankeril, G., Jayasekera, C. R., & Ahmed, A. (2017). Expanding Treatment Access for Chronic Hepatitis C with Task-shifting in the Era of Direct-acting Antivirals. Journal of Clinical and Translational Hepatology, 5(2), 130–133.

Association between body size-metabolic phenotype and non-alcoholic steatohepatitis and significant fibrosis
Kim, W., Kim, D., Harrison, S., Younossi, Z., & Ahmed, A. (2019). Association between body size-metabolic phenotype and non-alcoholic steatohepatitis and significant fibrosis. JOURNAL OF HEPATOLOGY. ELSEVIER SCIENCE BV.

Elevated urinary bisphenol A levels are associated with non-alcoholic fatty liver disease among adults in the United States
Kim, D., Yoo, E., Li, A., Cholankeril, G., Tighe, S., Kim, W., … Ahmed, A. (2019). Elevated urinary bisphenol A levels are associated with non-alcoholic fatty liver disease among adults in the United States. JOURNAL OF HEPATOLOGY. ELSEVIER SCIENCE BV.

Predictors of outcomes for patients with non-alcoholic steatohepatitis undergoing liver transplantation in the United States
Stepanova, M., Mishra, A., Younossi, I., Kim, D., Ahmed, A., & Younossi, Z. (2019). Predictors of outcomes for patients with non-alcoholic steatohepatitis undergoing liver transplantation in the United States. JOURNAL OF HEPATOLOGY, 70, E573.

Association between advanced fibrosis in fatty liver disease and overall mortality in terms of body size and body fat distribution
Chung, G. E., Heo, N. J., Yim, J. Y., Kwak, M.-S., Kim, J. S., Ahmed, A., & Kim, D. (2019). Association between advanced fibrosis in fatty liver disease and overall mortality in terms of body size and body fat distribution. JOURNAL OF HEPATOLOGY. ELSEVIER SCIENCE BV.

Changing Trends in Etiology-Based and Ethnicity-Based Annual Mortality Rates of Cirrhosis and Hepatocellular Carcinoma in the United States
Kim, D., Li, A. A., Perumpail, B. J., Gadiparthi, C., Kim, W., Cholankeril, G., … Ahmed, A. (2019). Changing Trends in Etiology-Based and Ethnicity-Based Annual Mortality Rates of Cirrhosis and Hepatocellular Carcinoma in the United States. HEPATOLOGY, 69(3), 1064–74.

Disparities in mortality for chronic liver disease among Asian subpopulations in the United States from 2007 to 2016
Li, A. A., Kim, D., Kim, W., Dibba, P., Wong, K., Cholankeril, G., … Ahmed, A. (2018). Disparities in mortality for chronic liver disease among Asian subpopulations in the United States from 2007 to 2016. JOURNAL OF VIRAL HEPATITIS, 25(12), 1608–16.

Trends in Hospitalizations for Chronic Liver Disease-related Liver Failure in the United States, 2005-2014.
Kim, D., Cholankeril, G., Li, A. A., Kim, W., Tighe, S. P., Hameed, B., … Ahmed, A. (2019). Trends in Hospitalizations for Chronic Liver Disease-related Liver Failure in the United States, 2005-2014. Liver International : Official Journal of the International Association for the Study of the Liver.

Temporal Trends Associated With the Rise in Alcoholic Liver Disease-related Liver Transplantation in the United States
Cholankeril, G., Gadiparthi, C., Yoo, E. R., Dennis, B. B., Li, A. A., Hu, M., … Ahmed, A. (2019). Temporal Trends Associated With the Rise in Alcoholic Liver Disease-related Liver Transplantation in the United States. TRANSPLANTATION, 103(1), 131–39.

Economic burden and healthcare utilization in nonalcoholic fatty liver disease.
Yoo, E. R., Ahmed, A., & Kim, D. (2019). Economic burden and healthcare utilization in nonalcoholic fatty liver disease. Hepatobiliary Surgery and Nutrition, 8(2), 181–183.

Nonalcoholic fatty liver disease in the over-60s: Impact of sarcopenia and obesity.
Wijarnpreecha, K., Panjawatanan, P., Aby, E., Ahmed, A., & Kim, D. (2019). Nonalcoholic fatty liver disease in the over-60s: Impact of sarcopenia and obesity. Maturitas, 124, 48–54.

Pre-Operative Delta-MELD is an Independent Predictor of Higher Mortality following Liver Transplantation.
Cholankeril, G., Li, A. A., Dennis, B. B., Gadiparthi, C., Kim, D., Toll, A. E., … Ahmed, A. (2019). Pre-Operative Delta-MELD is an Independent Predictor of Higher Mortality following Liver Transplantation. Scientific Reports, 9(1), 8312.

Hepatocellular carcinoma is leading in cancer-related disease burden among hospitalized baby boomers.
Gadiparthi, C., Yoo, E. R., Are, V. S., Charilaou, P., Kim, D., Cholankeril, G., … Ahmed, A. (2019). Hepatocellular carcinoma is leading in cancer-related disease burden among hospitalized baby boomers. Annals of Hepatology.

Extrahepatic Manifestations of Nonalcoholic Fatty Liver Disease.
Li, A. A., Ahmed, A., & Kim, D. (2019). Extrahepatic Manifestations of Nonalcoholic Fatty Liver Disease. Gut and Liver.

Potential Mechanisms Influencing the Inverse Relationship Between Cannabis and Nonalcoholic Fatty Liver Disease: A Commentary
Dibba, P., Li, A. A., Cholankeril, G., Khan, M. A., Kim, D., & Ahmed, A. (2019). Potential Mechanisms Influencing the Inverse Relationship Between Cannabis and Nonalcoholic Fatty Liver Disease: A Commentary. NUTRITION AND METABOLIC INSIGHTS, 12.

Impact of sarcopenia on the progression of nonalcoholic fatty liver disease: a frequently forgotten association
Li, A. A., Ahmed, A., & Kim, D. (2019). Impact of sarcopenia on the progression of nonalcoholic fatty liver disease: a frequently forgotten association. HEPATOBILIARY SURGERY AND NUTRITION, 8(3), 260–61.

Increasing Mortality Among Patients With Diabetes and Chronic Liver Disease From 2007 Through 2017.
Kim, D., Cholankeril, G., Kim, S. H., Abbasi, F., Knowles, J. W., & Ahmed, A. (2019). Increasing Mortality Among Patients With Diabetes and Chronic Liver Disease From 2007 Through 2017. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association.

Nonalcoholic fatty liver disease in the over-60s: Impact of sarcopenia and obesity
Wijampreecha, K., Panjawatanan, P., Aby, E., Ahmed, A., & Kim, D. (2019). Nonalcoholic fatty liver disease in the over-60s: Impact of sarcopenia and obesity. MATURITAS, 124, 48–54.

Trends in overall, cardiovascular and cancer-related mortality among individuals with diabetes reported on death certificates in the United States between 2007 and 2017
Kim, D., Li, A. A., Cholankeril, G., Kim, S. H., Ingelsson, E., Knowles, J. W., … Ahmed, A. (2019). Trends in overall, cardiovascular and cancer-related mortality among individuals with diabetes reported on death certificates in the United States between 2007 and 2017. DIABETOLOGIA, 62(7), 1185–94.

Liver transplantation for hepatitis C virus (HCV) non-viremic recipients with HCV viremic donors
Kwong, A. J., Wall, A., Melcher, M., Wang, U., Ahmed, A., Subramanian, A., & Kwo, P. Y. (2019). Liver transplantation for hepatitis C virus (HCV) non-viremic recipients with HCV viremic donors. AMERICAN JOURNAL OF TRANSPLANTATION, 19(5), 1380–87.

Impact of sarcopenia on the progression of nonalcoholic fatty liver disease: a frequently forgotten association.
Li, A. A., Ahmed, A., & Kim, D. (2019). Impact of sarcopenia on the progression of nonalcoholic fatty liver disease: a frequently forgotten association. Hepatobiliary Surgery and Nutrition, 8(3), 260–261.

Effects of Alcohol Consumption and Metabolic Syndrome on Mortality in Patients With Nonalcoholic and Alcohol-Related Fatty Liver Disease
Younossi, Z. M., Stepanova, M., Ong, J., Yilmaz, Y., Duseja, A., Eguchi, Y., … Afendy, A. (2019). Effects of Alcohol Consumption and Metabolic Syndrome on Mortality in Patients With Nonalcoholic and Alcohol-Related Fatty Liver Disease. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 17(8), 1625-+.

Disparate Trends in Mortality of Etiology-Specific Chronic Liver Diseases Among Hispanic Subpopulations
Kim, D., Li, A. A., Perumpail, R. B., Cholankeril, G., Gonzalez, S. A., Kim, W., & Ahmed, A. (2019). Disparate Trends in Mortality of Etiology-Specific Chronic Liver Diseases Among Hispanic Subpopulations. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 17(8), 1607-+.

Increasing Trends in Transplantation of HCV-Positive Livers Into Uninfected Recipients
Cholankeril, G., Li, A. A., Dennis, B. B., Toll, A. E., Kim, D., Bonham, C. A., … Ahmed, A. (2019). Increasing Trends in Transplantation of HCV-Positive Livers Into Uninfected Recipients. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 17(8), 1634–36.

Trends in Mortality From Extrahepatic Complications in Patients With Chronic Liver Disease, From 2007 Through 2017.
Kim, D., Adejumo, A. C., Yoo, E. R., Iqbal, U., Li, A. A., Pham, E. A., … Ahmed, A. (2019). Trends in Mortality From Extrahepatic Complications in Patients With Chronic Liver Disease, From 2007 Through 2017. Gastroenterology.

Association between Advanced Fibrosis in Fatty Liver Disease and Overall Mortality based on Body Fat Distribution.
Chung, G. E., Heo, N. J., Kim, D., Kwak, M.-S. S., Yim, J. Y., Kim, J. S., & Ahmed, A. (2019). Association between Advanced Fibrosis in Fatty Liver Disease and Overall Mortality based on Body Fat Distribution. Journal of Gastroenterology and Hepatology.

Potential Mechanisms Influencing the Inverse Relationship Between Cannabis and Nonalcoholic Fatty Liver Disease: A Commentary.
Dibba, P., Li, A. A., Cholankeril, G., Ali Khan, M., Kim, D., & Ahmed, A. (2019). Potential Mechanisms Influencing the Inverse Relationship Between Cannabis and Nonalcoholic Fatty Liver Disease: A Commentary. Nutrition and Metabolic Insights, 12, 1178638819847480.

Liver Transplantation for Nonalcoholic Steatohepatitis: Pathophysiology of Recurrence and Clinical Challenges.
Samji, N. S., Verma, R., Keri, K. C., Singal, A. K., Ahmed, A., Rinella, M., … Satapathy, S. K. (2019). Liver Transplantation for Nonalcoholic Steatohepatitis: Pathophysiology of Recurrence and Clinical Challenges. Digestive Diseases and Sciences.

Depression is associated with non-alcoholic fatty liver disease among adults in the United States.
Kim, D., Yoo, E. R., Li, A. A., Tighe, S. P., Cholankeril, G., Harrison, S. A., & Ahmed, A. (2019). Depression is associated with non-alcoholic fatty liver disease among adults in the United States. Alimentary Pharmacology & Therapeutics.

Elevated urinary bisphenol A levels are associated with non-alcoholic fatty liver disease among adults in the United States
Kim, D., Yoo, E. R., Li, A. A., Cholankeril, G., Tighe, S. P., Kim, W., … Ahmed, A. (2019). Elevated urinary bisphenol A levels are associated with non-alcoholic fatty liver disease among adults in the United States. LIVER INTERNATIONAL, 39(7), 1335–42.

Treatment of inoperable hepatocellular carcinoma with immunotherapy.
Tighe, S. P., Iqbal, U., Fernandes, C. T., & Ahmed, A. (2019). Treatment of inoperable hepatocellular carcinoma with immunotherapy. BMJ Case Reports, 12(7).

Readmission Rates and Associated Outcomes for Alcoholic Hepatitis: A Nationwide Cohort Study.
Adejumo, A. C., Cholankeril, G., Iqbal, U., Yoo, E. R., Boursiquot, B. C., Concepcion, W. C., … Ahmed, A. (2019). Readmission Rates and Associated Outcomes for Alcoholic Hepatitis: A Nationwide Cohort Study. Digestive Diseases and Sciences.

Suboptimal Use of Inpatient Palliative Care Consultation May Lead to Higher Readmissions and Costs in End-Stage Liver Disease.
Adejumo, A. C., Kim, D., Iqbal, U., Yoo, E. R., Boursiquot, B. C., Cholankeril, G., … Ahmed, A. (2019). Suboptimal Use of Inpatient Palliative Care Consultation May Lead to Higher Readmissions and Costs in End-Stage Liver Disease. Journal of Palliative Medicine.

Association between body size-metabolic phenotype and nonalcoholic steatohepatitis and significant fibrosis.
Kim, D., Kim, W., Joo, S. K., Han, J., Kim, J. H., Harrison, S. A., … Ahmed, A. (2019). Association between body size-metabolic phenotype and nonalcoholic steatohepatitis and significant fibrosis. Journal of Gastroenterology.

Trends in hospitalizations for chronic liver disease-related liver failure in the United States, 2005-2014
Kim, D., Cholankeril, G., Li, A. A., Kim, W., Tighe, S. P., Hameed, B., … Ahmed, A. (2019). Trends in hospitalizations for chronic liver disease-related liver failure in the United States, 2005-2014. LIVER INTERNATIONAL, 39(9), 1661–71.

Genetic Factors and Continental Ancestry Account for Some Disparities in Nonalcoholic Fatty Liver Disease Among Hispanic Subgroups
Yoo, E. R., Ahmed, A., & Kim, D. (2019). Genetic Factors and Continental Ancestry Account for Some Disparities in Nonalcoholic Fatty Liver Disease Among Hispanic Subgroups. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 17(11), 2176–78.

Low-Normal Thyroid Function Is Associated With Advanced Fibrosis Among Adults in the United States
Kim, D., Yoo, E. R., Li, A. A., Fernandes, C. T., Tighe, S. P., Cholankeril, G., … Ahmed, A. (2019). Low-Normal Thyroid Function Is Associated With Advanced Fibrosis Among Adults in the United States. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 17(11), 2379–81.

CLINICOPATHOLOGICAL FEATURES OF NONALCOHOLIC STEATOHEPATITIS (NASH)-RELATED HEPATOCELLULAR CARCINOMA (HCC)
Arjunan, V., Prabhakar, V., Raghavan, S. S., Tulu, Z., Kambham, N., Ahmed, A., … Dhanasekaran, R. (2019). CLINICOPATHOLOGICAL FEATURES OF NONALCOHOLIC STEATOHEPATITIS (NASH)-RELATED HEPATOCELLULAR CARCINOMA (HCC). HEPATOLOGY, 70, 548A.

IS IT GOOD IDEA TO OFFER TRANSPLANT EXCEPTION POINTS FOR SEPTUAGENARIANS WITH HEPATOCELLULAR CARCINOMA (HCC)?
Arjunan, V., Prabhakar, V., Raghavan, S. S., Tulu, Z., Kambham, N., Ahmed, A., … Dhanasekaran, R. (2019). IS IT GOOD IDEA TO OFFER TRANSPLANT EXCEPTION POINTS FOR SEPTUAGENARIANS WITH HEPATOCELLULAR CARCINOMA (HCC)? HEPATOLOGY, 70, 557A–558A.

THE ROLE OF LOCOREGIONAL THERAPY (LRT), POST LRT IMAGING, AND EXPLANT PATHOLOGY AS PREDICTORS OF HEPATOCELLULAR CARCINOMA (HCC) RECURRENCE POST ORTHOTOPIC LIVER TRANSPLANT (OLT)
Prabhakar, V., Dhanasekaran, R., Arjunan, V., Tulu, Z., Ahmed, A., Daugherty, T., … Kwo, P. Y. (2019). THE ROLE OF LOCOREGIONAL THERAPY (LRT), POST LRT IMAGING, AND EXPLANT PATHOLOGY AS PREDICTORS OF HEPATOCELLULAR CARCINOMA (HCC) RECURRENCE POST ORTHOTOPIC LIVER TRANSPLANT (OLT). HEPATOLOGY. WILEY.

HOSPITALIZATION OUTCOMES AND READMISSION RATES ASSOCIATED WITH NONALCOHOLIC FATTY LIVER DISEASE IN THE US: A NATIONAL COHORT STUDY UTILIZING ICD-10 ADMINISTRATIVE DATA
Murag, S., Yoo, E., Dennis, B., Adejumo, A., Hu, M., Kim, D., … Cholankeril, G. (2019). HOSPITALIZATION OUTCOMES AND READMISSION RATES ASSOCIATED WITH NONALCOHOLIC FATTY LIVER DISEASE IN THE US: A NATIONAL COHORT STUDY UTILIZING ICD-10 ADMINISTRATIVE DATA. HEPATOLOGY, 70, 745A–746A.

CLINICAL AND PATIENT-REPORTED OUTCOMES (PROs) IN PATIENTS WITH CHRONIC HEPATITIS B VIRUS (HBV) INFECTION SEEN IN REAL-WORLD PRACTICES ACROSS THE WORLD: DATA FROM THE GLOBAL LIVER REGISTRY
Younossi, Z. M., Yu, M.-L., El Kassas, M., Esmat, G., Yilmaz, Y., Fernandez, M. C., … Stepanova, M. (2019). CLINICAL AND PATIENT-REPORTED OUTCOMES (PROs) IN PATIENTS WITH CHRONIC HEPATITIS B VIRUS (HBV) INFECTION SEEN IN REAL-WORLD PRACTICES ACROSS THE WORLD: DATA FROM THE GLOBAL LIVER REGISTRY. HEPATOLOGY, 70, 577A–578A.

TRENDS AND OUTCOMES ASSOCIATED WITH ALCOHOL-RELATED HOSPITALIZATIONS IN THE UNITED STATES: A RETROSPECTIVE COHORT STUDY
Murag, S., Yoo, E., Dennis, B. B., Adejumo, A., Hu, M., Kim, D., … Cholankeril, G. (2019). TRENDS AND OUTCOMES ASSOCIATED WITH ALCOHOL-RELATED HOSPITALIZATIONS IN THE UNITED STATES: A RETROSPECTIVE COHORT STUDY. HEPATOLOGY, 70, 392A–393A.

NON-ALCOHOLIC STEATOHEPATITIS (NASH) IS THE MOST RAPIDLY GROWING CAUSE OF LISTING FOR LIVER TRANSPLANTATION: THE SCIENTIFIC REGISTRY OF TRANSPLANT RECIPIENTS (SRTR) DATA FROM 1994 TO 2018
Younossi, Z. M., Stepanova, M., Ong, J., Trimble, G., Ahmed, A., Alqahtani, S., … Racila, A. (2019). NON-ALCOHOLIC STEATOHEPATITIS (NASH) IS THE MOST RAPIDLY GROWING CAUSE OF LISTING FOR LIVER TRANSPLANTATION: THE SCIENTIFIC REGISTRY OF TRANSPLANT RECIPIENTS (SRTR) DATA FROM 1994 TO 2018. HEPATOLOGY, 70, 697A–698A.

NATIONAL ESTIMATE OF THE FREQUENCY, TRENDS AND HEALTHCARE BURDEN OF CARE FRAGMENTATION IN READMISSIONS FOR END-STAGE LIVER DISEASE IN THE US
Adejumo, A., Dennis, B., Cholankeril, G., Wong, R. J., Kim, D., Younossi, Z. M., & Ahmed, A. (2019). NATIONAL ESTIMATE OF THE FREQUENCY, TRENDS AND HEALTHCARE BURDEN OF CARE FRAGMENTATION IN READMISSIONS FOR END-STAGE LIVER DISEASE IN THE US. HEPATOLOGY, 70, 449A.

ETIOLOGY SPECIFIC LIVER TRANSPLANT (LT) LISTINGS AND DETERMINANTS OF WAITLIST MORTALITY AMONG PATIENTS WITH ACUTE ON CHRONIC LIVER FAILURE (ACLF) IN THE US.
Tariq, R., Arora, S., Ahmed, A., Terrault, N., Lucey, M. R., Kuo, Y.-F., & Singal, A. K. (2019). ETIOLOGY SPECIFIC LIVER TRANSPLANT (LT) LISTINGS AND DETERMINANTS OF WAITLIST MORTALITY AMONG PATIENTS WITH ACUTE ON CHRONIC LIVER FAILURE (ACLF) IN THE US. HEPATOLOGY, 70, 161A–162A.

CLINICAL AND PATIENT-REPORTED OUTCOMES DATA FOR PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND NON-ALCOHOLIC STEATOHEPATITIS (NASH) ACROSS THE WORLD: DATA FROM THE GLOBAL NASH REGISTRY
Younossi, Z. M., Yu, M.-L., El Kassas, M., Esmat, G., Yilmaz, Y., Fernandez, M. C., … Stepanova, M. (2019). CLINICAL AND PATIENT-REPORTED OUTCOMES DATA FOR PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND NON-ALCOHOLIC STEATOHEPATITIS (NASH) ACROSS THE WORLD: DATA FROM THE GLOBAL NASH REGISTRY. HEPATOLOGY, 70, 749A–750A.

DIFFERENCES IN THE CLINICAL PROFILE OF THE MOST COMMON CAUSES OF CHRONIC LIVER DISEASE (CLD) ACROSS THE WORLD: DATA FROM THE GLOBAL LIVER REGISTRY.
Younossi, Z. M., Yu, M.-L., El Kassas, M., Esmat, G., Yilmaz, Y., Fernandez, M. C., … Stepanova, M. (2019). DIFFERENCES IN THE CLINICAL PROFILE OF THE MOST COMMON CAUSES OF CHRONIC LIVER DISEASE (CLD) ACROSS THE WORLD: DATA FROM THE GLOBAL LIVER REGISTRY. HEPATOLOGY, 70, 463A–465A.

THE IMPACT OF FUNCTIONAL STATUS AT TIME OF LIVER TRANSPLANTATION ON POST-TRANSPLANT SURVIVAL AMONG US ADULTS WITH AUTOIMMUNE-RELATED LIVER DISEASES: AN ANALYSIS OF THE 2004-2017 UNITED NETWORK FOR ORGAN SHARING DATABASE
Galoosian, A., Hanlon, C., Ahmed, A., & Wong, R. J. (2019). THE IMPACT OF FUNCTIONAL STATUS AT TIME OF LIVER TRANSPLANTATION ON POST-TRANSPLANT SURVIVAL AMONG US ADULTS WITH AUTOIMMUNE-RELATED LIVER DISEASES: AN ANALYSIS OF THE 2004-2017 UNITED NETWORK FOR ORGAN SHARING DATABASE. HEPATOLOGY, 70, 667A.

DIET QUALITY AND ITS ASSOCIATION WITH NONALCOHOLIC FATTY LIVER DISEASE AND MORTALITY - A POPULATION-BASED STUDY
Yoo, E., Li, A., Cholankeril, G., Kim, D., & Ahmed, A. (2019). DIET QUALITY AND ITS ASSOCIATION WITH NONALCOHOLIC FATTY LIVER DISEASE AND MORTALITY - A POPULATION-BASED STUDY. HEPATOLOGY. WILEY.

PNPLA3 GENE POLYMORPHISM AND OVERALL AND CARDIOVASCULAR MORTALITY IN THE UNITED STATES
Wijarnpreecha, K., Scribani, M., Raymond, P., Harnois, D. M., Keaveny, A. P., Ahmed, A., & Kim, D. (2019). PNPLA3 GENE POLYMORPHISM AND OVERALL AND CARDIOVASCULAR MORTALITY IN THE UNITED STATES. HEPATOLOGY, 70, 727A.

DISPARITIES IN PATIENTS WITH AUTOIMMUNE LIVER DISEASES AWAITING LIVER TRANSPLANTATION - HISPANIC ETHNICITY OR MEDICARE/MEDICAID INSURANCE IS ASSOCIATED WITH SIGNIFICANTLY LOWER PROBABILITY OF RECEIVING LIVER TRANSPLANTATION
Hanlon, C., Galoosian, A., Ahmed, A., & Wong, R. J. (2019). DISPARITIES IN PATIENTS WITH AUTOIMMUNE LIVER DISEASES AWAITING LIVER TRANSPLANTATION - HISPANIC ETHNICITY OR MEDICARE/MEDICAID INSURANCE IS ASSOCIATED WITH SIGNIFICANTLY LOWER PROBABILITY OF RECEIVING LIVER TRANSPLANTATION. HEPATOLOGY, 70, 858A.

SEVERE IMPAIRMENT OF PATIENT-REPORTED OUTCOMES (PROs) IN PATIENTS WITH CHRONIC HEPATITIS C VIRUS (HCV) INFECTION SEEN IN REAL-WORLD PRACTICES ACROSS THE WORLD: DATA FROM THE GLOBAL LIVER REGISTRY
Younossi, Z. M., Yu, M.-L., El Kassas, M., Esmat, G., Yilmaz, Y., Fernandez, M. C., … Stepanova, M. (2019). SEVERE IMPAIRMENT OF PATIENT-REPORTED OUTCOMES (PROs) IN PATIENTS WITH CHRONIC HEPATITIS C VIRUS (HCV) INFECTION SEEN IN REAL-WORLD PRACTICES ACROSS THE WORLD: DATA FROM THE GLOBAL LIVER REGISTRY. HEPATOLOGY, 70, 359A–360A.

Post-transplant Outcome of Lean Compared to Obese Nonalcoholic Steatohepatitis in the United States: The Obesity Paradox.
Satapathy, S. K., Jiang, Y., Agbim, U., Wu, C., Bernstein, D. E., Teperman, L. W., … Singal, A. K. (2019). Post-transplant Outcome of Lean Compared to Obese Nonalcoholic Steatohepatitis in the United States: The Obesity Paradox. Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Associations between sarcopenia and nonalcoholic fatty liver disease and advanced fibrosis in the USA
Wijarnpreecha, K., Kim, D., Raymond, P., Scribani, M., & Ahmed, A. (2019). Associations between sarcopenia and nonalcoholic fatty liver disease and advanced fibrosis in the USA. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 31(9), 1121–28.

Meeting Report: The Dallas consensus conference on liver transplantation for alcohol related hepatitis.
Asrani, S. K., Trotter, J., Lake, J., Ahmed, A., Bonagura, A., Cameron, A., … Klintmalm, G. (2019). Meeting Report: The Dallas consensus conference on liver transplantation for alcohol related hepatitis. Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Regional Trends in Mortality from Alcohol-Induced Causes in the United States, 2000-2017.
Cholankeril, G., Dennis, B. B., Kim, D., & Ahmed, A. (2019). Regional Trends in Mortality from Alcohol-Induced Causes in the United States, 2000-2017. Journal of General Internal Medicine.

Pathogenesis of Insulin Resistance and Atherogenic Dyslipidemia in Nonalcoholic Fatty Liver Disease
Akhtar, D. H., Iqbal, U., Vazquez-Montesino, L. M., Dennis, B. B., & Ahmed, A. (2019). Pathogenesis of Insulin Resistance and Atherogenic Dyslipidemia in Nonalcoholic Fatty Liver Disease. JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 7(4), 362–70.

Diet Quality and its Association with Nonalcoholic Fatty Liver Disease and All-cause and Cause-specific Mortality.
Yoo, E. R., Kim, D., Vazquez-Montesino, L. M., Escober, J. A., Li, A. A., Tighe, S. P., … Ahmed, A. (2020). Diet Quality and its Association with Nonalcoholic Fatty Liver Disease and All-cause and Cause-specific Mortality. Liver International : Official Journal of the International Association for the Study of the Liver.

Pathogenesis of Insulin Resistance and Atherogenic Dyslipidemia in Nonalcoholic Fatty Liver Disease.
Akhtar, D. H., Iqbal, U., Vazquez-Montesino, L. M., Dennis, B. B., & Ahmed, A. (2019). Pathogenesis of Insulin Resistance and Atherogenic Dyslipidemia in Nonalcoholic Fatty Liver Disease. Journal of Clinical and Translational Hepatology, 7(4), 362–370.

Recent advances in liver transplantation with HCV seropositive donors.
Murag, S., Dennis, B. B., Kim, D., Ahmed, A., & Cholankeril, G. (2019). Recent advances in liver transplantation with HCV seropositive donors. F1000Research, 8.

Inadequate Physical Activity and Sedentary Behavior Are Independent Predictors of Nonalcoholic Fatty Liver Disease.
Kim, D., Vazquez-Montesino, L. M., Li, A. A., Cholankeril, G., & Ahmed, A. (2020). Inadequate Physical Activity and Sedentary Behavior Are Independent Predictors of Nonalcoholic Fatty Liver Disease. Hepatology (Baltimore, Md.).

Tenofovir versus entecavir in prevention of hepatocellular carcinoma and mortality in patients with chronic hepatitis B.
Kamal, F., Khan, M. A., Ahmed, A., & Nair, S. (2020). Tenofovir versus entecavir in prevention of hepatocellular carcinoma and mortality in patients with chronic hepatitis B. Gut.

The impact of chronic liver disease in patients receiving active pharmacological therapy for opioid use disorder: One-year findings from a prospective cohort study.
Dennis, B. B., Akhtar, D., Cholankeril, G., Kim, D., Sanger, N., Hillmer, A., … Ahmed, A. (2020). The impact of chronic liver disease in patients receiving active pharmacological therapy for opioid use disorder: One-year findings from a prospective cohort study. Drug and Alcohol Dependence, 209, 107917.

Sustained Decline of Noninvasive Fibrosis Index Values in Patients With Chronic Hepatitis C (CHC) With Sustained Virologic Response (SVR) After Receiving Direct-Acting Antiviral Agents (DAAs)
Prabhakar, V., Lutchman, G., Ahmed, A., Nguyen, M. H., Daugherty, T., & Kwo, P. (2019). Sustained Decline of Noninvasive Fibrosis Index Values in Patients With Chronic Hepatitis C (CHC) With Sustained Virologic Response (SVR) After Receiving Direct-Acting Antiviral Agents (DAAs). AMERICAN JOURNAL OF GASTROENTEROLOGY, 114, S553–S554.

Longitudinal Change in Thyroid-stimulating Hormone and Risk of Nonalcoholic Fatty Liver Disease.
Chung, G. E., Kim, D., Kwak, M.-S. S., Yim, J. Y., Ahmed, A., & Kim, J. S. (2020). Longitudinal Change in Thyroid-stimulating Hormone and Risk of Nonalcoholic Fatty Liver Disease. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association.

Trends in Hospitalizations for Clostridioides difficile Infection in End-Stage Liver Disease, 2005-2014.
Kim, D., Yoo, E. R., Li, A. A., Tighe, S. P., Cholankeril, G., & Ahmed, A. (2020). Trends in Hospitalizations for Clostridioides difficile Infection in End-Stage Liver Disease, 2005-2014. Digestive Diseases and Sciences.

Therapeutic Impact of Probiotic-based Diet Supplementation in Nonalcoholic Fatty Liver Disease
Cholankeril, R., Ahmed, A., & Varghese, R. (2020). Therapeutic Impact of Probiotic-based Diet Supplementation in Nonalcoholic Fatty Liver Disease. METABOLISM-CLINICAL AND EXPERIMENTAL, 104.

PNPLA3 Gene Polymorphism and Overall and Cardiovascular Mortality in the United States.
Wijarnpreecha, K., Scribani, M., Raymond, P., Harnois, D. M., Keaveny, A. P., Ahmed, A., & Kim, D. (2020). PNPLA3 Gene Polymorphism and Overall and Cardiovascular Mortality in the United States. Journal of Gastroenterology and Hepatology.

Treating Alcohol Use Disorder in Chronic Liver Disease.
Yoo, E. R., Cholankeril, G., & Ahmed, A. (2020). Treating Alcohol Use Disorder in Chronic Liver Disease. Clinical Liver Disease, 15(2), 77–80.

Road to identifying endpoint biomarkers in the treatment of nonalcoholic steatohepatitis: are we there yet?
Kim, D., Vazquez-Montesino, L. M., & Ahmed, A. (2020). Road to identifying endpoint biomarkers in the treatment of nonalcoholic steatohepatitis: are we there yet? HEPATOBILIARY SURGERY AND NUTRITION, 9(2), 244–46.

High Prevalence of Concurrent Gastrointestinal Manifestations in Patients with SARS-CoV-2: Early Experience from California.
Cholankeril, G., Podboy, A., Aivaliotis, V. I., Tarlow, B., Pham, E. A., Spencer, S., … Ahmed, A. (2020). High Prevalence of Concurrent Gastrointestinal Manifestations in Patients with SARS-CoV-2: Early Experience from California. Gastroenterology.

PNPLA3 Gene Polymorphism and Liver- and Extrahepatic Cancer-related Mortality in the United States.
Wijarnpreecha, K., Scribani, M., Raymond, P., Harnois, D. M., Keaveny, A. P., Ahmed, A., & Kim, D. (2020). PNPLA3 Gene Polymorphism and Liver- and Extrahepatic Cancer-related Mortality in the United States. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association.

Road to identifying endpoint biomarkers in the treatment of nonalcoholic steatohepatitis: are we there yet?
Kim, D., Vazquez-Montesino, L. M., & Ahmed, A. (2020). Road to identifying endpoint biomarkers in the treatment of nonalcoholic steatohepatitis: are we there yet? Hepatobiliary Surgery and Nutrition, 9(2), 244–246.

Decline in Annual Mortality of Hepatitis C Virus-related Hepatocellular Carcinoma in the United States, From 2009 to 2018.
Kim, D., Konyn, P., Cholankeril, G., Wong, R. J., Younossi, Z. M., & Ahmed, A. (2020). Decline in Annual Mortality of Hepatitis C Virus-related Hepatocellular Carcinoma in the United States, From 2009 to 2018. Gastroenterology.

Low Thyroid Function in Nonalcoholic Fatty Liver Disease Is an Independent Predictor of All-Cause and Cardiovascular Mortality.
Kim, D., Vazquez-Montesino, L. M., Escober, J. A., Fernandes, C. T., Cholankeril, G., Loomba, R., … Ahmed, A. (2020). Low Thyroid Function in Nonalcoholic Fatty Liver Disease Is an Independent Predictor of All-Cause and Cardiovascular Mortality. The American Journal of Gastroenterology.

Nonalcoholic Steatohepatitis is the Most Rapidly Increasing Indication for Liver Transplantation in the United States.
Younossi, Z. M., Stepanova, M., Ong, J., Trimble, G., AlQahtani, S., Younossi, I., … Henry, L. (2020). Nonalcoholic Steatohepatitis is the Most Rapidly Increasing Indication for Liver Transplantation in the United States. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association.

Identification of Patients with Advanced Fibrosis Due to Nonalcoholic Fatty Liver Disease: Considerations for Best Practice.
Augustin, S., Ahmed, A., Alkhouri, N., Canbay, A., Corless, L., Nakajima, A., … Romero-Gomez, M. (2020). Identification of Patients with Advanced Fibrosis Due to Nonalcoholic Fatty Liver Disease: Considerations for Best Practice. Journal of Gastrointestinal and Liver Diseases : JGLD, 29(2), 235–45.

Gender and Racial Differences in Hospitalizations for Primary Biliary Cholangitis in the USA.
Adejumo, A. C., Akhtar, D. H., Dennis, B. B., Cholankeril, G., Alayo, Q., Ogundipe, O. A., … Ahmed, A. (2020). Gender and Racial Differences in Hospitalizations for Primary Biliary Cholangitis in the USA. Digestive Diseases and Sciences.

Implementation and Impact of Universal Pre-procedure Testing of Patients for COVID-19 prior to Endoscopy.
Podboy, A., Cholankeril, G., Cianfichi, L., Guzman, E., Ahmed, A., & Banerjee, S. (2020). Implementation and Impact of Universal Pre-procedure Testing of Patients for COVID-19 prior to Endoscopy. Gastroenterology.

Upregulation of CD47 Is a Host Checkpoint Response to Pathogen Recognition.
Tal, M. C., Torrez Dulgeroff, L. B., Myers, L., Cham, L. B., Mayer-Barber, K. D., Bohrer, A. C., … Hasenkrug, K. J. (2020). Upregulation of CD47 Is a Host Checkpoint Response to Pathogen Recognition. MBio, 11(3).

Association of Digestive Symptoms and Hospitalization in Patients With SARS-CoV-2 Infection.
Cholankeril, G., Podboy, A., Aivaliotis, V. I., Pham, E. A., Spencer, S. P., Kim, D., & Ahmed, A. (2020). Association of Digestive Symptoms and Hospitalization in Patients With SARS-CoV-2 Infection. The American Journal of Gastroenterology, 115(7), 1129–32.

COVID-19 and liver injury: a meta-analysis.
Wijarnpreecha, K., Ungprasert, P., Panjawatanan, P., Harnois, D. M., Zaver, H. B., Ahmed, A., & Kim, D. (2020). COVID-19 and liver injury: a meta-analysis. European Journal of Gastroenterology & Hepatology.

Early Impact of COVID-19 on Solid Organ Transplantation in the United States.
Cholankeril, G., Podboy, A., Alshuwaykh, O. S., Kim, D., Kanwal, F., Esquivel, C. O., & Ahmed, A. (2020). Early Impact of COVID-19 on Solid Organ Transplantation in the United States. Transplantation.

NAFLD Epidemiology, Emerging Pharmacotherapy, Liver Transplantation Implications and the Trends in the United States
Gadiparthi, C., Spatz, M., Greenberg, S., Iqbal, U., Kanna, S., Satapathy, S. K., … Ahmed, A. (2020). NAFLD Epidemiology, Emerging Pharmacotherapy, Liver Transplantation Implications and the Trends in the United States. JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 8(2), 215–21.

Physical Activity, Measured Objectively, is Associated With Lower Mortality in Patients With Nonalcoholic Fatty Liver Disease.
Kim, D., Murag, S., Cholankeril, G., Cheung, A., Harrison, S. A., Younossi, Z. M., & Ahmed, A. (2020). Physical Activity, Measured Objectively, is Associated With Lower Mortality in Patients With Nonalcoholic Fatty Liver Disease. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association.

Prevalence of Fatty Liver Disease and Fibrosis detected by Fibroscan in Adults in the United States, 2017-2018.
Kim, D., Cholankeril, G., Loomba, R., & Ahmed, A. (2020). Prevalence of Fatty Liver Disease and Fibrosis detected by Fibroscan in Adults in the United States, 2017-2018. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association.

NAFLD Epidemiology, Emerging Pharmacotherapy, Liver Transplantation Implications and the Trends in the United States.
Gadiparthi, C., Spatz, M., Greenberg, S., Iqbal, U., Kanna, S., Satapathy, S. K., … Ahmed, A. (2020). NAFLD Epidemiology, Emerging Pharmacotherapy, Liver Transplantation Implications and the Trends in the United States. Journal of Clinical and Translational Hepatology, 8(2), 215–221.

Association of Sarcopenia and NAFLD: An Overview.
Li, A. A., Kim, D., & Ahmed, A. (2020). Association of Sarcopenia and NAFLD: An Overview. Clinical Liver Disease, 16(2), 73–76.

Recent Epidemiology of Nonalcoholic Fatty Liver Disease.
Murag, S., Ahmed, A., & Kim, D. (2020). Recent Epidemiology of Nonalcoholic Fatty Liver Disease. Gut and Liver.

Understanding Gaps in the Hepatocellular Carcinoma Cascade of Care: Opportunities to Improve Hepatocellular Carcinoma Outcomes.
Wong, R. J., & Ahmed, A. Understanding Gaps in the Hepatocellular Carcinoma Cascade of Care: Opportunities to Improve Hepatocellular Carcinoma Outcomes. Journal of Clinical Gastroenterology, 54(10), 850–56.

Impact of Bridging Locoregional Therapies for Hepatocellular Carcinoma on Post-Transplant Clinical Outcome.
Adeniji, N., Arjunan, V., Prabhakar, V., Tulu, Z., Kambham, N., Ahmed, A., … Dhanasekaran, R. (2020). Impact of Bridging Locoregional Therapies for Hepatocellular Carcinoma on Post-Transplant Clinical Outcome. Clinical Transplantation, e14128.

Patients with hepatocellular carcinoma from more rural and lower income households have more advanced tumor stage at diagnosis and significantly higher mortality.
Wong, R. J., Kim, D., Ahmed, A., & Singal, A. K. (2020). Patients with hepatocellular carcinoma from more rural and lower income households have more advanced tumor stage at diagnosis and significantly higher mortality. Cancer.

Trends in Mortality in Hepatitis C Infection and Alcoholic Liver Disease based on Drug Overdose in the United States.
Kim, D., Alshuwaykh, O. S., Cholankeril, G., Wong, R. J., & Ahmed, A. (2020). Trends in Mortality in Hepatitis C Infection and Alcoholic Liver Disease based on Drug Overdose in the United States. Journal of Viral Hepatitis.

NORTH AMERICA'S LARGEST META-ANALYSIS ON THE PREVALENCE OF NAFLD, NASH, AND ADVANCED FIBROSIS (F3-F4)
Ahmed, A., Espinueva, A., Bam, R. A., Lu, K., Wang, L., Wang, Y., … Bambha, K. (2020). NORTH AMERICA'S LARGEST META-ANALYSIS ON THE PREVALENCE OF NAFLD, NASH, AND ADVANCED FIBROSIS (F3-F4). HEPATOLOGY. WILEY.

THE INCIDENCE OF HEPATOCELLULAR CARCINOMA IN CHRONIC HEPATITIS B VIRUS INFECTION SUBJECTS NOT MEETING CRITERIA FOR ANTIVIRAL THERAPY
Alshuwaykh, O., Goel, A., Daugherty, T., Cheung, A., Kim, W. R., Kwong, A. J., … Kwo, P. Y. (2020). THE INCIDENCE OF HEPATOCELLULAR CARCINOMA IN CHRONIC HEPATITIS B VIRUS INFECTION SUBJECTS NOT MEETING CRITERIA FOR ANTIVIRAL THERAPY. HEPATOLOGY. WILEY.

CLINICAL AND PATIENT-REPORTED OUTCOMES DATA OF NON-ALCOHOLIC FATTY LIVER DISEASE: LONGITUDINAL DATA FROM THE GLOBAL NASH REGISTRY (TM)
Younossi, Z. M., Yilmaz, Y., Yu, M.-L., Wong, V. W.-S., Castellanos Fernandez, M., Isakov, V. A., … Stepanova, M. (2020). CLINICAL AND PATIENT-REPORTED OUTCOMES DATA OF NON-ALCOHOLIC FATTY LIVER DISEASE: LONGITUDINAL DATA FROM THE GLOBAL NASH REGISTRY (TM). HEPATOLOGY. WILEY.

THE IMPACT OF CHRONIC HEPATITIS B ON PATIENT-REPORTED OUTCOMES FROM THE GLOBAL LIVER REGISTRY (TM)
Yilmaz, Y., Yu, M.-L., Lam, B. P., Ferret, M. A. B., Papatheodoridis, G., Chan, W. K., … Younossi, Z. M. (2020). THE IMPACT OF CHRONIC HEPATITIS B ON PATIENT-REPORTED OUTCOMES FROM THE GLOBAL LIVER REGISTRY (TM). HEPATOLOGY. WILEY.

COVID-19 AND LIVER INJURY: A META-ANALYSIS
Zaver, H., Wijarnpreecha, K., Ungprasert, P., Panjawatanan, P., Hamois, D. M., Ahmed, A., & Kim, D. (2020). COVID-19 AND LIVER INJURY: A META-ANALYSIS. HEPATOLOGY, 72, 265A–266A.

The case for simplifying and using absolute targets for viral hepatitis elimination goals
Razavi, H., Blach, S., Razavi-Shearers, D., Abaalkhail, F., Abbas, Z., Abdallah, A., … Zeuzem, S. (2020). The case for simplifying and using absolute targets for viral hepatitis elimination goals. JOURNAL OF VIRAL HEPATITIS.

Post-Transplant Outcomes in Older Patients with Hepatocellular Carcinoma (HCC) are Driven by non-HCC Factors.
Adeniji, N., Arjunan, V., Prabhakar, V., Mannalithara, A., Ghaziani, T., Ahmed, A., … Dhanasekaran, R. (2020). Post-Transplant Outcomes in Older Patients with Hepatocellular Carcinoma (HCC) are Driven by non-HCC Factors. Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Association of Anti-TNF Therapy With Increased Risk of Acute Cholangitis in Patients With Primary Sclerosing Cholangitis.
Kulkarni, C., Murag, S., Cholankeril, G., Fardeen, T., Mannalithara, A., Lerrigo, R., … Sinha, S. R. (2020). Association of Anti-TNF Therapy With Increased Risk of Acute Cholangitis in Patients With Primary Sclerosing Cholangitis. Inflammatory Bowel Diseases.

Evaluation and Management of Extrahepatic Manifestations of Nonalcoholic Fatty Liver Disease.
Wijarnpreecha, K., Aby, E. S., Ahmed, A., & Kim, D. (2020). Evaluation and Management of Extrahepatic Manifestations of Nonalcoholic Fatty Liver Disease. Clinical and Molecular Hepatology.

Validating a novel score based on interaction between ACLF grade and MELD score to predict waitlist mortality.
Abdallah, M. A., Kuo, Y.-F. F., Asrani, S., Wong, R. J., Ahmed, A., Kwo, P., … Singal, A. K. (2020). Validating a novel score based on interaction between ACLF grade and MELD score to predict waitlist mortality. Journal of Hepatology.

Predictors of Outcomes of Patients Referred to a Transplant Center for Urgent Liver Transplantation Evaluation
Alshuwaykh, O., Kwong, A., Goel, A., Cheung, A., Dhanasekaran, R., Ahmed, A., … Kwo, P. Y. (2020). Predictors of Outcomes of Patients Referred to a Transplant Center for Urgent Liver Transplantation Evaluation. HEPATOLOGY COMMUNICATIONS.

Chronic Liver Disease and Silymarin: A Biochemical and Clinical Review.
Tighe, S. P., Akhtar, D., Iqbal, U., & Ahmed, A. (2020). Chronic Liver Disease and Silymarin: A Biochemical and Clinical Review. Journal of Clinical and Translational Hepatology, 8(4), 454–58.

Clinical Response to Treatment for Acute Kidney Injury (AKI) in Patients With Cirrhosis
John, N., Alshuwaykh, O., Goel, A., Ahmed, A., Cheung, A., Dronamraju, D., … Kwo, P. Y. (2020). Clinical Response to Treatment for Acute Kidney Injury (AKI) in Patients With Cirrhosis. AMERICAN JOURNAL OF GASTROENTEROLOGY. LIPPINCOTT WILLIAMS & WILKINS.

Characterizing Ascites in Subjects With Nonhepatic Solid Tumors
Alshuwaykh, O., Cheung, A., Goel, A., Dhanasekaran, R., Ahmed, A., Dronamraju, D., … Kwo, P. Y. (2020). Characterizing Ascites in Subjects With Nonhepatic Solid Tumors. AMERICAN JOURNAL OF GASTROENTEROLOGY. LIPPINCOTT WILLIAMS & WILKINS.

Sarcopenia in Nonalcoholic Fatty Liver Disease and All-Cause and Cause-Specific Mortality in the United States.
Kim, D., Wijarnpreecha, K., Sandhu, K. K., Cholankeril, G., & Ahmed, A. (2021). Sarcopenia in Nonalcoholic Fatty Liver Disease and All-Cause and Cause-Specific Mortality in the United States. Liver International : Official Journal of the International Association for the Study of the Liver.

Predictors of Outcomes of Patients Referred to a Transplant Center for Urgent Liver Transplantation Evaluation.
Alshuwaykh, O., Kwong, A., Goel, A., Cheung, A., Dhanasekaran, R., Ahmed, A., … Kwo, P. Y. (2021). Predictors of Outcomes of Patients Referred to a Transplant Center for Urgent Liver Transplantation Evaluation. Hepatology Communications, 5(3), 516–525.

Prevalence of Nonalcoholic Fatty Liver Disease and Hepatic Fibrosis Among US Adults with Prediabetes and Diabetes, NHANES 2017-2018.
Kim, D., Cholankeril, G., Loomba, R., & Ahmed, A. (2021). Prevalence of Nonalcoholic Fatty Liver Disease and Hepatic Fibrosis Among US Adults with Prediabetes and Diabetes, NHANES 2017-2018. Journal of General Internal Medicine.

Signatures of immune dysfunction in HIV and HCV infection share features with chronic inflammation in aging and persist after viral reduction or elimination.
Lopez Angel, C. J., Pham, E. A., Du, H., Vallania, F., Fram, B. J., Perez, K., … Furman, D. (2021). Signatures of immune dysfunction in HIV and HCV infection share features with chronic inflammation in aging and persist after viral reduction or elimination. Proceedings of the National Academy of Sciences of the United States of America, 118(14).

Trends in the Mortality of Biliary Tract Cancers Based on Their Anatomical Site in the United States From 2009 to 2018.
Kim, D., Konyn, P., Cholankeril, G., Bonham, C. A., & Ahmed, A. (2021). Trends in the Mortality of Biliary Tract Cancers Based on Their Anatomical Site in the United States From 2009 to 2018. The American Journal of Gastroenterology, 116(5), 1053–62.

Association between Sarcopenic Obesity and Nonalcoholic Fatty Liver Disease and Fibrosis detected by Fibroscan.
Wijarnpreecha, K., Aby, E. S., Ahmed, A., & Kim, D. (2021). Association between Sarcopenic Obesity and Nonalcoholic Fatty Liver Disease and Fibrosis detected by Fibroscan. Journal of Gastrointestinal and Liver Diseases : JGLD.

Physical Activity is Associated with Nonalcoholic Fatty Liver Disease and Significant Fibrosis measured by Fibroscan.
Kim, D., Konyn, P., Cholankeril, G., & Ahmed, A. (2021). Physical Activity is Associated with Nonalcoholic Fatty Liver Disease and Significant Fibrosis measured by Fibroscan. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association.

Current Trends in Liver Transplantation for Alcoholic Hepatitis.
Bhatti, S., Kim, D., Ahmed, A., & Cholankeril, G. (2021). Current Trends in Liver Transplantation for Alcoholic Hepatitis. Clinics in Liver Disease, 25(3), 625–634.

Incorporating fatty liver disease in multidisciplinary care and novel clinical trial designs for patients with metabolic diseases.
Eslam, M., Ahmed, A., Després, J.-P. P., Jha, V., Halford, J. C., Wei Chieh, J. T., … George, J. (2021). Incorporating fatty liver disease in multidisciplinary care and novel clinical trial designs for patients with metabolic diseases. The Lancet. Gastroenterology & Hepatology.

Mortality Trends in Chronic Liver Disease and Cirrhosis in the United States, before and during COVID-19 Pandemic.
Kim, D., Bonham, C. A., Konyn, P., Cholankeril, G., & Ahmed, A. (2021). Mortality Trends in Chronic Liver Disease and Cirrhosis in the United States, before and during COVID-19 Pandemic. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association.

The impact of alteration in gut microbiome in the pathogenesis of nonalcoholic fatty liver disease.
Jacob, J. S., Ahmed, A., & Cholankeril, G. (2021). The impact of alteration in gut microbiome in the pathogenesis of nonalcoholic fatty liver disease. Current Opinion in Infectious Diseases.

Impact of COVID-19 pandemic on liver transplantation and alcohol-associated liver disease in the United States.
Cholankeril, G., Goli, K., Rana, A., Hernaez, R., Podboy, A., Jalal, P., … Kanwal, F. (2021). Impact of COVID-19 pandemic on liver transplantation and alcohol-associated liver disease in the United States. Hepatology (Baltimore, Md.).

Association between sarcopenic obesity and non-alcoholic fatty liver disease and fibrosis detected by fibroscan
Wijarnpreecha, K., Aby, E., Ahmed, A., & Kim, D. (2021). Association between sarcopenic obesity and non-alcoholic fatty liver disease and fibrosis detected by fibroscan. JOURNAL OF HEPATOLOGY. ELSEVIER.

Ethical and allocation issues in liver transplant candidates with alcohol related liver disease
Sedki, M., Ahmed, A., & Goel, A. (2020). Ethical and allocation issues in liver transplant candidates with alcohol related liver disease. TRANSLATIONAL GASTROENTEROLOGY AND HEPATOLOGY.

Metabolic dysfunction-associated fatty liver disease is associated with increased all-cause mortality in the United States.
Kim, D., Konyn, P., Sandhu, K. K., Dennis, B. B., Cheung, A. C., & Ahmed, A. (2021). Metabolic dysfunction-associated fatty liver disease is associated with increased all-cause mortality in the United States. Journal of Hepatology.

New hope for hepatitis C virus: Summary of global epidemiologic changes and novel innovations over 20 years.
Dennis, B. B., Naji, L., Jajarmi, Y., Ahmed, A., & Kim, D. (2021). New hope for hepatitis C virus: Summary of global epidemiologic changes and novel innovations over 20 years. World Journal of Gastroenterology, 27(29), 4818–4830.

Management of Cardiometabolic Complications in Patients With Nonalcoholic Fatty Liver Disease: A Review of the Literature With Recommendations.
Dennis, B. B., Sallam, S., Perumpail, B. J., Shah, N. D., Kim, D., Cholankeril, G., & Ahmed, A. (2021). Management of Cardiometabolic Complications in Patients With Nonalcoholic Fatty Liver Disease: A Review of the Literature With Recommendations. Journal of Clinical Gastroenterology, 55(9), 747–756.

Gastrointestinal manifestations of coronavirus disease 2019
Joshi, T., Ahmed, A., & Cholankeril, G. (2021). Gastrointestinal manifestations of coronavirus disease 2019. CURRENT OPINION IN INFECTIOUS DISEASES, 34(5), 471–476.

Current Epidemiology in Hepatocellular Carcinoma.
Konyn, P., Ahmed, A., & Kim, D. (2021). Current Epidemiology in Hepatocellular Carcinoma. Expert Review of Gastroenterology & Hepatology.

Extrahepatic causes of death in cirrhosis compared to other chronic conditions in the United States, 1999-2017.
Shankar, N., Ramani, A., Griffin, C., Agbim, U., Kim, D., Ahmed, A., & Asrani, S. K. (2021). Extrahepatic causes of death in cirrhosis compared to other chronic conditions in the United States, 1999-2017. Annals of Hepatology, 100565.

Reply: NAFLD Vs MAFLD - It is not the name but the disease that decides the outcome in fatty liver.
Kim, D., & Ahmed, A. (2021). Reply: NAFLD Vs MAFLD - It is not the name but the disease that decides the outcome in fatty liver. Journal of Hepatology.

Sex-specific Risk Factors and Health Disparity Among Hepatitis C Positive Patients Receiving Pharmacotherapy for Opioid Use Disorder: Findings From a Propensity Matched Analysis.
Dennis, B. B., Martin, L. J., Naji, L., Akhtar, D., Cholankeril, G., Kim, D., … Ahmed, A. (2021). Sex-specific Risk Factors and Health Disparity Among Hepatitis C Positive Patients Receiving Pharmacotherapy for Opioid Use Disorder: Findings From a Propensity Matched Analysis. Journal of Addiction Medicine.

Trends in the Prevalence of Hepatitis C Virus Infection based on the Insurance Status in the United States from 2013 to 2018.
Kim, D., Cholankeril, G., Dennis, B. B., Alshuwaykh, O., Kumari, R., Wong, R. J., & Ahmed, A. (2021). Trends in the Prevalence of Hepatitis C Virus Infection based on the Insurance Status in the United States from 2013 to 2018. Liver International : Official Journal of the International Association for the Study of the Liver.

THE INCIDENCE OF HEPATOCELLULAR CARCINOMA IN CHRONIC HEPATITIS B VIRUS INFECTION SUBJECTS WITH CIRRHOSIS NOT MEETING CURRENT TREATMENT GUIDANCE
Alshuwaykh, O., Goel, A., Ghaziani, T. T., Daugherty, T., Dhanasekaran, R., Ahmed, A., … Kwo, P. Y. (2021). THE INCIDENCE OF HEPATOCELLULAR CARCINOMA IN CHRONIC HEPATITIS B VIRUS INFECTION SUBJECTS WITH CIRRHOSIS NOT MEETING CURRENT TREATMENT GUIDANCE. HEPATOLOGY. WILEY.

Nonalcoholic Fatty Liver Disease and Chronic Kidney Disease: A Review of Links and Risks.
Cheung, A., & Ahmed, A. (2021). Nonalcoholic Fatty Liver Disease and Chronic Kidney Disease: A Review of Links and Risks. Clinical and Experimental Gastroenterology, 14, 457–465.

SURVIVAL OUTCOMES AND PROGNOSTIC FACTORS ASSOCIATED WITH LIVER TRANSPLANTATION FOR HEMOCHROMATOSIS
Lymberopoulos, P., Cholankeril, G., Jalal, P. K., Alshuwaykh, O., Goli, K., Kim, D., & Ahmed, A. (2021). SURVIVAL OUTCOMES AND PROGNOSTIC FACTORS ASSOCIATED WITH LIVER TRANSPLANTATION FOR HEMOCHROMATOSIS. HEPATOLOGY. WILEY.

PSYCHOSOCIAL PREDICTORS OF ALCOHOL RELAPSE AMONG LIVER TRANSPLANT CANDIDATES WITH ALCOHOL-RELATED LIVER DISEASE
Sedki, M., Kwo, P. Y., Ahmed, A., Hussain, F., Kwong, A. J., & Goel, A. (2021). PSYCHOSOCIAL PREDICTORS OF ALCOHOL RELAPSE AMONG LIVER TRANSPLANT CANDIDATES WITH ALCOHOL-RELATED LIVER DISEASE. HEPATOLOGY. WILEY.

STANFORD INTEGRATED PSYCHOSOCIAL ASSESSMENT FOR TRANSPLANT (SIPAT) IS SUPERIOR TO SALT AND HRAR IN IDENTIFYING LT CANDIDATES WITH ALD AT LOW RISK OF RELAPSE
Sedki, M., Kwo, P. Y., Ahmed, A., Hussain, F., Kwong, A. J., & Goel, A. (2021). STANFORD INTEGRATED PSYCHOSOCIAL ASSESSMENT FOR TRANSPLANT (SIPAT) IS SUPERIOR TO SALT AND HRAR IN IDENTIFYING LT CANDIDATES WITH ALD AT LOW RISK OF RELAPSE. HEPATOLOGY. WILEY.

IN CIRRHOSIS, HEMORRHAGIC ASCITES IS ASSOCIATED WITH REDUCED SURVIVAL: A META-ANALYSIS AND SYSTEMATIC REVIEW
Iqbal, U., Ahmed, Z., Anwar, H., Shah, N. M., Lee, W., Nawras, A., … Khurana, S. (2021). IN CIRRHOSIS, HEMORRHAGIC ASCITES IS ASSOCIATED WITH REDUCED SURVIVAL: A META-ANALYSIS AND SYSTEMATIC REVIEW. HEPATOLOGY. WILEY.

WEIGHT GAIN AND NONALCOHOLIC FATTY LIVER DISEASE AND FIBROSIS DETECTED BY FIBROSCAN IN THE UNITED STATES
Wijarnpreecha, K., Aby, E., Ahmed, A., & Kim, D. (2021). WEIGHT GAIN AND NONALCOHOLIC FATTY LIVER DISEASE AND FIBROSIS DETECTED BY FIBROSCAN IN THE UNITED STATES. HEPATOLOGY. WILEY.

Hemorrhagic Ascites Is Associated With Reduced Survival in Cirrhosis: A Systematic Review and Meta-Analysis
Iqbal, U., Ahmed, Z., Anwar, H., Shah, N. M., Lee, W., Nawras, A., … Khurana, S. (2022). Hemorrhagic Ascites Is Associated With Reduced Survival in Cirrhosis: A Systematic Review and Meta-Analysis. GASTROENTEROLOGY RESEARCH.

The association of weight gain with nonalcoholic fatty liver disease and fibrosis detected by FibroScan in the United States
Wijarnpreecha, K., Aby, E. S., Ahmed, A., & Kim, D. (2022). The association of weight gain with nonalcoholic fatty liver disease and fibrosis detected by FibroScan in the United States. ANNALS OF GASTROENTEROLOGY.

Interactions of physical activity, muscular fitness, adiposity, and genetic risk for NAFLD.
Schnurr, T. M., Katz, S. F., Justesen, J. M., O'Sullivan, J. W., Saliba-Gustafsson, P., Assimes, T. L., … Knowles, J. W. (2022). Interactions of physical activity, muscular fitness, adiposity, and genetic risk for NAFLD. Hepatology Communications.

Comparable survival for hepatitis C-related hepatocellular carcinoma after liver transplantation irrespective of viremic status.
Lymberopoulos, P., Shaikh, A., Rich, N. E., Benhammou, J. N., Kanwal, F., Cholankeril, G., … Ahmed, A. (2022). Comparable survival for hepatitis C-related hepatocellular carcinoma after liver transplantation irrespective of viremic status. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association.

Nonalcoholic fatty liver disease in early life and all-cause and cause-specific mortality
Kim, D., & Ahmed, A. (2022). Nonalcoholic fatty liver disease in early life and all-cause and cause-specific mortality. HEPATOBILIARY SURGERY AND NUTRITION.

Early Impact of MMaT-3 Policy on Liver Transplant Waitlist Outcomes for Hepatocellular Carcinoma.
Shaikh, A., Goli, K., Rich, N. E., Benhammou, J. N., Khaderi, S., Hernaez, R., … Cholankeril, G. (2022). Early Impact of MMaT-3 Policy on Liver Transplant Waitlist Outcomes for Hepatocellular Carcinoma. Transplantation Direct, 8(5), e1313.

Trends in All-Cause and Cause-Specific Mortality Among Individuals With Diabetes Before and During the COVID-19 Pandemic in the U.S.
Kim, D., Alshuwaykh, O., Sandhu, K. K., Dennis, B. B., Cholankeril, G., & Ahmed, A. (2022). Trends in All-Cause and Cause-Specific Mortality Among Individuals With Diabetes Before and During the COVID-19 Pandemic in the U.S. Diabetes Care.

The association of weight gain with nonalcoholic fatty liver disease and fibrosis detected by FibroScan in the United States.
Wijarnpreecha, K., Aby, E. S., Ahmed, A., & Kim, D. (2022). The association of weight gain with nonalcoholic fatty liver disease and fibrosis detected by FibroScan in the United States. Annals of Gastroenterology, 35(2), 194–202.

Nonalcoholic fatty liver disease in early life and all-cause and cause-specific mortality.
Kim, D., & Ahmed, A. (2022). Nonalcoholic fatty liver disease in early life and all-cause and cause-specific mortality. Hepatobiliary Surgery and Nutrition, 11(2), 317–319.

Gallstone Disease and its Association with Nonalcoholic Fatty Liver Disease, All-Cause and Cause-Specific Mortality.
Konyn, P., Alshuwaykh, O., Dennis, B. B., Cholankeril, G., Ahmed, A., & Kim, D. (2022). Gallstone Disease and its Association with Nonalcoholic Fatty Liver Disease, All-Cause and Cause-Specific Mortality. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association.

Severe Cardiovascular Complications Following Liver Transplantation in Patients With Iron Overload.
Rhee, J.-W., Zhang, S., Gallo, A., Ahmed, A., & Kawana, M. (2022). Severe Cardiovascular Complications Following Liver Transplantation in Patients With Iron Overload. JACC. Case Reports, 4(11), 677–681.

Ethical and allocation issues in liver transplant candidates with alcohol related liver disease
Sedki, M., Ahmed, A., & Goel, A. (2022). Ethical and allocation issues in liver transplant candidates with alcohol related liver disease. TRANSLATIONAL GASTROENTEROLOGY AND HEPATOLOGY, 7.

Bariatric surgery, obesity and liver transplantation
Ahmed, Z., Khan, M. A., Vazquez-Montesino, L. M., & Ahmed, A. (2022). Bariatric surgery, obesity and liver transplantation. TRANSLATIONAL GASTROENTEROLOGY AND HEPATOLOGY, 7.

Trends in Etiology-based Mortality from Chronic Liver Disease before and during COVID-19 Pandemic in the United States.
Kim, D., Alshuwaykh, O., Dennis, B. B., Cholankeril, G., & Ahmed, A. (2022). Trends in Etiology-based Mortality from Chronic Liver Disease before and during COVID-19 Pandemic in the United States. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association.

Bariatric surgery, obesity and liver transplantation.
Ahmed, Z., Khan, M. A., Vazquez-Montesino, L. M., & Ahmed, A. (2022). Bariatric surgery, obesity and liver transplantation. Translational Gastroenterology and Hepatology, 7, 25.

Ethical and allocation issues in liver transplant candidates with alcohol related liver disease.
Sedki, M., Ahmed, A., & Goel, A. (2022). Ethical and allocation issues in liver transplant candidates with alcohol related liver disease. Translational Gastroenterology and Hepatology, 7, 26.

Changing Trends in Etiology-Based Hospitalizations with End-Stage Liver Disease in the United States from 2016 to 2019.
Kim, D., Perumpail, B. J., Alshuwaykh, O., Dennis, B. B., Cholankeril, G., & Ahmed, A. (2022). Changing Trends in Etiology-Based Hospitalizations with End-Stage Liver Disease in the United States from 2016 to 2019. Liver International : Official Journal of the International Association for the Study of the Liver.

Reply: Does Fatty Liver Play a Role in the Risk of All-Cause and Cause-Specific Mortality in Patients with Gallstone Disease?
Kim, D., Konyn, P., & Ahmed, A. (2022). Reply: Does Fatty Liver Play a Role in the Risk of All-Cause and Cause-Specific Mortality in Patients with Gallstone Disease? Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association.

Incidence of hepatocellular carcinoma in chronic hepatitis B virus infection in those not meeting criteria for antiviral therapy.
Alshuwaykh, O., Daugherty, T., Cheung, A., Goel, A., Dhanasekaran, R., Ghaziani, T. T., … Kwo, P. Y. (2022). Incidence of hepatocellular carcinoma in chronic hepatitis B virus infection in those not meeting criteria for antiviral therapy. Hepatology Communications.

Clinical characteristics and outcomes in those with primary extrahepatic malignancy and malignant ascites.
Alshuwaykh, O., Cheung, A., Goel, A., Kwong, A., Dhanasekaran, R., Ghaziani, T. T., … Kwo, P. Y. (2022). Clinical characteristics and outcomes in those with primary extrahepatic malignancy and malignant ascites. BMC Gastroenterology, 22(1), 410.

Chronic liver disease-related mortality in diabetes before and during the COVID-19 in the United States.
Kim, D., Alshuwaykh, O., Dennis, B. B., Cholankeril, G., Knowles, J. W., & Ahmed, A. (2022). Chronic liver disease-related mortality in diabetes before and during the COVID-19 in the United States. Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Body fat distribution: a crucial target for intervention in nonalcoholic fatty liver disease and fibrosis
Wijarnpreecha, K., Ahmed, A., & Kim, D. (2022). Body fat distribution: a crucial target for intervention in nonalcoholic fatty liver disease and fibrosis. HEPATOBILIARY SURGERY AND NUTRITION.

Improved Survival after Liver Transplantation for Patients with HIV and HIV/HCV Coinfection in the INSTI and DAA eras.
Jacob, J. S., Shaikh, A., Goli, K., Rich, N. E., Benhammou, J. N., Ahmed, A., … Cholankeril, G. (2022). Improved Survival after Liver Transplantation for Patients with HIV and HIV/HCV Coinfection in the INSTI and DAA eras. Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America.

Body fat distribution: a crucial target for intervention in nonalcoholic fatty liver disease and fibrosis.
Wijarnpreecha, K., Ahmed, A., & Kim, D. (2022). Body fat distribution: a crucial target for intervention in nonalcoholic fatty liver disease and fibrosis. Hepatobiliary Surgery and Nutrition, 11(5), 738–742.

Risk of advanced fibrosis in first-degree relatives of patients with nonalcoholic fatty liver disease.
Tamaki, N., Ahlholm, N., Luukkonen, P. K., Porthan, K., Sharpton, S. R., Ajmera, V., … Loomba, R. (2022). Risk of advanced fibrosis in first-degree relatives of patients with nonalcoholic fatty liver disease. The Journal of Clinical Investigation, 132(21).

Causes and Risk Profiles of Mortality among Individuals with Nonalcoholic Fatty Liver.
Konyn, P., Ahmed, A., & Kim, D. (2022). Causes and Risk Profiles of Mortality among Individuals with Nonalcoholic Fatty Liver. Clinical and Molecular Hepatology.

Reduction in racial and ethnic disparity in survival following liver transplant for hepatocellular carcinoma in DAA era.
Shaikh, A., Goli, K., Lee, T.-H., Rich, N. E., Benhammou, J. N., Keeling, S., … Cholankeril, G. (2022). Reduction in racial and ethnic disparity in survival following liver transplant for hepatocellular carcinoma in DAA era. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association.

CLINICAL AND PATIENT-REPORTED OUTCOME (PRO) PROFILE OF PATIENTS WITH HEPATITIS B VIRAL (HBV) INFECTION FROM THE GLOBAL LIVER REGISTRY (TM) (GLR (TM))
Younossi, Z. M., Yilmaz, Y., Yu, M.-L., Alswat, K. A., Buti, M., Fernandez, M. I. C., … Stepanova, M. (2022). CLINICAL AND PATIENT-REPORTED OUTCOME (PRO) PROFILE OF PATIENTS WITH HEPATITIS B VIRAL (HBV) INFECTION FROM THE GLOBAL LIVER REGISTRY (TM) (GLR (TM)). HEPATOLOGY. WILEY.

RACIAL AND ETHNIC DISPARITIES IN CURE RATES FOR HCV INFECTION AT LIVER TRANSPLANTATION IN THE UNITED STATES
Lymberopoulos, P., Shaikh, A., Cholankeril, R., Parakadavil, N., Poche, M., Ahmed, A., … Cholankeril, G. (2022). RACIAL AND ETHNIC DISPARITIES IN CURE RATES FOR HCV INFECTION AT LIVER TRANSPLANTATION IN THE UNITED STATES. HEPATOLOGY. WILEY.

POST-TRANSPLANT OUTCOMES FOR ALCOHOL-ASSOCIATED LIVER DISEASE DURING THE COVID-19 PANDEMIC
Goli, K., Lymberopoulos, P., Shaikh, A., Parakadavil, N., Kim, D., Ahmed, A., … Cholankeril, G. (2022). POST-TRANSPLANT OUTCOMES FOR ALCOHOL-ASSOCIATED LIVER DISEASE DURING THE COVID-19 PANDEMIC. HEPATOLOGY. WILEY.

DEPRESSION AND EMOTIONAL DISTRESS IN PATIENTS WITH CHRONIC LIVER DISEASE (CLD): DATA FROM THE GLOBAL LIVER REGISTRY (TM) (GLR (TM))
Younossi, Z. M., Stepanova, M., Fernandez, M. I. C., Yilmaz, Y., Yu, M.-L., El Kassas, M., … Racila, A. (2022). DEPRESSION AND EMOTIONAL DISTRESS IN PATIENTS WITH CHRONIC LIVER DISEASE (CLD): DATA FROM THE GLOBAL LIVER REGISTRY (TM) (GLR (TM)). HEPATOLOGY. WILEY.

CLINICAL IMPACT OF METABOLIC-ASSOCIATED FATTY LIVER DISEASE ON LIVER TRANSPLANTATION FOR HEPATOCELLULAR CARCINOMA
Shaikh, A., Lymberopoulos, P., Benhammou, J. N., Rich, N. E., Patel, A., Bhatnagar, A., … Cholankeril, G. (2022). CLINICAL IMPACT OF METABOLIC-ASSOCIATED FATTY LIVER DISEASE ON LIVER TRANSPLANTATION FOR HEPATOCELLULAR CARCINOMA. HEPATOLOGY. WILEY.

POST-TRANSPLANT OUTCOMES FOR HEPATITIS B CORE ANTIBODY OR SURFACE ANTIGEN POSITIVE DONORS - OPPORTUNITY TO EXPAND DONOR POOL
Bhatnagar, A., Prakash, S., Cholankeril, R., Lymberopoulos, P., Ahmed, A., Goff, C., … Lee, T.-H. (2022). POST-TRANSPLANT OUTCOMES FOR HEPATITIS B CORE ANTIBODY OR SURFACE ANTIGEN POSITIVE DONORS - OPPORTUNITY TO EXPAND DONOR POOL. HEPATOLOGY. WILEY.

Muscle Strength in Nonalcoholic Fatty Liver Disease and All-cause and Cause-specific Mortality.
Kim, D., Dennis, B. B., Wijarnpreecha, K., Cholankeril, G., & Ahmed, A. (2022). Muscle Strength in Nonalcoholic Fatty Liver Disease and All-cause and Cause-specific Mortality. Liver International : Official Journal of the International Association for the Study of the Liver.

Sodium-glucose cotransporter-2 inhibitors improve liver enzymes in patients with co-existing non-alcoholic fatty liver disease: a systematic review and meta-analysis.
Amjad, W., Malik, A., Qureshi, W., Dennis, B., Mumtaz, M., Haider, R., … Ahmed, A. (2022). Sodium-glucose cotransporter-2 inhibitors improve liver enzymes in patients with co-existing non-alcoholic fatty liver disease: a systematic review and meta-analysis. Przeglad Gastroenterologiczny, 17(4), 288–300.

Clinical and Patient-Reported Outcome Profile of Patients with Hepatitis B Viral Infection from the Global Liver Registry™.
Younossi, Z. M., Yu, M.-L. L., Yilmaz, Y., Alswat, K. A., Buti, M., Fernandez, M. I., … Alqahtani, S. (2023). Clinical and Patient-Reported Outcome Profile of Patients with Hepatitis B Viral Infection from the Global Liver Registry™. Journal of Viral Hepatitis.

An Open-Access, Interactive Decision-Support Tool to Facilitate Guideline-Driven Care for Hepatocellular Carcinoma.
Wong, R. J., Jayasekera, C., Jones, P., Kanwal, F., Singal, A. G., Ahmed, A., … Mehta, N. (2022). An Open-Access, Interactive Decision-Support Tool to Facilitate Guideline-Driven Care for Hepatocellular Carcinoma. Gastroenterology Research, 15(6), 297–307.

Association between depression and metabolic dysfunction-associated fatty liver disease/significant fibrosis.
Kim, D., Dennis, B. B., Cholankeril, G., & Ahmed, A. (2023). Association between depression and metabolic dysfunction-associated fatty liver disease/significant fibrosis. Journal of Affective Disorders.

Post-transplant outcomes for alcohol-associated liver disease during the COVID-19 pandemic.
Goli, K., Lymberopoulos, P., Samuel, R., Shaikh, A., Parakadavil, N., Kim, D., … Cholankeril, G. (2023). Post-transplant outcomes for alcohol-associated liver disease during the COVID-19 pandemic. Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Types of Physical Activity in Nonalcoholic Fatty Liver Disease and All-Cause and Cardiovascular Mortality.
Kim, D., Wijarnpreecha, K., Dennis, B. B., Cholankeril, G., & Ahmed, A. (2023). Types of Physical Activity in Nonalcoholic Fatty Liver Disease and All-Cause and Cardiovascular Mortality. Journal of Clinical Medicine, 12(5).

The current trends in the health burden of primary liver cancer across the globe.
Konyn, P., Ahmed, A., & Kim, D. (2023). The current trends in the health burden of primary liver cancer across the globe. Clinical and Molecular Hepatology.

Cardiovascular Disease Risk and Statin Use Among Adults with Metabolic Dysfunction Associated Fatty Liver Disease.
Yeoh, A., Cheung, R., Ahmed, A., Chitnis, A. S., Do, A., & Wong, R. J. (2023). Cardiovascular Disease Risk and Statin Use Among Adults with Metabolic Dysfunction Associated Fatty Liver Disease. The American Journal of Medicine.

Transplanting Hepatitis B Surface Antigen Positive Livers in the U.S.: Outcomes and Opportunities.
Bhatnagar, A., Prakash, S., Lymberopoulos, P., Goff, C., Shaikh, A., Kim, D., … Lee, T.-H. H. (2023). Transplanting Hepatitis B Surface Antigen Positive Livers in the U.S.: Outcomes and Opportunities. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Survival following liver transplantation for hepatocellular carcinoma after implementation of MMaT-3 policy.
Shaikh, A., Lee, T.-H., Rich, N. E., Benhammou, J. N., Lymberopoulos, P., Agopian, V. G., … Cholankeril, G. (2023). Survival following liver transplantation for hepatocellular carcinoma after implementation of MMaT-3 policy. Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Trends in aetiology-based hospitalisation for cirrhosis before and during the COVID-19 pandemic in the United States.
Kim, D., Perumpail, B. J., Wijarnpreecha, K., Manikat, R., Cholankeril, G., & Ahmed, A. (2023). Trends in aetiology-based hospitalisation for cirrhosis before and during the COVID-19 pandemic in the United States. Alimentary Pharmacology & Therapeutics.

Significance of Conducting 2 Types of Fecal Tests in Patients With Ulcerative Colitis (vol 18, pg 1102, 2020)
Kim, D., Konyn, P., & Ahmed, A. (2023). Significance of Conducting 2 Types of Fecal Tests in Patients With Ulcerative Colitis (vol 18, pg 1102, 2020). CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 21(4), 1124.

Trends in mortality of liver cancer before and during the COVID-19 pandemic, 2017-2021.
Kim, D., Manikat, R., Cholankeril, G., & Ahmed, A. (2023). Trends in mortality of liver cancer before and during the COVID-19 pandemic, 2017-2021. Liver International : Official Journal of the International Association for the Study of the Liver.

Depression in nonalcoholic fatty liver disease and all-cause/cause-specific mortality.
Kim, D., Manikat, R., Shaikh, A., Cholankeril, G., & Ahmed, A. (2023). Depression in nonalcoholic fatty liver disease and all-cause/cause-specific mortality. European Journal of Clinical Investigation, e14087.

Proton pump inhibitors in critically ill mechanically ventilated patients with COVID-19: protocol for a substudy of the Re-EValuating the Inhibition of Stress Erosions (REVISE) Trial.
Dennis, B. B., Thabane, L., Heels-Ansdell, D., Dionne, J. C., Binnie, A., Tsang, J., … Cook, D. (2023). Proton pump inhibitors in critically ill mechanically ventilated patients with COVID-19: protocol for a substudy of the Re-EValuating the Inhibition of Stress Erosions (REVISE) Trial. Trials, 24(1), 561.

Incidence of Cirrhosis and Hepatocellular Carcinoma Among Veterans With Noncirrhotic Metabolic Dysfunction-associated Fatty Liver Disease.
Yeoh, A., Yang, Z., Cheung, R., Do, A., Ahmed, A., & Wong, R. J. (2023). Incidence of Cirrhosis and Hepatocellular Carcinoma Among Veterans With Noncirrhotic Metabolic Dysfunction-associated Fatty Liver Disease. Journal of Clinical Gastroenterology.

Metabolic Dysfunction-Associated Steatotic Liver Disease and All-Cause/Cause-Specific Mortality among Adults in the United States.
Kim, D., Wijarnpreecha, K., Cholankeril, G., & Ahmed, A. (2023). Metabolic Dysfunction-Associated Steatotic Liver Disease and All-Cause/Cause-Specific Mortality among Adults in the United States. Journal of Hepatology.

Transplanting hepatitis B surface antigen-positive livers in the United States: Outcomes and opportunities
Bhatnagar, A., Prakash, S., Lymberopoulos, P., Goff, C., Shaikh, A., Kim, D., … Lee, T.-H. (2023). Transplanting hepatitis B surface antigen-positive livers in the United States: Outcomes and opportunities. AMERICAN JOURNAL OF TRANSPLANTATION, 23(8), 1221–1226.

Total Bilirubin Levels in Nonalcoholic Fatty Liver Disease and All- cause and Cause-specific Mortality in US Adults.
Moss, K., Dennis, B. B., Naji, L., Ahmed, A., & Kim, D. (2023). Total Bilirubin Levels in Nonalcoholic Fatty Liver Disease and All- cause and Cause-specific Mortality in US Adults. Journal of Gastrointestinal and Liver Diseases : JGLD, 32(3), 323–331.

Chronic liver disease-related mortality during the COVID-19 pandemic.
Kim, D., Manikat, R., Wijarnpreecha, K., Cholankeril, G., & Ahmed, A. (2023). Chronic liver disease-related mortality during the COVID-19 pandemic. European Journal of Internal Medicine.

The Impact of Alcohol Consumption and Addiction on Liver Transplantation Programs in the COVID-19 Era.
Manikat, R., Ahmed, A., & Kim, D. (2023). The Impact of Alcohol Consumption and Addiction on Liver Transplantation Programs in the COVID-19 Era. Hepatic Medicine : Evidence and Research, 15, 141–149.

Alcohol Use in Liver Transplant Recipients With Alcohol-related Liver Disease: A Comparative Assessment of Relapse Prediction Models.
Sedki, M., Kwong, A., Bhargava, M., Ahmed, A., Daugherty, T., Kwo, P., … Goel, A. (2023). Alcohol Use in Liver Transplant Recipients With Alcohol-related Liver Disease: A Comparative Assessment of Relapse Prediction Models. Transplantation.

Endogenous sex hormones and nonalcoholic fatty liver disease in US adults.
Kim, D., Manikat, R., Cholankeril, G., & Ahmed, A. (2023). Endogenous sex hormones and nonalcoholic fatty liver disease in US adults. Liver International : Official Journal of the International Association for the Study of the Liver.

Up-to-date global epidemiology of nonalcoholic fatty liver disease
Manikat, R., Ahmed, A., & Kim, D. (2023). Up-to-date global epidemiology of nonalcoholic fatty liver disease. HEPATOBILIARY SURGERY AND NUTRITION.

Evaluating the Association Between Concurrent Human Immunodeficiency Virus Infection and Risk of Cardiovascular Disease in Patients With Metabolic Dysfunction-Associated Fatty Liver Disease
Wong, R. J., Yang, Z., Yeoh, A., Do, A., Ahmed, A., & Cheung, R. (2023). Evaluating the Association Between Concurrent Human Immunodeficiency Virus Infection and Risk of Cardiovascular Disease in Patients With Metabolic Dysfunction-Associated Fatty Liver Disease. AMERICAN JOURNAL OF GASTROENTEROLOGY. LIPPINCOTT WILLIAMS & WILKINS.

Up-to-date global epidemiology of nonalcoholic fatty liver disease.
Manikat, R., Ahmed, A., & Kim, D. (2023). Up-to-date global epidemiology of nonalcoholic fatty liver disease. Hepatobiliary Surgery and Nutrition, 12(6), 956–959.

High-Risk Alcohol Use Is Associated With Significantly Greater Risk of Incident Hepatocellular Carcinoma in a National Cohort of US Veterans With Metabolic Dysfunction Associated Fatty Liver Disease
Wong, R. J., Yang, Z., Cheung, R., Singal, A. K., Do, A., Ahmed, A., & Yeoh, A. (2023). High-Risk Alcohol Use Is Associated With Significantly Greater Risk of Incident Hepatocellular Carcinoma in a National Cohort of US Veterans With Metabolic Dysfunction Associated Fatty Liver Disease. AMERICAN JOURNAL OF GASTROENTEROLOGY. LIPPINCOTT WILLIAMS & WILKINS.

THE ASSOCIATION BETWEEN BASELINE ALCOHOL USE AND LONG-TERM RISK OF INCIDENT CIRRHOSIS AMONG A NATIONAL COHORT OF US VETERANS WITH METABOLIC DYSFUNCTION ASSOCIATED FATTY LIVER DISEASE
Wong, R. J., Yang, Z., Cheung, R., Singal, A. K., Do, A., Ahmed, A., & Yeoh, A. (2023). THE ASSOCIATION BETWEEN BASELINE ALCOHOL USE AND LONG-TERM RISK OF INCIDENT CIRRHOSIS AMONG A NATIONAL COHORT OF US VETERANS WITH METABOLIC DYSFUNCTION ASSOCIATED FATTY LIVER DISEASE. HEPATOLOGY. LIPPINCOTT WILLIAMS & WILKINS.

OUTCOMES OF LIVER TRANSPLANTATION IN PATIENTS WITH ACUTE ALCOHOLIC HEPATITIS BASED ON WAITLIST DURATION
Alshuwaykh, O., Cholankeril, G., Kim, D., & Ahmed, A. (2023). OUTCOMES OF LIVER TRANSPLANTATION IN PATIENTS WITH ACUTE ALCOHOLIC HEPATITIS BASED ON WAITLIST DURATION. HEPATOLOGY. LIPPINCOTT WILLIAMS & WILKINS.

PREVALENCE OF NONALCOHOLIC FATTY LIVER DISEASE AND FIBROSIS IN PATIENTS WITH PREDIABETES/DIABETES BASED ON BODY MASS INDEX
Alshuwaykh, O., Ahmed, A., Cholankeril, G., & Kim, D. (2023). PREVALENCE OF NONALCOHOLIC FATTY LIVER DISEASE AND FIBROSIS IN PATIENTS WITH PREDIABETES/DIABETES BASED ON BODY MASS INDEX. HEPATOLOGY. LIPPINCOTT WILLIAMS & WILKINS.

Association between food insecurity and metabolic dysfunction-associated steatotic liver disease/significant fibrosis measured by fibroscan.
Kim, D., Perumpail, B. J., Cholankeril, G., & Ahmed, A. (2024). Association between food insecurity and metabolic dysfunction-associated steatotic liver disease/significant fibrosis measured by fibroscan. European Journal of Nutrition.

Impact of the COVID-19 pandemic on hospitalizations with hepatocellular carcinoma in the United States.
Konyn, P., Perumpail, B. J., Wijarnpreecha, K., Cholankeril, G., Ahmed, A., & Kim, D. (2024). Impact of the COVID-19 pandemic on hospitalizations with hepatocellular carcinoma in the United States. Expert Review of Gastroenterology & Hepatology.

Editorial: Updated epidemiology of steatotic liver disease in people with HIV in the United States.
Manikat, R., Kim, S. U., Ahmed, A., & Kim, D. (2024). Editorial: Updated epidemiology of steatotic liver disease in people with HIV in the United States. Alimentary Pharmacology & Therapeutics, 59(6), 789–790.

Editorial: Using machine learning to predict significant fibrosis in metabolic dysfunction-associated steatotic liver disease.
Manikat, R., Ahmed, A., & Kim, D. (2024). Editorial: Using machine learning to predict significant fibrosis in metabolic dysfunction-associated steatotic liver disease. Alimentary Pharmacology & Therapeutics, 59(7), 893–895.

The prevalence and predictors of metabolic dysfunction-associated steatotic liver disease and fibrosis/cirrhosis among adolescents/young adults.
Perumpail, B. J., Manikat, R., Wijarnpreecha, K., Cholankeril, G., Ahmed, A., & Kim, D. (2024). The prevalence and predictors of metabolic dysfunction-associated steatotic liver disease and fibrosis/cirrhosis among adolescents/young adults. Journal of Pediatric Gastroenterology and Nutrition.

Steatotic liver disease-associated all-cause/cause-specific mortality in the United States.
Kim, D., Wijarnpreecha, K., Cholankeril, G., & Ahmed, A. (2024). Steatotic liver disease-associated all-cause/cause-specific mortality in the United States. Alimentary Pharmacology & Therapeutics.

Estimated pulse wave velocity in metabolic dysfunction-associated steatotic liver disease and all-cause/cause-specific mortality.
Kim, D., Manikat, R., Wijarnpreecha, K., Cholankeril, G., & Ahmed, A. (2024). Estimated pulse wave velocity in metabolic dysfunction-associated steatotic liver disease and all-cause/cause-specific mortality. Journal of Gastroenterology and Hepatology.

Financial hardship and cost-related nonadherence to medication in patients with liver disease in the United States.
Kim, D., Manikat, R., Wijarnpreecha, K., & Ahmed, A. (2024). Financial hardship and cost-related nonadherence to medication in patients with liver disease in the United States. Alimentary Pharmacology & Therapeutics.

Current epidemiology of chronic liver disease.
Manikat, R., Ahmed, A., & Kim, D. (2024). Current epidemiology of chronic liver disease. Gastroenterology Report, 12, goae069.

Burden of Mortality from Hepatocellular Carcinoma and Biliary Tract Cancers by Race and Ethnicity and Sex in US, 2018-2023.
Kim, D., Manikat, R., Wijarnpreecha, K., Cholankeril, G., & Ahmed, A. (2024). Burden of Mortality from Hepatocellular Carcinoma and Biliary Tract Cancers by Race and Ethnicity and Sex in US, 2018-2023. Clinical and Molecular Hepatology.

Clinical Trials

Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.

Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.

Open Trials Closed Trials

A Longitudinal Observational Study of Patients With Nonalcoholic Steatohepatitis (NASH) and Related Conditions Across the Entire Spectrum of Nonalcoholic Fatty Liver Disease (NAFLD)

Specializing In

Hepatitis B
Hepatitis B Treatment
Hepatitis C
Hepatitis C Treatment
Hepatitis D
Hepatology (Liver Conditions)
Liver Disease Prevention
Liver Disease Testing
Liver Transplant
Polycystic Liver Disease
Primary Biliary Cirrrhosis
Primary Sclerosing Cholangitis
Upper GI endoscopy

Practice Locations

Advanced Endoscopy in Palo Alto Stanford, CA

Stanford, CA

Advanced Endoscopy in Palo Alto

300 Pasteur Drive, Ground Floor

Stanford , CA 94305

(650) 736-5555

More Clinic Information

Liver Transplant Program in Santa Maria Santa Maria, CA

Santa Maria, CA

Liver Transplant Program in Santa Maria

361 Town Center West

Santa Maria , CA 93454

(650) 725-1988

More Clinic Information

Liver Transplant Program in Reno, 655 Sierra Rose Drive Reno, NV

Reno, NV

Liver Transplant Program in Reno, 655 Sierra Rose Drive

655 Sierra Rose Drive

Reno , NV 89511

(650) 725-1988

More Clinic Information

Liver Transplant Program in Henderson Henderson, NV

Henderson, NV

Liver Transplant Program in Henderson

2465 W Horizon Ridge Pkwy, Suite 100

Henderson , NV 89052

(650) 725-1988

More Clinic Information

Liver Transplant Program in Reno, 880 Ryland Street Reno, NV

Reno, NV

Liver Transplant Program in Reno, 880 Ryland Street

880 Ryland Street

Reno , NV 89502

(650) 725-1988

More Clinic Information

Liver Transplant Clinic in Pleasanton Pleasanton, CA

Pleasanton, CA

Liver Transplant Clinic in Pleasanton

5565 W Las Positas Blvd

Pleasanton , CA 94588

(650) 498-7999

More Clinic Information

Digestive Health Center in Palo Alto (Endoscopy Suite) Stanford, CA

Stanford, CA

Digestive Health Center in Palo Alto (Endoscopy Suite)

300 Pasteur Drive, Ground Floor

Stanford , CA 94305

(650) 736-5555

More Clinic Information

Liver (Hepatology) Clinic in Redwood City Redwood City, CA

Redwood City, CA

Liver (Hepatology) Clinic in Redwood City

420 Broadway Street, Pavilion D, 2nd Floor

Redwood City , CA 94063

(650) 498-7999

More Clinic Information

Digestive Health Center in Redwood City Redwood City, CA

Redwood City, CA

Digestive Health Center in Redwood City

420 Broadway Street, Pavilion D, 2nd Floor

Redwood City , CA 94063

(650) 736-5555

More Clinic Information

Digestive Health Center in Redwood City (Endoscopy Suite) Redwood City, CA

Redwood City, CA

Digestive Health Center in Redwood City (Endoscopy Suite)

420 Broadway Street, 3rd Floor

Redwood City , CA 94063

(650) 736-5555

More Clinic Information

General Endoscopy Redwood City, CA

Redwood City, CA

General Endoscopy

420 Broadway Street, Pavilion D, 2nd Floor

Redwood City , CA 94063

(650) 736-5555

More Clinic Information

Liver Transplant Program in Fresno Fresno, CA

Fresno, CA

Liver Transplant Program in Fresno

7710 N Fresno Street, Suite 102

Fresno , CA 93720

(650) 725-1988

More Clinic Information

Liver Transplant Program in San Luis Obispo San Luis Obispo, CA

San Luis Obispo, CA

Liver Transplant Program in San Luis Obispo

1551 Bishop Street, Suite 510

San Luis Obispo , CA 93401

(650) 725-1988

More Clinic Information

Liver Transplant Program in Templeton Templeton, CA

Templeton, CA

Liver Transplant Program in Templeton

1255 Las Tablas Road, Suite 201

Templeton , CA 93465

(650) 725-1988

More Clinic Information

Important Information about Our Organizations and Physician Affiliation

Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners are each independent nonprofit organizations that are affiliated with but separate from each other and from Stanford University. The physicians who provide care at facilities operated by Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners are faculty, foundation, or community physicians who are not employees, representatives, or agents of Stanford Health Care, Stanford Health Care Tri- Valley, or Stanford Medicine Partners. Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners do not exercise control over the care provided by such faculty, foundation, and community physicians and are not responsible for their actions.

Patient Ratings

(21 Ratings)

Overall Rating

4.7/5

View Ratings by Category

4.9/5

Friendliness

4.7/5

Explanations

4.8/5

Listens

4.8/5

Care provider's efforts to include you in decisions about your care

4.9/5

Recommended to others

0.0/5

Wait times

How Our Ratings Work

The Patients Ratings and comments are gathered from our Patient Satisfaction Survey and displayed in their entirety.

Patient Satisfaction Survey Disclaimer

Patient Reviews

(229 reviews)

Answers all my questions thoroughly

May 2024

•

Verified SHC Patient

Dr. Ahmed has been incredible, professional, and always listens to my needs. I would recommend him to anyone in need of expert care in this field. I am nearing 9 years post Liver Transplant, and his knowledge has saved my life!

May 2024

•

Verified SHC Patient

He is a dedicated terrific doctor.

Apr 2024

•

Verified SHC Patient

He was extremely helpful and though.

Apr 2024

•

Verified SHC Patient

I am blessed to have Dr Ahmed as my doctor. He is thorough and makes sure I have a good understanding of what we discussed. Stanford and the patients here are very lucky to have him as their physician. We need more doctors like him!!

Mar 2024

•

Verified SHC Patient

He is always clear & to the point.

Mar 2024

•

Verified SHC Patient

Thank you

Mar 2024

•

Verified SHC Patient

He is very compassionate and caring doctor

Mar 2024

•

Verified SHC Patient

Dr. Ahmed is a great Dr. and always makes me feel confident is the care I am getting. Great Dr. and person.

Feb 2024

•

Verified SHC Patient

Excelente doctor

Feb 2024

•

Verified SHC Patient

Excellent

Feb 2024

•

Verified SHC Patient

Excellent service. Spot on issues with good explanations, and patient with my questions and provided needed answers. Very cordial, very professional. Highly recommended.

Feb 2024

•

Verified SHC Patient

I really liked Dr Ahmedâ€™s thoroughness and calming demeanor â€¦

Feb 2024

•

Verified SHC Patient

Great Doctor. Always prepared and thorough. I feel lucky to have him as my physician.

Feb 2024

•

Verified SHC Patient

Would eventually like regular office visit ,, but very happy with transplant

Jan 2024

•

Verified SHC Patient

He is an amazing doctor. He really listens and cares about his patients, not just about their liver!

Jan 2024

•

Verified SHC Patient

Wonderful doctor

Jan 2024

•

Verified SHC Patient

Dissatisfied

Jan 2024

•

Verified SHC Patient

A caring doctor

Jan 2024

•

Verified SHC Patient

He was very nice and thorough

Jan 2024

•

Verified SHC Patient

very knowledgeable; good personality

Jan 2024

•

Verified SHC Patient

Happy New Year!!

Dec 2023

•

Verified SHC Patient

I was able to get all my questions and concerns answered by Dr Ahmed. He is very easy to talk to.

Dec 2023

•

Verified SHC Patient

I am doing the best I can thank you for your help

Dec 2023

•

Verified SHC Patient

He is the best care provider Iâ€™ve had the pleasure of having as my specialty Doctor.

Nov 2023

•

Verified SHC Patient

Dr. Aijaz is a very good doctorâ€¦

Nov 2023

•

Verified SHC Patient

Thank you for being there for me all these years. Dr. Ahmed is a pleasure to talk to you.

Nov 2023

•

Verified SHC Patient

looking forward to talking to the doctor soon.

Nov 2023

•

Verified SHC Patient

Nice doctor

Oct 2023

•

Verified SHC Patient

Dr. Ahmed is a treasure of a man and a great human. I throughly enjoy my visits with him as I was there with him in his earlier years.

Oct 2023

•

Verified SHC Patient

Dr Ahmed explained everything fully and I agree with his suggested next steps.

Sep 2023

•

Verified SHC Patient

Dr. Ahmed is excellent and a huge asset to Stanford.

Sep 2023

•

Verified SHC Patient

Dr. Ahmed cares a lot he made me feel important

Sep 2023

•

Verified SHC Patient

Excellent Dr. Very informative and very relaxing to meet with. Always enjoy my contact with him.

Sep 2023

•

Verified SHC Patient

For a specialist, he takes the extra time with me, and explains things, that I don

Aug 2023

•

Verified SHC Patient

He is thorough in his visit with me

Aug 2023

•

Verified SHC Patient

Dr. Ahmed is an excellent Doctor, very much on top of what is going on with my health and what could possibly go wrong. I have total trust in him.

Aug 2023

•

Verified SHC Patient

Excellent!

Aug 2023

•

Verified SHC Patient

Being new to Dr Ahmed, I found him to be very clear in his guidance and knowledgeable about my condition

Aug 2023

•

Verified SHC Patient

kind, smart, efficient, and has an amazing memory.

Jul 2023

•

Verified SHC Patient

Dr. Ahmed is a great doctor. He did my transplant 12 years ago and he has monitored my health ever since then.

Jul 2023

•

Verified SHC Patient

Great Visit! Very personable, informative, And should great concern about my health.

Jul 2023

•

Verified SHC Patient

Dr. Ahmed has been great. I feel like I am in good hands with Dr.Ahmed and Stanford.

Jul 2023

•

Verified SHC Patient

He is very nice and professional

Jul 2023

•

Verified SHC Patient

He is great. He answers questions and makes sure I know what's next and what's important or of no concern.

May 2023

•

Verified SHC Patient

Wonderful, personable, extremely intelligent and kind doctor.

May 2023

•

Verified SHC Patient

Dr. Ahmed is very good at listening and answering every question.

May 2023

•

Verified SHC Patient

He has been my hepatologist throughout my transplant and follow up afterwards and has been excellent.

May 2023

•

Verified SHC Patient

Very well prepared and completely up to date on my medical condition. Also very interested in how I was doing.

May 2023

•

Verified SHC Patient

Doctor Aijaz is the best doctor I have ever had and I would definitely recommend him to everyone.

Apr 2023

•

Verified SHC Patient

Dr. Ahmed is a wonderful doctor!

Apr 2023

•

Verified SHC Patient

Excellent

Apr 2023

•

Verified SHC Patient

The best!!!

Mar 2023

•

Verified SHC Patient

Dr. Ahmed is well informed and conveyed the information very well to me and explained the next steps so I could understand rather than be overwhelmed with little or no information.

Mar 2023

•

Verified SHC Patient

I found it difficult to get across what needed to be said and Iâ€™m not sure it was even worth it.

Feb 2023

•

Verified SHC Patient

Dr Ahmed is a very good doctor heâ€™s been treating me for 17 years now and I really respect him

Feb 2023

•

Verified SHC Patient

Was professional and polite. Answered my questions and spent adequate amount of time reviewing my case.

Feb 2023

•

Verified SHC Patient

Couldn't ask for a better doctor!!

Feb 2023

•

Verified SHC Patient

Wonderful physician

Jan 2023

•

Verified SHC Patient

He is a great dr and Iâ€™m blessed to have him as my dr.!

Jan 2023

•

Verified SHC Patient

An excellent doctor

Dec 2022

•

Verified SHC Patient

Very attentive & polite

Dec 2022

•

Verified SHC Patient

Extremely knowledgeable doctor. Also very approachable and kind.

Dec 2022

•

Verified SHC Patient

Dr. Ahmed is terrific. He covers all the bases and answers questions. I always leave with a clear idea of what to do next.

Dec 2022

•

Verified SHC Patient

Engaged, caring and easy to understand his medical explanations. Excellent Doctor.

Dec 2022

•

Verified SHC Patient

Very pleasant call and glad I donâ€™t have any serious medical followup.

Dec 2022

•

Verified SHC Patient

Itâ€™s been a pleasure to have been under the care of Dr. Ahmed for the past eight years.

Dec 2022

•

Verified SHC Patient

Dr. Ahmed I always extremely engaged and knowledgable. I feel like he knows my medical history and takes a genuine interest in my family and interests. He is always caring and compassionate. I am very grateful to have him as my doctor.

Nov 2022

•

Verified SHC Patient

Excellent and easy to understand the guidance. Thank you

Nov 2022

•

Verified SHC Patient

Excellent Doctor

Oct 2022

•

Verified SHC Patient

He was very nice and personable!

Oct 2022

•

Verified SHC Patient

Dr. Ahmed is excellent.

Oct 2022

•

Verified SHC Patient

Has a very nice manner with me the patient.

Sep 2022

•

Verified SHC Patient

Dr. Aijaz Ahmed is a great listener and quick to understand what I'm saying. He covers so much in a short period of time. I believe without Dr. Ahmed in my life since 2005 that I would not be alive. He's gentle and firm at the same time. Because of Dr. Ahmed I have received nutritional help as well as liver help this year. I have lost over 25 pounds in the last 9 months and it is all because of him and his referrals. He is a blessing. I like that he shares stories about himself.

Sep 2022

•

Verified SHC Patient

Excellent health care advisor. Very well prepared, great communication skills and balanced.

Sep 2022

•

Verified SHC Patient

Professional, informative, caring.

Sep 2022

•

Verified SHC Patient

Dr. Ahmed has been my doctor for over a decade and has been nothing short of exemplary. He (and his team saved my life) he is never to busy to explain things and I couldn't recommend him more highly!

Jul 2022

•

Verified SHC Patient

Heâ€™s the best

Jul 2022

•

Verified SHC Patient

very competent and an excellent communicator.

Jul 2022

•

Verified SHC Patient

Dr Aijaz Ahmed is very caring and thoughtful person who is always eager to help.

Jul 2022

•

Verified SHC Patient

Dr. Ahmed is not only very knowledgeable but also thoughtful and so very kind. I trust him implicitly. Stanford should be honored to have him for all these past years. He is one on the physicians that supports and promotes Stanford Healthcare's reputation. Thank you Dr. Ahmed.

Jul 2022

•

Verified SHC Patient

Dr. Ahmed is great, brilliant, easy to talk to.

Jul 2022

•

Verified SHC Patient

Dr. Aijaz Ahmed is the most caring Doctor I've met in my life. He's an example of how a doctor should treat and work with patients. I'm grateful for having Dr. Aijaz Ahmed as my doctor.

Jul 2022

•

Verified SHC Patient

Thoughtful, well-researched, read my chart before the appointment and seemed to know my case. Kind and friendly.

Jul 2022

•

Verified SHC Patient

It was a great visit. Very good doctor

Jun 2022

•

Verified SHC Patient

I am happy with detailed questions that Dr.Aijaz asked and am confident we will be on top of health.

Jun 2022

•

Verified SHC Patient

He is a great doctor. I am blessed to have him as my doctor.

May 2022

•

Verified SHC Patient

Excellent. Thank You ðŸ™ .

May 2022

•

Verified SHC Patient

Great doctor

May 2022

•

Verified SHC Patient

Thank you!

May 2022

•

Verified SHC Patient

Dr. Ahmed has always had my long-term best interests in mind and this latest visit continued that theme.

May 2022

•

Verified SHC Patient

Dr. Ahmed is thorough, friendly and makes sure I understand my status and follow-up plan. I left the appointment feeling assured.

Apr 2022

•

Verified SHC Patient

Very pleased with Dr. Ahmed. The quesion about how likely I would recommend him is not about him. I just don't recommend specific doctors (but I do recommend Stanford Health Care). That said, If someone asked me directly about Dr Ahmed, I would highly recommend him.

Apr 2022

•

Verified SHC Patient

The appointment was very informative, and Dr Ahmed was knowledgeable and provided a thorough review of my situation. I am most appreciative.

Apr 2022

•

Verified SHC Patient

Dr. Ahmed is excellent.

Apr 2022

•

Verified SHC Patient

Dr. Ahmed is very good in his own field, but like all other doctors, does not wish to discuss anything medical other than his own expertise.

Mar 2022

•

Verified SHC Patient

Great.

Mar 2022

•

Verified SHC Patient

He is excellent!

Mar 2022

•

Verified SHC Patient

He is very knowledgeable, repeated the instructions making sure my brother understood. Encouraged patient to keep up with the good nutrition.

Mar 2022

•

Verified SHC Patient

He's great

Mar 2022

•

Verified SHC Patient

I was really happy to get services from Dr. Aijaz Ahmed. He was through in covering all aspect of the symptoms. I would highly recommend him to others.

Feb 2022

•

Verified SHC Patient

Dr. Ahmed was polite and very forthcoming and realistic. I appreciate his honesty.

Jan 2022

•

Verified SHC Patient

He's a great caring doctor and doesn't just limit his questions and comments to my liver but keeps aware of any other health problems I might have.

Jan 2022

•

Verified SHC Patient

THANKS TO THE DOCTOR, ALL INQUIRIES WERE ANSWERED.

Dec 2021

•

Verified SHC Patient

He is easy to talk to and knows what he's talking about He explains everything and makes sure that you understand

Dec 2021

•

Verified SHC Patient

Excellent listener, caring and interested in my problem and questions.

Nov 2021

•

Verified SHC Patient

I really appreciate having Dr. Aijaz Ahmed as my liver doctor. He is a wonderful, caring and very knowledgeable physician.

Nov 2021

•

Verified SHC Patient

Dr Ahmed was very informative and I was very pleased that my case was being reviewed and possibly updated it to my diagnosis. I look forward to visiting the liver clinic in January for tests for my Pending liver transplant.

Nov 2021

•

Verified SHC Patient

Dr Ahmed, is smart, thorough, articulate and easy to understand. He spoke with easily understood explanations but did not talk down or make me feel ignorant. He is wonderful.

Nov 2021

•

Verified SHC Patient

It is always a pleasure to see Dr. Ahmed and my wife and I are forever grateful for his expertise.

Oct 2021

•

Verified SHC Patient

I THINK Aijaz Ahmed is a miracle worker. A FANTASTIC DOCTOR,AND A CARING HUMAN BEING. He is a True ANGEL. I HAVE BEEN BLESSED TO HAVE HIM AS MY DOCTOR. Thank You,forever.

Oct 2021

•

Verified SHC Patient

I am very happy every time I have an appointment with DR. Aijaz Ahmed through video visits from two years ago. Dr. Aijaz Ahmed has always mastered my health records and made comments about my health condition. Dr. Aijaz Ahmed also guided me through the preparations to get ready for a liver implant. I am extremely grateful and thank Dr. Aijaz Ahmed and his staff

Oct 2021

•

Verified SHC Patient

Thank you for the follow-up and for coordinating the lab work asap.

Oct 2021

•

Verified SHC Patient

He was very thorough and helpful.

Sep 2021

•

Verified SHC Patient

Seemed very experienced and knowledgeable. Had completed research regarding the issues I am concerned about prior to the video conference. Very professional.

Sep 2021

•

Verified SHC Patient

very professional and pleasant personality

Sep 2021

•

Verified SHC Patient

Very thorough, takes his time with you , answers all questions and follows up

Aug 2021

•

Verified SHC Patient

I have seen Dr. Ahmed since January 2005. He is kind, helpful and informative and I have recommended him to many people.

Aug 2021

•

Verified SHC Patient

I've been seeing him for 21 years or so, and, should I live so long, I'd be happy to see him for 21 more. (Miracles [rarely] happen!)

Aug 2021

•

Verified SHC Patient

Reliable

Aug 2021

•

Verified SHC Patient

He is always pleasant and personable. He answers all my questions and even provided me some additional information, via text. He carefully reviewed my medical status and advised me on continuation of labwork and medications, etc. After the visit I received a report on the visit, which was also promptly forwarded to my primary care doctor. I have been his patient for eight years and have received excellent care. I look forward to being his patient for many more years!

Aug 2021

•

Verified SHC Patient

I would to comment that he is an excellent Dr if it wasn't for him I might not be alive right now. I will forever be grateful to him.

Aug 2021

•

Verified SHC Patient

Dr. Ahmed is a very caring professional. Nice personality and bed-side manners.

Aug 2021

•

Verified SHC Patient

Dr. Ahmed was very personable and he took the time to understand what and how Iâ€™m doing and gave me a fair and clear assessment of my test results. His demeanor was very personal and I feel so good to have him as my doctor. I will continue to be in his care for my health issues.

Aug 2021

•

Verified SHC Patient

He is great. He puts everything into perspective, and that is encouraging. I appreciate the fact that he orders testing to monitor my situation but doesn't overdo it. He isn't overly aggressive but has found a treatment that works for me. Finally!!!

Aug 2021

•

Verified SHC Patient

Thank you for taken care of my mom health!

Jul 2021

•

Verified SHC Patient

No concern

Jun 2021

•

Verified SHC Patient

Dr. Ahmed answered my questions, not specifically in detail, but I understood what the end result of all the tests were and I am okay with that.

Jun 2021

•

Verified SHC Patient

Very professional and personable!

Jun 2021

•

Verified SHC Patient

He is a very good doctor and I have been seeing him since 2004. I would highly recommend him if asked.

Jun 2021

•

Verified SHC Patient

I am very appreciated this video visit with Dr. Aijaz Ahmed because : 1. He knew all details of my last MRI and CT scan 2. He explained clearly every questions that I asked him Thank you Dr. Aijaz Ahmed

Jun 2021

•

Verified SHC Patient

I like him. He seems caring, smart and someone I appreciate as my doctor.

Jun 2021

•

Verified SHC Patient

Would like to thank Dr Ahmed for his time and for answering all my questions

Jun 2021

•

Verified SHC Patient

Dr. Ahmed is an excellent, caring doctor.

Jun 2021

•

Verified SHC Patient

Very Good to visit with Dr. Ahmed.

Jun 2021

•

Verified SHC Patient

Dr. Ahmed provided amazing care for my yearly appt.

Jun 2021

•

Verified SHC Patient

Fantastic doctor!!

May 2021

•

Verified SHC Patient

good

Apr 2021

•

Verified SHC Patient

Very clear about expectations.

Apr 2021

•

Verified SHC Patient

Great

Sep 2019

•

Verified SHC Patient

Dr Ahmed is awesome.

Sep 2019

•

Verified SHC Patient

DR Amead is the most passionate brilliant dr I have ever had

Sep 2019

•

Verified SHC Patient

I appreciate everything Stanford Medical, doctors, assistants, all staff have done for me. Without Stanford, the doctors and staff I probably would not be here today.

Sep 2019

•

Verified SHC Patient

I feel like I am in good hands for the treatment of my health issue.

Aug 2019

•

Verified SHC Patient

Explained everything very well and gave me a plan to help my condition.

Aug 2019

•

Verified SHC Patient

All that I have been seen by so far have been very thorough explaining what they are testing for and what to expect for those tests.

Jul 2019

•

Verified SHC Patient

Dr. Ahmed is an excellent and very caring physician. I have full confidence in the care he provides.

Jul 2019

•

Verified SHC Patient

Dr. Ahmed is an excellent doctor and his PA are also the best.

Jun 2019

•

Verified SHC Patient

I was impressed with Dr. Ahmed's knowledge & expertise, but was informed this was a LIVER CLINIC & didn't relate to my symptoms. I would have liked to have had some type of other referral for my F/U.

Jun 2019

•

Verified SHC Patient

Very good.

Jun 2019

•

Verified SHC Patient

Very good!

May 2019

•

Verified SHC Patient

Very good.

Apr 2019

•

Verified SHC Patient

Doesn't get any better.

Feb 2019

•

Verified SHC Patient

Dr. Ahmed is one of the friendliest and most down to earth doctors at Stanford.

Dec 2018

•

Verified SHC Patient

Dr. Ahmed is the best!

Sep 2018

•

Verified SHC Patient

Very good.

Jun 2018

•

Verified SHC Patient

Excellent dr.

May 2018

•

Verified SHC Patient

Dr. Aijaz Ahmed is a true professional in every respect.

May 2018

•

Verified SHC Patient

Doctors and nurses are very friendly & helpful.

Apr 2018

•

Verified SHC Patient

Dr. A. Ahmed is great. He knows all the answers. He has saved my life.

Jan 2018

•

Verified SHC Patient

very please

Jan 2018

•

Verified SHC Patient

He saved my life!

Dec 2017

•

Verified SHC Patient

Dr. Ahmed is a great doctor, and the resident assisting him was very professional too

Dec 2017

•

Verified SHC Patient

Dr Ahmed is a great Doctor, appreciate having him in charge of my care

Nov 2017

•

Verified SHC Patient

Doctor & nurse made me feel very comfortable.

Nov 2017

•

Verified SHC Patient

Dr. Ahmed is one of the best. Very courteous, sensitive person. Always listens to what I have to say. Always makes me feel as thought I'm his only patient. I know that is not true, he is one of a kind!!

Nov 2017

•

Verified SHC Patient

Dr. Ahmed is outstanding in every aspect of his interaction with me.

Sep 2017

•

Verified SHC Patient

We had a hard reality to accept and Doctor Ahmed was so kind and patient.

Sep 2017

•

Verified SHC Patient

good

Jul 2017

•

Verified SHC Patient

Very good.

May 2017

•

Verified SHC Patient

Clear detail information; very caring. #1. Excellent.

Apr 2017

•

Verified SHC Patient

Dr Ahmed is really busy. Because he does not have time to spend with me, he said the nurse practitioners in and they do a great job.

Apr 2017

•

Verified SHC Patient

I feel most positive about Dr. Ahmed. he is knowledgeable, kind, warm and addressed my concerned and questions.

Mar 2017

•

Verified SHC Patient

Doctor is very knowledgeable, shares lots of information, takes sufficient time with patient (me) and is very professional.

Mar 2017

•

Verified SHC Patient

Dr. Aijaz Ahmed was wonderful in all respects. Could not ask for more. Thank you so much.

Feb 2017

•

Verified SHC Patient

I feel so blessed to have Dr. Ahmed as my physician. He treats me with such care-

Feb 2017

•

Verified SHC Patient

Dr Ahmed is phenomenal. He pays attention to my test results and always is on top of any tests that need to be done

Feb 2017

•

Verified SHC Patient

Dr. Ahmed is wonderfully compassionate and knowledgeable!! I'm so thankful that he's my doctor!!

Jan 2017

•

Verified SHC Patient

I understand that Stanford is teaching hospital. but my doctor seemed rushed and only spent 6-7 min with me. I spent more time with his new resident than me. he said we talking about u in hallway but didn't answer when I said as to what/ about.

Dec 2016

•

Verified SHC Patient

Good.

Dec 2016

•

Verified SHC Patient

Dr. Ahmed is a wonderful/caring/knowledgeable physician!!!

Nov 2016

•

Verified SHC Patient

Dr Ahmed is an excellent Doctor

Sep 2016

•

Verified SHC Patient

Dr. Ahmed is excellent!

Sep 2016

•

Verified SHC Patient

Dr Ahmed is outstanding in every way...

Aug 2016

•

Verified SHC Patient

excellent

Jul 2016

•

Verified SHC Patient

Very informed doctor, takes personal interest in concerns, updates on research.

Jul 2016

•

Verified SHC Patient

My provider is very thorough and clear about my medications, follow-up, the explanation about my medical care is done with compassion. My provider calls about my medical condition.

Jul 2016

•

Verified SHC Patient

Dr. Ahmed is amazing - straight forward, direct, no overkill! He is knowledgeable in his area and does not prescribe things that are not absolutely needed.

Apr 2016

•

Verified SHC Patient

My relationship with my doctor has improved a lot.

Apr 2016

•

Verified SHC Patient

I can't say enough good things about Dr. Ahmed, I bless the day I met him.

Apr 2016

•

Verified SHC Patient

Doctor Ahmed took time asking questions concerning my health & medications. Just recently losing my mother he had some very nice touching words that really stuck w/me for personalized what was happening in my life w/his very thoughtful moment.

Mar 2016

•

Verified SHC Patient

Dr. Ahmed is an expert and I value his opinion and trust the doctor completely.

Mar 2016

•

Verified SHC Patient

Dr. Ahmed and his staff have provided care "above and beyond"! Don't think I've EVER had a doctor so willing to spend the time to answer my questions.

Feb 2016

•

Verified SHC Patient

Dr. Ahmed has been amazing! He's always very friendly, positive, and helps me feel more empowered about my health. I'm very impressed!

Feb 2016

•

Verified SHC Patient

Good.

Feb 2016

•

Verified SHC Patient

Dr. Ahmed is the very best. I appreciate his care and expertise.

Feb 2016

•

Verified SHC Patient

The only reason I came to Stanford Hospital is because I like my doctor.

Feb 2016

•

Verified SHC Patient

Very knowledgeable doctor. Easy to talk to & patient.

Jan 2016

•

Verified SHC Patient

All Good

Jan 2016

•

Verified SHC Patient

I feel very confident in my doctor. He answers my questions and really listens to my concerns. I trust him.

Dec 2015

•

Verified SHC Patient

Very good.

Nov 2015

•

Verified SHC Patient

Dr. Ahmed is the best. It has been almost 20 years.

Nov 2015

•

Verified SHC Patient

Dr. Ahmed is outstanding and well informed regarding new research. His PhD fellow was well versed re: my history.

Nov 2015

•

Verified SHC Patient

Very good.

Nov 2015

•

Verified SHC Patient

We felt that Dr. Ahmed really CARED. I was not impressed with the "fellowship" person that spoke with us before.

Nov 2015

•

Verified SHC Patient

always excellent.

Nov 2015

•

Verified SHC Patient

All is very good

Oct 2015

•

Verified SHC Patient

Good knowing he's education history and glad I'm part of his team.

Sep 2015

•

Verified SHC Patient

Good -

Jun 2015

•

Verified SHC Patient

Doctor Ahmed is a most excellent doctor, and therefore is solidly booked to see many patients in the near future.

Jun 2015

•

Verified SHC Patient

Dr. Ahmed is truly an expert medical professional, and I'm very fortunate to have the Doctor as my physician. I trust Dr. Ahmed immensely and he makes me feel safe and provides outstanding care for both my physical and mental wellbeing.

Apr 2015

•

Verified SHC Patient

Follow up care for labs was frustrating. I got follow up care instructions to get labs done outside of facility but, when I called for these orders the nurse said that the doctor would not provide them. No explanation for this was given other than that was what he said.

Mar 2015

•

Verified SHC Patient

Doctor Aijaz Ahmed is the very BEST!!! I depend on his knowledge and expertise that enables me to make good choices regarding my health. I rely upon him to make decisions regarding my health that best affects me.

Mar 2015

•

Verified SHC Patient

Dr. Ahmed is an exceptional doctor and I admire his expertise very much.

Mar 2015

•

Verified SHC Patient

A dr. trainee came in before Dr. Ahmed & explained my condition to me.

Feb 2015

•

Verified SHC Patient

Dr. Ahmed said I have "fatty liver." Other than telling me to lose weight, he gave me no info about this diagnosis.

Feb 2015

•

Verified SHC Patient

Dr. Ahmed has always been wonderful. He explains things, well, knows my case and really makes me feel like he's in my corner.

Jan 2015

•

Verified SHC Patient

Dr. Ahmed is the best specialist you could ask for.

Nov 2014

•

Verified SHC Patient

I came to see Dr. Ahmed because of new cure for Hep C. He was not only informative, but gave me explanations on different meds & how they would affect me in particular, etc.

Nov 2014

•

Verified SHC Patient

No problems!

Oct 2014

•

Verified SHC Patient

This was my first visit to Stanford.

Oct 2014

•

Verified SHC Patient

Dr. Ahmed is an expert and his care is outstanding. I always enjoy my time with Dr. Ahmed.

Sep 2014

•

Verified SHC Patient

Good.

Jun 2014

•

Verified SHC Patient

Always has been good.

Jun 2014

•

Verified SHC Patient

Drove 450 miles to see my doctor and nothing was done at my appointment waste of time, someone should have called me.

Jun 2014

•

Verified SHC Patient

Dr. Ahmed is the best dr. I have treating my healthcare needs.

Feb 2014

•

Verified SHC Patient

Like Dr. Keefe before him, Dr. Ahmed is a superb doctor, good friend.

Jan 2014

•

Verified SHC Patient

Doctor seemed to be in a hurry.

Dec 2013

•

Verified SHC Patient

I asked three questions, I also wrote them down. Possibly we needed more info from lab work to answer. Also, I wrote down & said my meds presently being taken. My health report on-line is wrong.

Dec 2013

•

Verified SHC Patient

Referring Physicians

PHYSICIAN HELPLINE

Phone: 1-866-742-4811
Fax: 650-320-9443
Monday–Friday, 8 a.m.–5 p.m.

Stanford Health Care provides comprehensive services to refer and track patients, as well as the latest information and news for physicians and office staff. For help with all referral needs and questions, visit Referral Information.

You may also submit a web referral or complete a referral form and fax it to 650-320-9443 or email the Referral Center at ReferralCenter@stanfordhealthcare.org.

Send referrals online
Place radiology and lab orders
View referral status
Access medical records

Learn More About MedLink

LOG INTO MEDLINK

New to MyHealth?

ALREADY HAVE AN ACCESS CODE?

DON'T HAVE AN ACCESS CODE?

NEED MORE DETAILS?

MyHealth for Mobile

WELCOME BACK

Aijaz Ahmed, MD

Hepatologist, Transplant hepatologist

Get In Touch

Biography

Professional Summary

Education & Certifications

Administrative Appointments

Publications

Clinical Trials

Specializing In

Practice Locations

Advanced Endoscopy in Palo Alto Stanford, CA

Advanced Endoscopy in Palo Alto

Liver Transplant Program in Santa Maria Santa Maria, CA

Liver Transplant Program in Santa Maria

Liver Transplant Program in Reno, 655 Sierra Rose Drive Reno, NV

Liver Transplant Program in Reno, 655 Sierra Rose Drive

Liver Transplant Program in Henderson Henderson, NV

Liver Transplant Program in Henderson

Liver Transplant Program in Reno, 880 Ryland Street Reno, NV

Liver Transplant Program in Reno, 880 Ryland Street

Liver Transplant Clinic in Pleasanton Pleasanton, CA

Liver Transplant Clinic in Pleasanton

Digestive Health Center in Palo Alto (Endoscopy Suite) Stanford, CA

Digestive Health Center in Palo Alto (Endoscopy Suite)

Liver (Hepatology) Clinic in Redwood City Redwood City, CA

Liver (Hepatology) Clinic in Redwood City

Digestive Health Center in Redwood City Redwood City, CA

Digestive Health Center in Redwood City

Digestive Health Center in Redwood City (Endoscopy Suite) Redwood City, CA

Digestive Health Center in Redwood City (Endoscopy Suite)

General Endoscopy Redwood City, CA

General Endoscopy

Liver Transplant Program in Fresno Fresno, CA

Liver Transplant Program in Fresno

Liver Transplant Program in San Luis Obispo San Luis Obispo, CA

Liver Transplant Program in San Luis Obispo

Liver Transplant Program in Templeton Templeton, CA

Liver Transplant Program in Templeton

Important Information about Our Organizations and Physician Affiliation

Patient Ratings

How Our Ratings Work

Patient Reviews

(229 reviews)

Referring Physicians

PHYSICIAN HELPLINE